ISIE Imaging Conference
Transcription
ISIE Imaging Conference
ISIE Imaging Conference Saturday, May 3, 2014 8:30-5:30 pm Orlando, Florida Orange County Convention Center, South Building Paper Sessions S 310A - D Posters & Exhibits S 310E - H Table of Contents Program Organizers/Committee.............................................................................................1 Program Information................................................................................................................3 Conflict of Interest Disclosures…............................................................................................5 Agenda .......................................................................................................................................7 Presentations Retinal Imaging........................................................................................................................19 Functional Retinal Imaging…………………………………………………………………31 Glaucoma / Anterior Eye……………………………………………………………………43 Novel methods for Small Animal Imaging………………………………………………..58 Posters...................................................................................................................................68 Program Organizers James G. Fujimoto, PhD Dept. of Electrical Engineering & Computer Science Massachusetts Inst of Technology Cambridge, Mass. Joel S. Schuman, MD, FARVO UPMC Eye Center/Univ of Pittsburgh Pittsburgh, Penn. Wolfgang Drexler, PhD Center for Medical Physics & Biomedical Engineering Medical University Vienna Vienna, Austria Program Committee Members Bruce Berkowitz, PhD, FARVO Anatomy/Cell Biology & Ophthalmology Wayne State University School of Medicine Joachim Hornegger, PhD Pattern Recognition Laboratory Friedrich-Alexander University Erlangen-Nuremberg Joseph Carroll, PhD Medical College of Wisconsin Milwaukee, Wisc. Joseph A. Izatt, PhD Biomedical Engineering Dept Duke University Brad Fortune, OD, PhD Discoveries in Sight Research Laboratories Legacy Research Institute Devers Eye Institute Jost Jonas, MD, FARVO Faculty of Clinical Medicine Heidelberg University Giovanni Gregori, PhD U Miami Bascom Palmer Eye Institute Fabrice Manns, PhD Ophthalmic Biophysics Center Bascom Palmer Eye Institute 1 Ronald Silverman, PhD Columbia University Medical Center Richard Spaide, MD Vitreous Retina Macula Consultants NY Susan Vitale, PhD, FARVO Division of Epidemiology & Clinical Applications National Eye Inst/NIH John S. Werner, PhD, FARVO Dept. of Ophthalmology University of California Davis Medical Center Yoshiaki Yasuno, PhD Institute of Applied Physics University of Tsukuba Linda M. Zangwill, PhD, FARVO Shiley Eye Center University of California‐San Diego 2 Program information Optical imaging is a noninvasive, non-contact technology that can image ocular structures in vivo. The anatomic layers of the eye can be differentiated and measured, by some technologies at a cellular or subcellular level. The resulting images can be extremely useful in basic understanding of disease and its pathogenesis, normal physiology and the diagnosis and follow-up of diseases affecting the eye, including glaucoma and age-related macular degeneration. Unfortunately, knowledge on imaging technologies is limited and evolving. Needs for this course are based on recent literature and expert opinion. Participants can expect to be exposed to the most up-to-date information regarding ocular imaging and its applications. The objective of the course is to enhance competence in this field and to advance the science of imaging. Clinical practice will improve through the implementation of strategies defined in this session. Course Format The ARVO/ISIE Imaging conference is a forum for the presentation of current clinical and basic science advances in glaucoma, retina, cornea, anterior segment, orbit and neuro-imaging in ophthalmology. Didactic paper presentations will be followed by poster presentations. Course Highlights This is your chance to hear original research on current advances, as well as state-of-the-art technology in ophthalmic imaging. This critical and informative research will help you further your practice and better care for your patients. Learn scientific principles behind ophthalmic imaging Discuss clinical applications of imaging technologies Explore new research and recent advances in imaging Who Should Attend Clinicians Scientists Engineers Regulators Learning Objectives Upon completion of this educational activity, participants will be able to: Review new advances in ophthalmic imaging Describe clinical applications of imaging technologies in ophthalmology Explain the importance of ophthalmic imaging Discuss imaging in glaucoma, retinal disease, corneal pathologies and neuro-ophthalmology 3 Disclosure Policy It is the policy of ARVO to ensure balance, independent objectivity, and scientific rigor in all its sponsored educational programs. All faculty and planning committee members participating in continuing medical education activities are required to disclose to the program audience any real or apparent conflict of interest related to the content of their presentations. In accordance with the ACCME's Standards for Commercial Support of Continuing Medical Education, all faculty and planning committee members must disclose any relevant financial relationship(s) or other relationship(s) held within the past 12 months. ARVO implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. Disclaimer ARVO Education Courses provide a forum for the open exchange and discussion of research results and scientific advancements in the field of ophthalmology; however, ARVO makes no representation or warranty as to the truth, originality, or accuracy of the information presented at the courses or in materials distributed in connection with them. Nor are the views expressed by the individual speakers necessarily the views of ARVO. ARVO supports the ACCME’s policy on evidence-based content and encourages faculty to adhere to these standards when planning a presentation. Audio and Video Recording of Sessions/Workshops Recording by any means (photographing, audiotaping or videotaping) of any presentations or sessions at any ARVO Meeting is prohibited, except by an ARVO-authorized agent for official purposes or by First Authors who wish to photograph their own poster presentations. Violators risk confiscation of their equipment and/or dismissal from the meeting as deemed appropriate by ARVO. Certificate of Attendance Certificates of Attendance are available to all participants. Attendees must complete an online evaluation form to receive a Certificate of Attendance. Attendees who preregistered for the conference by Monday, April 28, 2014, can submit the evaluation upon completion of the course. All others may access the system beginning Wednesday, May 14, 2014. http://www.planion.com/Web.Admin/Login?Account=ARVO. Use your ARVO ID and Password, or click “forgot your password” to log in. Select and evaluate the course you attended, then print or email your Certificate of Attendance. This activity does not offer AMA PRA Category 1 Credits™. 4 Financial Relationships Disclosures It is the policy of the ARVO that all faculty and planning partners disclose conflicts of interests relating to the topics of this educational activity. Faculty members and the planning committee are required to disclose to the learners any relevant financial relationship(s). ARVO considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner, or a dependent child. The following faculty members have stated they have no financial relationships to disclose. Bruce Berkowitz, PhD Joseph Carroll, PhD John S. Werner, PhD Susan Vitale, PhD The following faculty members have stated their financial relationship(s): Wolfgang Drexler, PhD- Zeiss (C) Brad Fortune, OD, PhD- Heidelberg Engineering, GmbH, Carl Zeiss Meditec, Inc (F) James Fujimoto, PhD- Carl Zeiss Meditec, Optovue (P); Optovue (I) Giovannni Gregori, PhD- Carl Zeiss Meditec (F), (P) Joachim Hornegger- Optovue Inc. (P) Joseph Izatt- Bioptigen, Inc. (I), (P), (S) Jost Jonas, MD- Allergan Inc., Merck Sharp & Dohme Co, Alimera Co, Boehringer Ingelheim Co, Sanofi Co (C), CellMed AG, Alzenau, Germany (P) Fabrice Manns, PhD- Bioptigen (F)(P) Joel S. Schuman, MD- Carl Zeiss Meditec (P) Ronald Silverman, PhD- Arcscan, Inc. (I) Rick Spaide, MD- Topcon (P)(C); TEVA Pharmaceuticals (C) Yoshiaki Yasuno- Topcon Corp. (F); Tomey Corp. (F), (P); Nidek (F) Linda Zangwill, PhD- Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc, Topcon Medical Systems, Nidek Inc (F) Financial Relationships Disclosure Codes Key: F (Financial Support) Indicates if you have received through your employing institution support from a for-profit company, or competing company, in the form of research funding, grants or research materials or services (e.g., protein sequencing) at no cost, such support being the subject matter of your presentation or publication. I (Personal Financial Interest) Indicates if you are an investor in a company or competing company, other than through a mutual or retirement fund, which provides a product, service, process or equipment that is the subject matter of your presentation or publication. 5 E (Employment) Indicates if you are an employee of a company or competing company with a business interest that is the subject matter of your presentation or publication. C (Consultant) Indicates if you are, or have been within the last 24 months prior to date of submission, a consultant for a company or competing company with a business interest that is the subject matter of your presentation or publication. P (Patent) Indicates if you are an inventor/developer designated on a patent, patent application, copyright, or trade secret, whether or not the patent, copyright, etc. is presently licensed or otherwise commercialized, which is the subject matter of your presentation or publication or could be in competition with the technology described. R (Recipient) Indicates if you have received gifts in kind, honoraria or travel reimbursement valued in any amount in the last twelve months from a company or competing company which provides a product, service, process or equipment that is the subject matter of your presentation or publication. N (No Commercial Relationship) Indicates there is no commercial relationship relevant to the subject matter of the abstract/article/presentation. S (non-remunerative) Indicates you have position(s) of influence such as officer, board member, trustee, spokesperson, etc. 6 ISIE Imaging Conference Saturday, May 3, 2014 Orlando, Florida Orange County Convention Center, South Building Paper Sessions S 310A - D 8:00am – 5:30pm Posters & Exhibits S 310E - H 8:00am – 4:00pm Poster Presentations: 10:00-10:30am, 12:00-1:30pm, 3:30-4:00pm Conference Agenda 7:00 am Registration 7:50 am Opening Remarks 8:00 - 10:00 am Retinal Imaging Moderator(s): James Fujimoto, PhD; Wolfgang Drexler, PhD; Joel Schuman, MD 8:00 -08:15 am Program Number 1: Improved Visualization of the Vitreous using Swept Source Optical Coherence Tomography with Dynamic Focus Sweeping Richard Spaide, Charles Reisman , Zhengo Wang, Kinpui Chan 7 08:15 -08:30 am Program Number 2: Choroidal, Haller’s and Sattler’s thickness analysis across different age related macular degeneration phenotypes imaged with 3D-1060nm-OCT Marieh Esmaeelpour, Siamak Ansari-Shahrezaei, Behrooz Zabihian, Martin F Kraus, Maximilian Gabriel, Ilse Krebs, Joachim Hornegger, Carl Glittenberg, Wolfgang Drexler, Susanne Binder 08:30 -08:45 am Program Number 3: Effects of optical opacity on retinal cone counts measured by a narrow angle Heidelberg Retina Angiograph Roger Anderson, Marketa Cilkova, Padraig Mulholland, Juliane Matlach, Nilpa Shah, Tony Redmond, David Garway-Heath, Steven Dakin 08:45 -09:00 am Program Number 4: Autofluorescent droplets in the sub-Retinal Pigment Epithelium (RPE)-space of eyes with age-related macular degeneration (AMD): ex vivo imaging Thomas Ach, Christine A. Curcio 09:00 -09:15 am Program Number 5: High resolution imaging of Gunn’s dots Michel Paques, Edouard Koch, Celine Chaumette, Alexandre Leseigneur 09:15 -09:30 am Program Number 6: Detection of Retinal Blood Flow Turbulence at Arteriovenous Crossings using Spectral Domain Optical Coherence Tomography Michael Larsen 9:30 -09:45 am Program Number 7: Ganglion Cell Analysis using High-Definition Optical Coherence Tomography in Patients with mild cognitive impairment and Alzheimer’s Disease Carol Y. Cheung, Yiting Ong, M. Kamran Ikram, Christopher Chan, Tien Yin Wong 09:45 -10:00 am Program Number 8: Automatic Analysis of Color Retinal Images for CMV Retinitis Screening Sandeep Bhat, Chaithanya Ramachandra, Todd P. Margolis, Jeremy Keenan, Kaushal Solanki 10:00-10:30 am Break and Posters/Exhibits 10:30 - 12:00 pm Functional Retinal Imaging Moderator(s): Wolfgang Drexler, PhD; Richard Spaide, MD 8 10:30-10:45 am Program Number 9: Optical Coherence Tomography Angiography of Macular Disease David Huang, Yali Jia, Steven T. Bailey, Thomas Hwang, Andreas K. Lauer, Christina J. Flaxel, Mark E. Pennesi, David J. Wilson, Joachim Hornegger, James G. Fujimoto 10:45-11:00 am Program Number 10: En Face Visualization of Retinal Pathologies Using Ultrahigh Speed Swept Source Optical Coherence Tomography Woo Jhon Choi, Mehreen Adhi, Eric Moult, ByungKun Lee, Zhao Wang, Martin F. Kraus, Jay S. Duker, Joachim Hornegger, James G. Fujimoto, Nadia K. Waheed 11:00-11:15 am Program Number 11: Quantitative Insights into Macular Microvascularity using Adaptive Optics Scanning Light Ophthalmoscopy Fluorescein Angiography Richard Rosen, Alexander Pinhas, Moataz Razeen, Nishit Shah, Alexander Gan, Richard Bavier, Rishard Weitz, Joseph Carroll, Alfredo Dubra, Yuen Ping T. Chui 11:15-11:30 am Program Number 12: Quantification of Absolute Number of Photoreceptors from Ultra-Widefield Imaging Daniel E. Croft, Charles C. Wykoff, David M. Brown, Jano VanHemert 11:30-11:45 am Program Number 13: Parafoveal cone hyporeflectivity and recovery seen by adaptive optics in posterior uveitis Phoebe Lin, Kristin Biggee, Michael Gale, Eric Suhler, Mark Pennesi 11:45-12:00 pm Program Number 14: Total Retinal Blood Flow Measurement with 70k Hz Spectral Domain OCT Ou Tan, Gangjun Liu, Yali Jia, David Huang 12:00-1:30 pm Lunch and Posters/Exhibits 1:30 - 3:30 pm Glaucoma / Anterior Eye Moderator(s): Brad Fortune, PhD; Susan Vitale, PhD 1:30-1:45 pm Program Number 15: Evaluation of the Spatial Relationship Between Glaucoma Progression using Confocal Scanning Laser Ophthalmoscopy (CSLO), Optical Coherence Tomography (OCT), and Visual Field (VF) Dingle Foote, Gadi Wollstein, Divya Narendra, Yun Ling, Richard A. Bilonick, Hiroshi Ishikawa, Larry Kagemann, Cynthia Mattox, James G. Fujimoto, Joel S. Schuman 9 1:45-2:00 pm Program Number 16: Identification of Glaucoma using Biomarkers of Retinal Vascular Morphology and Blood Flow Computed from Retinal Fundus Images David Meadows, Rick Clark, Daniel Dickrell 2:00-2:15 pm Program Number 17: Measurement of BMO plan-based anterior lamina cribrosa surface depth (ALCSD) parameter using a deconvolution approach applied to 3D spectral domain optical coherence tomography optic nerve head images Akram Belghith, Christopher Bowd, Zhiyong Yang, Felipe Medeiros, Robert N. Weinreb, Linda M. Zangwill 2:15-2:30 pm Program Number 18: Magic Angle-Enhanced MRI of Fibrous Structures in the Eye upon Intraocular Pressure Loading Leon C. Ho, Ian A. Sigal, Ning-Jiun Jan, Alexander Squires, Zion Tse, Ed X. Wu, Seong-Gi Kim, Joel S. Schuman, Kevin C. Chan 2:30-2:45 pm Program Number 19: Accuracy of a Method for Measuring MicronScale Collagen Fiber Orientation Ning-Jiun Jan, Jonathan L. Grimm, Bo Wang, Kira Lathrop, Huong Tran, Gadi Wollstein, Larry Kagemann, Hiroshi Ishikawa, Joel Schuman, Ian A. Sigal 2:45-3:00 pm Program Number 20: Automated identification of Schlemm’s canal and collector channels from spectral domain optical coherence tomography images. Siamak Yousefi, Amir Marvasti, Robert N. Weinreb, Christopher Bowd, Alex Huang 3:00-3:15 pm Program Number 21: Functional Microvascular Imaging of the Conjunctiva: a noninvasive tool to measure and quantify subtle variations and abnormalities in the microvasculature Delia Cabrera DeBuc, Hong Jiang, Nicole Stuebiger, Che Liu, Tian Jing, Gabor Mark Somfai, Janet Davis, William E. Smiddy, Jianhua Wang 3:15-3:30 pm Program Number 22: Ultra-High Resolution Optical Coherence Tomography for the Differentiation of Ocular Surface Squamous Neoplasia and Melanoma Juan Murillo, Anat Galor, Afshan A. Nanji, Madhura G. Joag, James R. Wong, Nabeel M. Shalabi, Marwan Atallah, Ibrahim Sayed-Ahmed, Carol L. Karp 3:30-4:00 pm Break and Posters/Exhibits 10 4:00 - 5:30 pm Novel Methods for Small Animal Imaging Richard Rosen, MD; Moderator(s): Yoshiaki Yasuno, PhD 4:00-4:15 pm Program Number 23: Two-photon imaging of inner and outer retina in the living primate eye Robin Sharma, David R. Williams, Grazyna Palczewska, Krzysztof Palczewski, Jennifer Hunter 4:15-4:30 pm Program Number 24: 3D-imaging of Rat Retina Using Contrast Enhanced X-ray Microtomography Kalle Lehto, Ilmari Tamminen, Soile Nymark, Tanja Ilmarinen, Hannu Uusitalo, Heli Skottman, Antti Aula, Jari Hyttinen 4:30-4:45 pm Program Number 25: The Influence of Metabolism on Retinal OCT Imaging: What We've Learned from a Hibernating Animal Model Brent A. Bell, Yichao Li, Fengyu Qiao, Haohua Qian, Joe G. Hollyfield, Wei Li 4:45-5:00 pm Program Number 26: Spatial relationship between retinal loss and neurodegeneration of the visual system using optical coherence tomography (OCT) and diffusion tensor MR imaging (DTI) Bo Wang, Leon C. Ho, Ian P. Conner, Richard A. Bilonick, Hiroshi Ishikawa, Amanda Woodside, Chieh-Li Chen, Gadi Wollstein, Joel S. Schuman, Kevin C. Chan Program Number 27: Engineering of Gold Nanorods for ContrastEnhanced Retinal OCT Andrew Gordon, Jason Craft, Ashwath Jayagopal 5:00-5:15 pm 5:15-5:30 pm Program Number 28: The Effect of Microtubule-stabilizing Agents on the Retinal Ganglion Cell Axons Studied by Second-Harmonic Generation Microscopy Hyungsik Lim, John Danias 11 Poster Presentations 10:00 - 10:30 am 12:00 - 1:30 pm 3:30 - 4:30 pm Poster Presentations Poster Board Number P1: Applications of photoacoustic tomography to imaging and estimation of oxygen saturation of hemoglobin in ocular tissue of rabbits K.Chan; Z. Tse; T.B. Pirkle; A. Squires; N. Jan; G. Wollstein; J. Schuman; S. Kim; I.A. Sigal Poster Board Number P2: Quantitative MRI-derived optic nerve microstructural features in a feline glaucoma model Gillian J. McLellan, Samuel A. Hurley, Pouria Mossahebi, Norman M. Ellinwood, Aaron S. Field Poster Board Number P3: Analysis of the Cellular Dynamics of LysM-Positive Cells in a Corneal Suture Mouse Model using Intravital Imaging Mayumi Ueta, Ayaka Koga, Masaru Ishii, Shigeru Kinoshita Poster Board Number P4: Optical coherence tomography imaging to assist the iMvalv prototype development. Rodrigo M. Torres, Diego Ramirez Arduh, Fabio A. Guarnieri Poster Board Number P5: MRI, CT, and UBM imaging after corneal and cataract surgery Sotiria Palioura, James Chodosh, Lois Hart, Karen Capaccioli, Daniel Ginat, Suzanne Freitag Poster Board Number P6: Rates of Glaucoma Progression as Detected by Optical Coherence Tomography (OCT) and Heidelberg Retinal Tomography (HRT) in a Long-Term Cohort Divya Narendra, Gadi Wollstein, Dingle Foote, Yun Ling, Richard A. Bilonick, Hiroshi Ishikawa, Larry Kagemann, Cynthia Mattox, James G. Fujimoto, Joel S. Schuman Poster Board Number P7: Estimation of Trabecular Meshwork Thickness by Area and Width Measurements Larry Kagemann, Hiroshi Ishikawa, Gadi Wollstein, Bo Wang, Yun Ling, Richard A. Bilonick, Joel S. Schuman 12 Poster Board Number P8: Predicting Future Observations of Functional and Structural Measurements in Glaucoma Using a Two-Dimensional State-based Progression Model Yu-Ying Liu, Hiroshi Ishikawa, Gadi Wollstein, Richard A. Bilonick, James G. Fujimoto, Cynthia Mattox, Jay S. Duker, Joel S. Schuman, James M. Rehg Poster Board Number P9: Assessment of retinal nerve fiber layer with color and red free images using Smartscope Fundus Camera Ramesh S Ve, Krithica Srinivasan Poster Board Number 10: Confocal microscopy for the analysis of the sub-basal corneal nerves Madhura G. Joag, Anat Galor, Nabeel M. Shalabi, James R. Wong, Juan Murillo, Afshan A. Nanji, Marwan Atallah, Parke Green, Mauro Campigotto, Carol L. Karp Poster Board Number 11: Role of Ultra High Resolution Optical Coherence Tomography (UHR-OCT) in the Diagnosis of Ocular Surface Squamous Neoplasia (OSSN) in Complex Ocular Surface Diseases Marwan Atallah, Guillermo Amescua, Anat Galor, Juan Murillo, Madhura G. Joag, James R. Wong, Nabeel M. Shalabi, Afshan A. Nanji, Carol L. Karp Poster Board Number 12: Noncontact direct observation of the human cornea by in vivo confocal microscopy with a high-power objective lens Kaori Ideguchi, Eriko Abe, Taiichiro Chikama, Yuko Kadohiro, Takashi Sone, Ryotaro Toda, Sosuke Inokawa, Yoshiaki Kiuchi Poster Board Number P13 Analysis of the cornea densitometry using Pentacan with different illuminance Fernando Abib, Mariele A. Maximo, Andre Heck Poster Board Number P14: OptoVue OCT as an imaging modality of scleral thickness following fluocinolone acetonide implant Kristin Biggee, Nicholas Schubach, Eric Suhler, Christina J. Flaxel Poster Board Number P15: Posterior capsular opacification in intraocular hydrophilic lenses compared to hydrophobic intraocular lenses using Scheimpflug images Arturo Olguin-Manriquez, Efrain Romo-Garcia, David Magana 13 Poster Board Number P16: Morphologic Changes In Angle Closure Glaucoma After Iridotomies Documented by Ultrabiomicroscopy Efrain Romo-Garcia, Nicolas Corona-Osuna, Silvia Lizarraga, David Magaña, arturo OlguinManriquez, Miguel Piña, Felipe Esquivel, Arturo Ramirez-Mondragon, Felipe Peraza-Garay Poster Board Number P17: Ocular Surface Health In Patients With Rheumatoid Arthritis In India Ramya Ravindran Poster Board Number P18: Improving the processing and analysis workflow of adaptive optics retinal imaging Benjamin Sajdak, Robert F. Cooper, Kathleen Bazan, Brian Higgins, Drew Scoles, Melissa Wilk, Alfredo Dubra, Joseph Carroll Poster Board Number P19: Clinical Assessment and Single Cell imaging in Unexplained Vision Loss Philip Severn, Adam M Dubis, Robert F. Cooper, Joseph Carroll, Alfredo Dubra, Ganeshan K Ramsamy, Fred W Fitzke, Gary Rubin, Cathy Egan, Michel Michaelides Poster Board Number P20: High-resolution En face images of microcystic macular edema in patients with autosomal dominant optic atrophy Shuhei Kameya, Kiyoko Gocho, Sachiko Kikuchi, Kei Shinoda, Atsushi Mizota, Kunihiko Yamaki, Hiroshi Takahashi Poster Board Number P21: Magnetic resonance imaging findings of the subretinal space in bilateral congenital retinal detachments in Norrie’s syndrome Rocio I. Diaz, Eric J. Sigler, Asim F. Choudhri, Jorge I. Calzada Poster Board Number P22: Fluorescence Lifetime Measurement in Central Artery Occlusion Chantal Dysli, Sebastian Wolf, Martin S. Zinkernagel Poster Board Number P23: Brownian Motion Imaging With Optical Coherence Tomography and Optical Coherence Tomography Angiography Gangjun Liu, Yan Li, Yali Jia, David Huang Poster Board Number P24: Histogram Matching Extends Acceptable Signal Strength (SS) Range on Optical Coherence Tomography (OCT) Images Chieh-Li Chen, Hiroshi Ishikawa, Gadi Wollstein, Richard A. Bilonick, Ian A. Sigal, Larry Kagemann, JoelS.Schuman 14 Poster Board Number P25: Effect of Scanning Incident Angle (IA) on Total Retinal Thickness (TRT) Measurement With A Phantom Eye Using Spectral-Domain Optical Coherence Tomography (SD-OCT) Hiroshi Ishikawa, Chieh-Li Chen, Jigesh Baxi, Anant Agrawal, Daniel X. Hammer, Gadi Wollstein, Richard A. Bilonick, Ian A. Sigal, Larry Kagemann, Joel S. Schuman Poster Board Number P26: Modeling the topography of the healthy human retina Rui Bernardes, Silvia Simão, Ana S. C.Silva, Angelina Meireles, João Figueira Poster Board Number P27: Preliminary evaluation of a prototype metabolic hyperspectral retinal camera in age related macular degeneration patients Jean-Philippe Sylvestre, Rachel Trussart, Jean Daniel Arbour Poster Board Number P28: Quantitative autofluorescence (qAF) in pseudophakic normal and dry Age-related macular degeneration (AMD) patients Camellia Nabati, Jonathan Greenberg, Dan Yoon, Elana Rosenberg, David Sackel, Roland Smith Poster Board Number P29: Comparison of Fundus Autofluorescence Imaging by 488 nm and 532 nm Confocal Scanning Laser Ophthalmoscopy in Central Serous Chorioretinopathy Seong-Woo Kim, Jaeryung Oh, Cheol Min Yun, Kuhl Huh Poster Board Number P30: Cone photopigment distribution measured using green autofluorescence imaging Kanako Itagaki, Kimihiro Imaizumi, Akira Ojima, Tetsuju Sekiryu Poster Board Number P31: Fundus Autofluorescence to Identify Plaques and Diagnose and Follow Retinal Artery Occlusions Yannis M. Paulus, Aazim Siddiqui, Adrienne W. Scott Poster Board Number P32: Infrared and Fundus Autofluorescence Imaging in the Evaluation and Monitoring of Peripheral Retinoschisis Timothy Kao, Sandra R. Montezuma, Dara Koozekanani, Philip Turner, Torey Miller Poster Board Number P33: False Negatives in the Delineation of Age-related Geographic Atrophy by Fundus Autofluorescence David J. Ramsey, Carol Applegate, Janet S. Sunness 15 Poster Board Number P34: Inexpensive 3D Telemedicine: Integrating smartphone technologies in an ophthalmological stereoscopic evaluation Jorge-Emmanuel Morales-León Poster Board Number P35: Fundus mask and lens dust detection in retinal images with applications to automated diabetic retinopathy screening Kaushal Solanki, Malavika Bhaskaranand Poster Board Number P36: Non mydriatic hand held camera -An effective screening tool for diabetic population in hands of paramedical health workers. Sundaram Natarajan, Purva Valvekar, Deepen Sheth, Sunita Mohan, Radhika Krishnan, Pandurang Kulkarni Poster Board Number P37: Hand-held non-mydriatic digital fundus imaging for the detection of diabetic retinopathy Steven R. Cohen, Grace E. Boynton, Cagri G. Besirli, Maria A. Woodward, Paula Anne Newman-Casey Poster Board Number P38: Can Heidelberg MultiColor images be used interchangeably with color fundus photography for grading age-related macular degeneration features? Katie Graham, Patrick Larkin, Katherine Alyson Muldrew, Vittorio Silvestri, Graham Young, Philip McIntyre, Helen McAtamney, Ruth E. Hogg Poster Board Number P39: Ultra high resolution imaging of subepithelial ocular pathologies James R. Wong, Madhura G. Joag, Afshan A. Nanji, Juan Murillo, Nabeel M. Shalabi, Marwan A. Atallah, Ibrahim Sayed-Ahmed, Anat Galor, Carol L. Karp Poster Board Number P40: Topographic analysis of outer retinal atrophy in type 2 idiopathic macular telangiectasia Ferenc B. Sallo, Irene Leung, Valérie Krivosic, Vincent Rocco, Kiyoko Gocho, Michel Paques, Tunde Peto, Alan C. Bird, Alain Gaudric Poster Board Number P41: Predicting Progression of Geographic Atrophy in Age-Related Macular Degeneration with Retinal Thickness Measurements using Spectral Domain Optical Coherence Tomography Praveena Gupta, Kevin Wells, Vincent Nguyen, Bernard F. Godley, Gibran Khurshid 16 Poster Board Number P42: En-Face Analysis of Spectral Domain Ocular Coherence Tomography (SD-OCT) in Acute Multifocal Placoid Pigment Epitheliopathy (AMPPE) Kanchan Bhan, Adam Dubis, Carlos Pavesio Poster Board Number P43: Optical Coherence Tomography (OCT) detects epiretinal membrane formation after intravitreal injection of anti VEGF in cases of Diabetic macular edema Soheir Mahmoud Ali Poster Board Number P44: Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Chinese Normal Highly Myopic Eyes Fenghua Wang, Yanping Zhou, Xiaodong Sun Poster Board Number P45: Optical Coherence Tomography (OCT) to Detect Disease Progression in Birdshot Chorioretinopathy (BCR) – A Novel Multi-View Approach William R. Tucker, Gregory Short, Robert Nussenblatt, Nida Sen Poster Board Number P46: Inferior chiasmal syndrome diagnosed by Optical Coherence Tomography (OCT) before any visual field defects Shawkat S. Michel, Monica Michel Poster Board Number P47: Assessment of choroidal metastases with the Enhanced Depth Imaging Optical Coherence Tomography Efthymia Pavlidou, Amit Arora, Victoria Cohen, Mandeep S. Sagoo Poster Board Number P48: Development of Imaging Biomarker Algorithms to Assess Drug Efficacy and Predict Responders Kristie Lin, Tom Chang, Allen Ho, Rami Mangoubi, David O'Dowd, Nathan Lowry, Lei Hamilton, John Irvine, Sicco Popma 17 Paper Presentations 8:00 AM – 5:30 PM S 310A – D 18 Retinal Imaging 08:00 AM-10:00 AM Moderators: James Fujimoto, PhD Joel Schuman, MD Wolfgang Drexler, PhD 19 08:00 AM-08:15 AM Program Number: 1 Improved Visualization of the Vitreous using Swept Source Optical Coherence Tomography with Dynamic Focus Sweeping Author(s): Richard Spaide1, Charles Reisman 2, Zhengo Wang2, Kinpui Chan2 1 Vitreous Retina Macula Consultants of NY, 2Topcon Advanced Biological Imaging Laboratory Purpose: To modify swept source (SS) optical coherence tomography (OCT) to attempt to improve imaging of the vitreous. Methods: : The SS-OCT experimental setup is based on Topcon’s DRI OCT-1, which has an A-scan rate of 100 kHz, with a light source centered at 1050 nm and a bandwidth of 100 nm; the scan depth is 2.6mm in tissue. Although the illuminating beam in conventional OCT has a low numerical aperture, it still converges to and diverges from the waist of the beam as focused in the eye, and thus yields a significant part of the scan depth out of focus. In this newly derived imaging method the focus of the beam is dynamically swept through the scan depth during acquisition of sequential B-scans. A windowed averaging technique synchronized with dynamic focus sweeping is performed. Local contrast within the resultant image is then accomplished through adaptive equalization methods . Results: The brightness, contrast, and the intrinsic sharpness of the vitreous was improved as compared with conventional SS-OCT. The vitreous was found to have the expected bursa premacularis and area of Martegiani posteriorly, but additional cisternal spaces were routinely imaged anterior to these structures. The appearance of the retina and choroid were not changed by the methodology employed. Conclusions: : Improved visualization of the vitreous is possible through modification of scanning technique and post-processing of the image information. The vitreous is not a mass of gel; it is a complex structure as described in the past in autopsy eyes by Worst. In vivo evaluation of this architecture may be possible using OCT. The vitreous appearance using the modified scanning technique employing swept source optical coherence tomography of a healthy 58 year-old. A corresponding image from a 28 year-old. Note the presence of a cisternal space anterior to the premacular bursa. 20 Commercial Relationships Disclosure (Abstract): Richard Spaide: Commercial Relationship(s);Topcon:Code P (Patent) | Charles Reisman : Commercial Relationship(s);Topcon:Code E (Emplyment) | Zhengo Wang: Commercial Relationship(s);Topcon:Code E (Emplyment) | Kinpui Chan: Commercial Relationship(s);Topcon:Code E (Emplyment) 21 08:15 AM-08:30 AM Program Number: 2 Choroidal, Haller’s and Sattler’s thickness analysis across different age related macular degeneration phenotypes imaged with 3D-1060nm-OCT Author(s): Marieh Esmaeelpour1, 2, Siamak Ansari-Shahrezaei1, Behrooz Zabihian2, Martin F Kraus3, Maximilian Gabriel1, Ilse Krebs1, Joachim Hornegger3, Carl Glittenberg1, Wolfgang Drexler2, Susanne Binder1 1 Ludwig Boltzmann Institute for Retinolgy and Biomicroscopic Laser Surgery , 2Medical University Vienna, 3 Pattern Recognition Lab Purpose: To examine choroidal thickness (ChT) maps and vascular structure in healthy subjects and in eyes with age-related-macular degeneration (AMD) using a 3D-1060nm-Widefield-OCT. Methods: Three-dimensional choroidal tomograms and vascular segmentations 95 subjects with AMD (25 with reticular pseudodrusen, 25 with stage 2 and 3 non-neovascular and 45 with neovascular AMD), and age and axial eye length matched healthy subjects (n=35) were recruited. Visual acuity, axial eye length, and fundus photographs were taken. Images taken with a 3D 1060 nm OCT (512x 512 A scans at ~7 µm axial resolution over 36° angle) were used to generate total choroidal, Haller’s and Sattler’s maps automatically. 10 healthy and AMD eyes were imaged for a repeatability analysis of vascular layer thickness mapping. Results: Choroidal thickness was increased below areas of reticular pseudodrusen (RPD). Between eyes with and without RPD Sattler’s and Haller’s layer thickness differed significantly. Sattler’s layer thinning in RPD suggests a choroidopathy of this vascular layer. In the remaining non-RPD cohort, eyes with stage 3 non-neovascular AMD and neovascular AMD on the fellow eye had the thinnest choroid (P<0.01). Segmentation differences where above coefficients of repeatability for healthy and AMD eyes. Conclusions: Enhanced depth penetration of 1060 nm OCT enabled the in vivo investigation of choroidal blood vessels and choroidal thickness. Choroidal thickness change and structural alterations may illustrate differences in the pathogenesis of the AMD phenotypes. Commercial Relationships Disclosure (Abstract): Marieh Esmaeelpour: Commercial Relationship: Code N (No Commercial Relationship) | Siamak Ansari-Shahrezaei: Commercial Relationship: Code N (No Commercial Relationship) | Behrooz Zabihian: Commercial Relationship: Code N (No Commercial Relationship) | Martin F Kraus: Commercial Relationship(s);Optovue:Code P (Patent) | Maximilian Gabriel: Commercial Relationship: Code N (No Commercial Relationship) | Ilse Krebs: Commercial Relationship: Code N (No Commercial Relationship) | Joachim Hornegger: Commercial Relationship(s);Optovue:Code P (Patent) | Wolfgang Drexler: Commercial Relationship(s);Carl Zeiss Meditec:Code C (Consultant);Femtolasers:Code C (Consultant) | Carl Glittenberg: Commercial Relationship(s);Zeiis Meditec :Code C (Consultant) | Susanne Binder: Commercial Relationship(s);Alcon:Code C (Consultant) 22 08:30 AM-08:45 AM Program Number: 3 Effects of optical opacity on retinal cone counts measured by a narrow angle Heidelberg Retina Angiograph Author(s): Roger Anderson1, 2, Marketa Cilkova1, Padraig Mulholland1, Juliane Matlach1, Nilpa Shah1, Tony Redmond3, David Garway-Heath1, Steven Dakin1 1 Moorfields Eye Hospital & UCL Institute of Ophthalmology, 2University of Ulster, 3Cardiff University Purpose: To evaluate the ability of a modified Heidelberg Retina Angiograph (HRA2) to visualize retinal cones in vivo and to determine the impact of optical opacity induced by cataract-simulating filters on the resultant cone counts. Methods: Age-related lens changes were simulated during image acquisition using a series of white opacity filters (Fog filters 1-5, Lee filters UK). These filters contain opaque particles and simulate wide-angle scatter similar to that caused by certain cataracts. The induced change in intraocular stray light was determined for each filter using a CQuant Stray Light Meter (Oculus, Wetzlar, Germany). Filters 1, 2, and 3 each add the equivalent of approximately 15 years to the subject’s baseline stray light measurement. Filters 4 and 5 induce optical opacity equivalent to significant cataract. Cone images of three healthy eyes were acquired using a scan angle of 3 degrees with a HRA2 using filter conditions ranging from “None” to “Fog 5” at a retinal eccentricity of 6 degrees. Cone counts were generated using customized MatLab image analysis software. Results: The average cone count within the scan window was 5006 (8,900 cells/mm2) without a filter and was not substantially affected by Fog filters 1-4. The average cone count declined to 3967 (7,052 cell/mm2) with Fog filter 5 (approx. 20% decline from baseline). Conclusions: Images of the retinal cones can be obtained in vivo using a modified HRA2 with minimal discomfort to the subject. Retinal cone images acquired using the modified narrow angle HRA2 are quite robust to the effects of simulated lens opacity. With current software, automated cone counts remain relatively unchanged until significant lens opacity develops. This imaging modality has great potential as an aid in diagnosis and monitoring of retinal pathologies in a clinical setting. Appearance of raw retinal scan without filter 23 Appearance of a processed image indicating cones included in count. Commercial Relationships Disclosure (Abstract): Roger Anderson: Commercial Relationship(s);Heidelberg Engineering:Code F (Financial Support) | Marketa Cilkova: Commercial Relationship: Code N (No Commercial Relationship) | Padraig Mulholland: Commercial Relationship: Code N (No Commercial Relationship) | Julian Matlach: Commercial Relationship: Code N (No Commercial Relationship) | Nilpa Shah: Commercial Relationship: Code N (No Commercial Relationship) | Tony Redmond: Commercial Relationship: Code N (No Commercial Relationship) | David Garway-Heath: Commercial Relationship(s);Heidelberg Engineering:Code F (Financial Support) | Steven Dakin: Commercial Relationship: Code N (No Commercial Relationship) 24 08:45 AM-09:00 AM Program Number: 4 Autofluorescent droplets in the sub-Retinal Pigment Epithelium (RPE)-space of eyes with age-related macular degeneration (AMD): ex vivo imaging Author(s): Thomas Ach, Christine A. Curcio University of Alabama at Birmingham Purpose: Drusen, the best-studied sub-RPE deposit, are clinically visible only if size exceeds 30 µm in diameter. Sub-clinical drusen, microdrusen, and entrapment sites are described in electron and light microscopy studies. Little is known about the autofluorescence (AF) of these sub-RPE deposits. The Purpose of this study is to examine and classify small (< 30 µm) autofluorescent deposits in flat-mounts of RPE/Bruch membrane. Methods: Human RPE/Bruch membrane (BrM) flat-mounts were prepared from donor eyes with (n = 4) and without (n = 4) AMD pathologies (death to preservation time: < 4 hours; previously cryo-preserved). Flat-mounts were imaged (z-stacks; 0.4 µm intervals) at fovea and perifovea at different excitation wavelengths (390, 488 nm) using a spinning disc confocal microscope. Results: Autofluorescent structures were found beneath the RPE on BrM. In en face view, they are circular like a droplet (Figure). The diameter ranges between a few microns and sub-clinical drusen size. Small droplets (≈ 2 µm diameter) are also located in deeper layers, probably within BrM. Single droplets may merge to become larger, yet still sub-clinical deposits, which displace and thin the overlying RPE. Because only few hyperfluorescent drusen > 30 µm were visible in donor eyes > 80 years with normal maculas, these structures may be specific for AMD eyes. Conclusions: En face imaging of RPE/BrM flat-mounts reveals small AF droplets within AMD eyes, comparable to the size of entrapment sites, microdrusen, and sub-clinical hard drusen, which all might be precursors of clinically relevant drusen. The fluorophore(s) remain to be determined. One possibility is retinyl esters within BrM lipoproteins that contribute cholesterol to drusen. Further analysis of these structures will help elucidate the relationship of drusen formation and RPE alteration in AMD eyes. Autofluorescent droplets on Bruch´s membrane, excited with 390 (A) and 488 nm (B). The diameter of autofluorescent droplets ranges from a few microns (red arrowhead in B) to clinically visible drusen (yellow arrowhead). 488 nm excitation shows heterogeneous AF within these droplets. Few autofluorescent RPE lipofuscin granules are also visible (white arrowhead). The RPE was unintentionally removed during preparation of this specimen. Donor: 87 year old female, Caucasian, early AMD. Commercial Relationships Disclosure (Abstract): Thomas Ach: Commercial Relationship: Code N (No Commercial Relationship) | Christine Curcio: Commercial Relationship: Code N (No Commercial Relationship) 25 09:00 AM-09:15 AM Program Number: 5 High resolution imaging of Gunn’s dots Author(s): Michel Paques, Edouard Koch, Celine Chaumette, Alexandre Leseigneur Quinze-Vingts Hospital Purpose: In healthy fundi, glistening whitish dots (so-called Gunn’s dots) can often be seen, especially in young subjects. They are commonly attributed to the reflectance of Müller cell’s footplates. However, despite their potential interest as biomarkers of retinal diseases, Gunn’s dots have received little attention. Here, we analyzed the imaging characteristics of Gunn's dots. Methods: Scanning laser ophthalmoscope reflectance imaging and adaptive optics infrared flood imaging were performed in 18 healthy subjects (age range, 18-58 years). The localization, density and shape of Gunn’s dots were analyzed. Results: Both modalities ensured accurate detection of Gunn’s dots. They were more frequently observed in the midperiphery, although some were detected in the macula. The reflectance of Gunn’s dots showed a strong directional variability, which paralleled that of the inner limiting membrane. The mean (±SD) diameter of Gunn’s dots was 13.3µm (±3.5). Their density peaked at ~120/mm², and linearly decreased with age. Conclusions: Gunn’s dots are highly anisotropic structures close to the inner limiting membrane. Their density, size and age-related disappearance suggests that they are hyalocytes rather than Müller cells. Further studies are necessary to progress in the determination of their origin and disease-related changes. Adaptive optics imaging of Gunn’s dots (arrowheads). On the left are magnification of four Gunn’s dots showing the variability of their shape. Commercial Relationships Disclosure (Abstract): Michel Paques: Commercial Relationship(s);ImagineEye:Code C (Consultant) | Edouard Koch: Commercial Relationship: Code N (No Commercial Relationship) | Celine Chaumette: Commercial Relationship: Code N (No Commercial Relationship) | Alexandre Leseigneur: Commercial Relationship: Code N (No Commercial Relationship) 26 09:15 AM-09:30 AM Program Number: 6 Detection of Retinal Blood Flow Turbulence at Arteriovenous Crossings using Spectral Domain Optical Coherence Tomography Author(s): Michael Larsen University of Copenhagen Purpose: To determine if spectral domain optical coherence tomography (SD-OCT) can distinguish turbulent from laminar blood flow in retinal blood vessels. Methods: Retrospective observational study of 7 arteriovenous crossings in 6 eyes from 6 patients who underwent SD-OCT and fluorescein angiography based on suspicion of manifest or imminent branch retinal vein occlusion. Results: Angiographic evidence of turbulence was seen at x crossings in 3 eyes whereas laminar angiographic flow was intact at y crossings in 3 eyes . All crossings involved veins of diameter 100 µm or larger. On SD-OCT complex or chaotic reflectivity patterns were seen at the point of crossing and downstream of it at all 3 sites with angiographic turbulence whereas OCT reflectivity patterns consistent with laminar flow were seen behind and downstream of the crossing site in the eyes without angiographic turbulence. Conclusions: Patterns of abnormal intravascular reflectivity were detected by SD-OCT at arteriovenous crossings where turbulent blood had been documented by fluorescein angiography. These proof-of-principle observations confirm that SD-OCT enables qualitative study of retinal blood flow that may be useful for distinguishing between branch retinal vein congestion and imminent branch retinal vein occlusion. Above: Longitudinal SD-OCT scan along the axis of a retinal vein showing vessel wall reflexes and an intraluminal five-layer pattern of reflectivity that presumably represents plasma-rich fluid near the endothelium, laminar shearpattern flow in the intermediate layers with the highest velocity gradients (high reflectivity), and absence of velocity gradients centrally in the vessel with randomly oriented blood cells (low reflectivity). The scan transects a retinal artery crosssing anterior of the vein. The flow pattern in the vein is laminar on both sides of the crossing, relative hypoflectivity being visible where the direction of flow is not perpendicular to the instrument’s line of sight. Below: A retinal vein and artery scanned in a manner comparable to the upper image, but differing from the former in that the vein is anterior to the artery and in that a disrupted reflectivity pattern presents evidence of turbulent flow at and downstream of the arteriovenous crossing. Commercial Relationships Disclosure (Abstract): Michael Larsen: Commercial Relationship: Code N (No Commercial Relationship) 27 09:30 AM-09:45 AM Program Number: 7 Ganglion Cell Analysis using High-Definition Optical Coherence Tomography in Patients with mild cognitive impairment and Alzheimer’s Disease Author(s): Carol Y. Cheung1, 2, Yiting Ong1, M. Kamran Ikram1, Christopher Chan3, Tien Yin Wong1, 2 1 Singapore Eye Research Institute, 2Duke-NUS Graduate Medical School, 3 National University Health System Purpose: Alzheimer disease (AD) is a neurodegenerative disorder with emerging evidence that it is associated with retinal ganglion cell loss; however, few data exist to establish this association. We determine whether the ganglion cell-inner plexiform layer (GC-IPL) and retinal nerve fiber layer (RNFL), as measured by non-invasive in vivo spectral-domain optical coherence tomography (SD-OCT), are altered in patients with AD and mild cognitive impairment (MCI). Methods: Patients with AD and MCI were recruited from dementia/memory clinics, and cognitively normal controls were selected from the Singapore Epidemiology of Eye Disease program. SD-OCT ( Cirrus HD-OCT, software version 6.0.2, Carl Zeiss Meditec Inc, Dublin, CA) was used to measure the GC-IPL and RNFL thicknesses. Analyses of covariance was performed to estimate mean GC-IPL and RNFL thicknesses in the groups adjusted for age, gender, ethnicity, SD-OCT signal strength and additionally for hypertension, diabetes and histroy of myocardial infarction. AUC was used to assess the ability of GC-IPL and RNFL thicknesses to discriminate AD and MCI from cognitively normal controls. Results: We included 100 patients with AD, 40 patients with MCI and 123 cognitively normal elderly. Compared with the cognitively normal controls, patients with AD had significantly thinner GC-IPL thicknesses in all six (superior, superonasal, inferonasal, inferior, inferotemporal and superotemporal) sectors (mean differences from 3.42 to -4.99µm, all p<0.05) and thinner RNFL thickness in the superior quadrant (111.1 vs. 105.1µm, p=0.039). Patients with MCI also had significant thinner average GC-IPL thicknesses and in half of the six sectors (superonasal, inferior and inferotemporal) compared with cognitively normal controls (mean differences from -3.62 to -5.83µm, all p<0.05). The AUC of GC-IPL were generally higher than that of RNFL to discriminate AD and MCI from cognitively normal controls. Conclusions: Our data strengthens the link between retinal ganglion cell neuronal and optic nerve axonal loss with AD, and suggest that assessment of macular GC-IPL can be a test to detect neuronal injury in early AD and MCI. Commercial Relationships Disclosure (Abstract): Carol Cheung: Commercial Relationship: Code N (No Commercial Relationship) | Yiting Ong: Commercial Relationship: Code N (No Commercial Relationship) | M. Kamran Ikram: Commercial Relationship: Code N (No Commercial Relationship) | Christopher Chan: Commercial Relationship: Code N (No Commercial Relationship) | Tien Yin Wong: Commercial Relationship: Code N (No Commercial Relationship) 28 09:45 AM-10:00 AM Program Number: 8 Automatic Analysis of Color Retinal Images for CMV Retinitis Screening Author(s): Sandeep Bhat1, Chaithanya Ramachandra1, Todd P. Margolis2, Jeremy Keenan3, Kaushal Solanki1 1 Eyenuk, Inc, 2 Washington University School of Medicine, 3University of California, San Francisco Medical Center Purpose: Cytomegalovirus retinitis (CMVR), a treatable retinal infection affecting HIV/AIDS patients, is a leading cause of blindness in many developing countries. For example, in Thailand there are less than 700 ophthalmologists to care for over 300,000 patients at risk for vision loss from the disease. The telemedicine framework setup by the Chiang Mai University Medical Centre, Thailand and UCSF is aiding the growing need for CMVR screening. To further scale this telemedicine solution, we have developed novel screening tools that use advanced image analysis techniques to automatically screen images and aid efficient triage of retinitis patients. Methods: 7-field color retinal fundus mosaics are first denoised using edge-preserving bilateral filter. Variations in the images, due to different lighting conditions, equipment used, technicians, and patient anatomy are “neutralized” using a novel median filter based normalization technique that uses local background estimation to enhance the image at every pixel. A Hessian-based interest region and “vesselness” map detection is then applied, and the following image descriptors are computed: sum-modified Laplacian (for focus/blur), saturation measure, Michelson contrast, color measure, local noise metric, image entropy, and local binary patterns (for texture). The descriptors are concatenated, subjected to dimensionality reduction using PCA, and used to train a support vector classifier in a 5fold cross-validation framework. Results: The tools were tested using 211 images, graded for CMVR, by randomly splitting them into 40 different training-testing datasets. In each split, 75% of the images were used for training and 25% were reserved for testing. The lesion-degraded retinitis images were flagged to be positive for CMVR by our system with an average accuracy of 85% (average area under ROC curve = 0.93). Conclusions: Proposed screening tool does a good job of automatically screening retinal images for signs of CMVR. In conjunction with telemedicine frameworks, it is expected to greatly reduce the risk of blindness in HIV/AIDS patients in developing countries. Fig 1: CMVR screening results for 7-field retinal mosaics from a Topcon TRC-NW 6S camera. (a,b) “Normal retina” screened as “No refer”. (c,d) “Retina with CMVR” screened as “refer”. (e,f) Images from “cannot determine” category screened as “refer”. 29 Commercial Relationships Disclosure (Abstract): Sandeep Bhat: Commercial Relationship(s);Eyenuk Inc:Code E (Emplyment) | Chaithanya Ramachandra: Commercial Relationship(s);Eyenuk Inc:Code E (Emplyment) | Todd Margolis: Commercial Relationship(s);Washington University School of Medicine in St. Louis:Code E (Emplyment) | Jeremy Keenan: Commercial Relationship(s);University of California, San Francisco:Code E (Emplyment) | Kaushal Solanki: Commercial Relationship(s);Eyenuk Inc:Code E (Emplyment) 30 Functional Retinal Imaging 10:30 AM-12:30 PM Moderators: Richard Spaide, MD Giovanni Gregori, PhD 31 10:30 AM-10:45 AM Program Number: 9 Optical Coherence Tomography Angiography of Macular Disease Author(s): David Huang1, Yali Jia1, Steven T. Bailey1, Thomas Hwang1, Andreas K. Lauer1, Christina J. Flaxel1, Mark E. Pennesi1, David J. Wilson1, Joachim Hornegger2, James G. Fujimoto3 1 Oregon Health & Science University, 2University of Erlangen-Nuremberg, 3MIT Purpose: To determine the characteristic features of common macular diseases using the novel imaging modality of optical coherence tomography (OCT) angiography. Methods: Healthy control subjects and subjects with a variety of macular pathologies underwent OCT angiography in prospective observational studies. Fluorescein angiography (FA) was obtained when clinically indicated. OCT angiography scans were obtained with a high-speed (100,000 A-scans/sec) 1050 nm wavelength swept-source OCT. The scans spanned 3.5×3.5 mm and was acquired in 4.0 sec. Flow was detected using the split-spectrum amplitudedecorrelation angiography algorithm. The volumetric angiography was segmented into four layers: inner retina, outer retina, inner choroid and outer choroid. En face maximum flow projection was used to obtain 2D angiograms of the 4 layers. Results: In all 5 healthy subjects, retinal capillary networks were visualized in the inner retinal layer, confluent choriocapillaris could be visualized in the inner choroid, and no flow was detected in the outer retina. In all 8 cases of neovascular age-related macular degeneration (AMD), OCT angiography demonstrated choroidal neovascularization (CNV) in the outer retinal layer. The depth of CNV relative to the retinal pigment epithelium (RPE) could be determined and the area and flow index could be quantified. The CNV area corresponded well to FA except in 3 cases where fluorescence was blockage by hemorrhage or RPE. In 2 cases of dry AMD, OCT angiography showed loss of choriocapillaris from the inner choroid in areas of geographic atrophy and some areas of large drusen. In 2 cases of nonproliferative diabetic retinopathy (DR), regions of retinal capillary dropout shown by OCT angiography agreed with FA. In 1 case of proliferative DR, OCT angiography showed retinal neovascularization (RNV) above inner limiting membrane (Figure 1). In 2 cases of retinal dystrophy, choriocapillaris dropout was shown on choroidal OCT angiogram. Conclusions: OCT angiography was able to detect the presence of abnormal vessels (CNV & RNV) by their location in the normally avascular outer retina and vitreous medium. Capillary dropout could be mapped in DR and choriocapillaris loss could be detected in AMD and retinal dystrophy. 32 Commercial Relationships Disclosure (Abstract): David Huang: Commercial Relationship(s);Optovue:Code F (Financial Support);Optovue:Code I (Personal Financial Interest);Optovue:Code P (Patent);Carl Zeiss Meditec:Code P (Patent) | Yali Jia: Commercial Relationship(s);Optovue:Code P (Patent) | Steven Bailey: Commercial Relationship: Code N (No Commercial Relationship) | Thomas Hwang: Commercial Relationship: Code N (No Commercial Relationship) | Andreas Lauer: Commercial Relationship: Code N (No Commercial Relationship) | Christina Flaxel: Commercial Relationship: Code N (No Commercial Relationship) | Mark Pennesi: Commercial Relationship: Code N (No Commercial Relationship) | David Wilson: Commercial Relationship: Code N (No Commercial Relationship) | Joachim Hornegger: Commercial Relationship(s);Optovue:Code P (Patent) | James Fujimoto: Commercial Relationship(s);Optovue:Code P (Patent);Carl Zeiss Meditec:Code P (Patent) 33 10:45 AM-11:00 AM Program Number: 10 En Face Visualization of Retinal Pathologies Using Ultrahigh Speed Swept Source Optical Coherence Tomography Author(s): Woo Jhon Choi1, Mehreen Adhi2, Eric Moult1, ByungKun Lee1, Zhao Wang1, Martin F. Kraus3, 1, Jay S. Duker2, Joachim Hornegger3, James G. Fujimoto1, Nadia K. Waheed2 1 Massachusetts Institute of Technology, 2New England Eye Center and Tufts University, 3University of ErlangenNuremberg Purpose: We investigate en face visualization of retinal pathologies using ultrahigh speed 400kHz swept source optical coherence tomography (SSOCT) and OCT angiography. Methods: Imaging was performed with an ultrahigh speed SSOCT prototype at 1um wavelengths using a vertical cavity surface emitting laser (VCSEL) swept light source at 400kHz A-scan rate. When necessary, a 3D motioncorrection / registration algorithm was used to suppress motion artifacts and increase signal-to-noise. Volumetric 3mm×3mm and 6mm×6mm scans were acquired from patients with age related macular degeneration, diabetic retinopathy and age matched normals. OCT angiography was performed using multiple B-scans from the same location to generate motion contrast 3D images of retinal, choriocapillaris and choroidal vasculature. Bruch’s membrane was segmented and en face OCT images were generated at different depths. Results: Patients with non-exudative age-related macular degeneration (dry AMD) with and without geographic atrophy (GA) and diabetics with and without retinopathy were imaged with ultrahigh speed SSOCT. Figure 1 shows an example of dry AMD patient with GA. Four orthogonally-scanned volumetric data sets over a 6mm×6mm area (shown in yellow on the fundus image) were acquired and motion-corrected. En face OCT at the RPE level shows the locations of drusen (Figure 1C). The area of RPE atrophy can be visualized by projecting all depths below the RPE, into the sclera (Figure 1D). The OCT angiogram of the choriocapillaris shows choriocapillaris atrophy in the region of GA (Figure 1E). Conclusions: Ultrahigh speed SSOCT and OCT angiography enables en face visualization of retinal / choroidal structure and vasculature. The ability to comprehensively image structure and vasculature features, especially the choriocapillaris, promises to be an important tool for assessing pathogenesis, early disease and disease progression. 34 Figure 1. 77 year old dry AMD patient with GA (A) Fundus photograph. (B-E) OCT fundus projection, en face OCT at the RPE level, sub RPE intensity projection showing GA, and OCT angiogram of choriocapillaris. OCT area marked by the yellow square in (A). 6mm×6mm field of view. Commercial Relationships Disclosure (Abstract): Woo Jhon Choi: Commercial Relationship: Code N (No Commercial Relationship) | Mehreen Adhi: Commercial Relationship: Code N (No Commercial Relationship) | Eric Moult: Commercial Relationship: Code N (No Commercial Relationship) | ByungKun Lee: Commercial Relationship: Code N (No Commercial Relationship) | Zhao Wang: Commercial Relationship: Code N (No Commercial Relationship) | Martin Kraus: Commercial Relationship(s);Optovue, Inc. :Code P (Patent) | Jay Duker: Commercial Relationship(s);Carl Zeiss Meditec Inc.:Code F (Financial Support);Optovue Inc.:Code F (Financial Support);Hemera Biosciences:Code I (Personal Financial Interest) | Joachim Hornegger: Commercial Relationship: Code N (No Commercial Relationship) | James Fujimoto: Commercial Relationship(s);Carl Zeiss Meditec Inc:Code P (Patent);Optovue Inc:Code P (Patent);Optovue Inc:Code I (Personal Financial Interest) | Nadia Waheed: Commercial Relationship: Code N (N Commercial Relationship) 35 11:00 AM-11:15 AM Program Number: 11 Quantitative Insights into Macular Microvascularity using Adaptive Optics Scanning Light Ophthalmoscopy Fluorescein Angiography Author(s): Richard Rosen1, 3, Alexander Pinhas1, Moataz Razeen1, Nishit Shah1, Alexander Gan1, Richard Bavier1, Rishard Weitz1, Joseph Carroll2, Alfredo Dubra2, Yuen Ping T. Chui1, 3 1 New York Eye & Ear Infirmary, Mount Sinai Health System, 2Medical College of Wisconsin, 3New York Medical College Purpose: Adaptive Optics Scanning Light Ophthalmoscopy (AOSLO), coupled with fluorescein angiography (FA) , is able to resolve dynamic cellular details of human retinal microvasculature in healthy and diseased eyes. Using quantitative image analysis, AOSLO provides a platform for characterizing retinal microvascular changes due to age, onset of disease or response to treatment. Here, we show how foveal avascular zone (FAZ), capillary density and lumen in diabetes (DR), central retinal vein occlusion (CRVO), and sickle cell retinopathy (SCR) are different from those in fellow eyes and/or normal eyes. Methods: During AOSLO FA imaging, simultaneous reflectance (790 nm) and fluorescence (488 nm) image sequences with 1.75° field of view were stitched together to create microvascular maps of a 6° square region centered on the fovea. AOSLO FA maps were skeletonized and divided into regions of interest (ROIs). Vessel length (mm) and density (mm-1) were then calculated per ROI. For FAZ attribute quantification, the FAZ was delineated manually creating an FAZ layer mask. Based on the masks, FAZ area (mm 2), effective diameter (µm, diameter of a uniform circle derived from FAZ area), perimeter (µm) and tortuosity index (TI) were computed. Results: Comparison of FAZ parameters of area, diameter, and perimeter in normal and vasculopathic eyes showed large variations, with CRVO eyes having highest values followed by SCR, DR, and controls . Tortuosity Index (TI), however, was highest in DR eyes followed by SCR, CRVO and controls . CRVO fellow eyes all showed some capillary dropout near the FAZ with significant decrease in vessel length and density compared to control eyes. FAZ mean capillary lumen diameter for early diabetic subjects was found to be 35% larger than that of the control subjects. Conclusions: Quantification of the microvascular geometry utilizing AOSLO in vivo microscopy shows significant potential for studying complex clinical questions involving retinal vascular diseases. This approach may help direct therapeutic interventions based upon fine numerical distinctions as opposed to clinical impressions derived from conventional clinical imaging modalities. AO SLO FA is assembled, skeletonized, and vascular density is measured.The FAZ is outlined to analyze tortuosity and perifoveal intercapillary area. 36 Ischemic Diabetic FAZ capillary remodelling Commercial Relationships Disclosure (Abstract): Richard Rosen: Commercial Relationship(s);Clarity:Code C (Consultant);Optovue:Code C (Consultant);OD-OS:Code C (Consultant);Opticology:Code P (Patent) | Alexander Pinhas: Commercial Relationship: Code N (No Commercial Relationship) | Moataz Razeen: Commercial Relationship: Code N (No Commercial Relationship) | Nishit Shah: Commercial Relationship: Code N (No Commercial Relationship)| Alexander Gan: Commercial Relationship: Code N (No Commercial Relationship) | Richard Bavier: Commercial Relationship: Code N (No Commercial Relationship) | Rishard Weitz: Commercial Relationship: Code N (No Commercial Relationship) | Joseph Carroll: Commercial Relationship(s);ImagineEyes:Code C (Consultant) | Alfredo Dubra: Commercial Relationship(s);University of Rochester:Code P (Patent) | Yuen Ping Chui: Commercial Relationship: Code N (No Commercial Relationship) 37 11:15 AM-11:30 AM Program Number: 12 Quantification of Absolute Number of Photoreceptors from Ultra-Widefield Imaging Author(s): Daniel E. Croft1, Charles C. Wykoff1, David M. Brown1, Jano VanHemert2 1 Retina Consultants of Houston, 2Optos plc Purpose: To develop a methodology which facilitates estimation of the absolute number of cones and rods in regions selected from ultra-widefield (UWF) fundus images and fluorescein angiograms, utilizing the Optos 200Tx scanning laser ophthalmoscope (SLO) (Optos, UK). Methods: Previously published retinal histology data sampled cone and rod density radially from the fovea at 1mm intervals in the superior, inferior, nasal and temporal directions (Curcio C.A., Sloan K.R, Kalina R.E. The Journal of Comparative Neurology. 1990). This data was mapped onto a 3-dimensional (3D) model eye with a 24mm diameter and interpolated across the entire retinal surface to create a map of approximate photoreceptor densities, including independent rod and cone density maps. To calculate retinal surface area, the location of the fovea was used to identify the gaze angle of the UWF image and a transformation was applied to project the image to its anatomically correct location on the 3D model eye. This was performed by ray tracing every pixel through a combined optical model of the Optos 200Tx SLO and the Navarro UWF model eye. This completed 3D model was then mapped to a 2D stereographic projection and regions of interest were selected for quantification. Area was metrically quantified with spherical trigonometry by projecting the selection back onto the 3D model eye. Quantification of photoreceptors was achieved by multiplying the surface area of selected regions by the density of photoreceptors in the selected regions. This methodology was applied to clinical examples. Results: Two clinical examples were analyzed - one eye with diabetic retinopathy and one eye with retinal vein occlusion. Both of these eyes demonstrated substantial areas of central and peripheral non-perfusion on UWF fluorescein angiography. These areas of non-perfusion were selected manually. In the eye with diabetic retinopathy 194.7 mm2 of non-perfusion were selected representing 19,241,461 rods and 863,807 cones. In the case of RVO 326 mm2 of non-perfusion were selected representing 31,657,976 rods and 1,248,816 cones. Conclusions: A method to estimate the absolute number of photoreceptors from ultra-widefield imaging was developed by combining previously published retinal histological data with metric quantification. This methodology was applied to clinical examples of retinal non-perfusion in diabetic retinopathy and retinal vein occlusion. Commercial Relationships Disclosure (Abstract): Daniel Croft: Commercial Relationship: Code N (No Commercial Relationship) | Charles Wykoff: Commercial Relationship: Code N (No Commercial Relationship) | David Brown: Commercial Relationship: Code N (No Commercial Relationship) | Jano VanHemert: Commercial Relationship(s);Optos plc:Code E (Emplyment) 38 11:30 AM-11:45 AM Program Number: 13 Parafoveal cone hyporeflectivity and recovery seen by adaptive optics in posterior uveitis Author(s): Phoebe Lin1, Kristin Biggee1, Michael Gale1, Eric Suhler1, 2, Mark Pennesi1 1 Oregon Health and Science University, 2VA hospital Portland Purpose: The Purpose of this study was to determine if the use of adaptive optics (AO) can detect subclinical changes in posterior uveitis affecting the outer retina. Methods: Sequential patients who had posterior uveitis affecting the outer retina were imaged with the Rtx1 Optics flood illumination AO camera using a field of view of 4° by 4°, and a resolution of 1 µm. These images were compiled into a montage and macular cone densities calculated using Matlab software. AO images were compared to SD-OCT, fluorescein angiography (FA), and fundus autofluorescence (FAF) images. Results: Four patients with posterior uveitis affecting the outer retina were imaged with the AO camera: one with serpiginous chorioretinitis, one with multiple evanescent white dot syndrome (MEWDS), and two patients with multifocal choroiditis (MFC) with acute outer retinal atrophy (AORA). In all 4 cases, the affected eye showed areas of altered photoreceptor reflectivity on AO images that corresponded to changes seen on FAF, SD-OCT, or FA. In some cases, abnormalities that were not seen on other imaging techniques were noted on AO. In one patient with MFC with AORA, AO images revealed abnormal parafoveal cone reflectivity in the unaffected eye that was not noted on examination or other images. In the patient with MEWDs, multifocal areas of altered cone reflectivity were more apparent than that expected by SD-OCT, FAF, or FA (Figure 1). In the case of serpiginous chorioretinitis, AO images obtained five weeks after initiating treatment with high dose prednisone and azathioprine demonstrated a reversal in the abnormal reflectivity of parafoveal cones (Figure 2). Conclusions: AO delineates areas of altered photoreceptor reflectivity not seen on other imaging techniques and may prove to be a useful imaging modality to gauge treatment efficacy and to monitor disease course in posterior uveitis. 39 A 17 year-old woman with MEWDS presented with multifocal parafoveal cone hyporeflectivity on AO that recovers upon follow up. Top panels: FAF; Middle panels, AO with cone density plot; Bottom panels, SD-OCT A 60 year-old woman with serpiginous chorioretinitis presenting with 20/20 vision OS has cone hyporeflectivity on AO outside the areas of involvement seen on other imaging modalities that reverses after treatment. Top panels: FAF; Middle panels, AO with cone density plot; Bottom panels, SD-OCT Commercial Relationships Disclosure (Abstract): Phoebe Lin: Commercial Relationship: Code N (No Commercial Relationship) | Kristin Biggee: Commercial Relationship: Code N (No Commercial Relationship) | Michael Gale: Commercial Relationship: Code N (No Commercial Relationship) | Eric Suhler: Commercial Relationship: Code N (No Commercial Relationship) | Mark Pennesi: Commercial Relationship: Code N (No Commercial Relationship) 40 11:45 AM-12:00 PM Program Number: 14 Total Retinal Blood Flow Measurement with 70k Hz Spectral Domain OCT Author(s): Ou Tan, Gangjun Liu, Yali Jia, David Huang Casey Eye Institute Purpose: To develop an automated algorithm to measure total retinal blood flow (TRBF) using 70k Hz Doppler spectral domain OCT Methods: One eye of each participant was scanned with a 70k Hz spectral domain OCT (RTVue-XR, Optovue, CA). The OCT is calibrated for the transformation from Doppler shift to speed based on a flow phantom. The TRBF scan pattern contains 5 repeated volume scans (depth=2.3mm, horizontal=1.6 mm, and vertical=2mm) obtained in 3 seconds, and centered on central retinal vessels. Each eye was scanned 3 times. Complex OCT signal was save and both reflectance and Doppler shift computed in postprocessing using a split-spectrum algorithm. An automated algorithm was developed for TRBF measurement using multiple plane en face Doppler summation. First, veins and arteries were segmented and classified based on both Doppler shift and reflectance. Second, phase unwrapping was applied to correct the Doppler shift in vessels (Figure 1). Then, for each retinal vein, blood flow was measured at an optimal plane where the calculated flow is maximized. The TRBF was calculated by summing flow in all veins. The algorithm tracks vascular branching so that either root or branch veins are summed, but never both. Finally, the TRBF in 5 repeated volumes were average to reduce variation due to pulsation during the cardiac cycle. Arterial flow was not summed because of greater noise due to pulsation and phase wrapping. Results: A total of 14 eyes of 14 participants (9 healthy controls, 5 glaucoma participants) were enrolled. The TRBF of healthy controls is 42.0±5.0 µl/min. The TRBF of glaucoma controls is 38.1±9.2 µl/min. The intra-visit repeatability was 11.1% (coefficient of variation) for healthy participants and 9.2% for glaucoma participants. Four out of 5 glaucoma participants had TRBF at least 1 standard deviation below health control group mean. Conclusions: An automated algorithm was developed for TRBF measurement using 70KHz spectral-domain OCT. The TRBF measured in healthy and glaucoma subjects are within the range described in literatures. The repeatability of a single scan is acceptable. Figure 1 (A) Color disc photograph showing volumetric Doppler scan area (green rectangular outline). 41 Figure 1 (B) En face color Doppler showing the veins (blue representing flow out of eye) and the measurement positions for each vein (circular outlines). Commercial Relationships Disclosure (Abstract): Ou Tan: Commercial Relationship(s);Zeiss Medtech:Code P (Patent);Optovue:Code P (Patent);Optovue:Code F (Financial Support) | Gangjun Liu: Commercial Relationship: Code N (No Commercial Relationship) | Yali Jia: Commercial Relationship(s);Optovue:Code P (Patent) | David Huang: Commercial Relationship(s);Zeiss Medtech:Code P (Patent);Optovue:Code F (Financial Support);Optovue:Code I (Personal Financial Interest);Optovue:Code P (Patent) 42 Glaucoma / Anterior Eye 01:30 PM-03:30 PM Moderators: Brand Fortune, PhD Susan Vitale, PhD 43 01:30 PM-01:45 PM Program Number: 15 Evaluation of the Spatial Relationship Between Glaucoma Progression using Confocal Scanning Laser Ophthalmoscopy (CSLO), Optical Coherence Tomography (OCT), and Visual Field (VF). Author(s): Dingle Foote1, Gadi Wollstein1, Divya Narendra1, Yun Ling1, 2, Richard A. Bilonick1, 2, Hiroshi Ishikawa1, 3, Larry Kagemann1, 3, Cynthia Mattox5, James G. Fujimoto4, Joel S. Schuman1, 3 1 University of Pittsburgh Medical Center, 2Graduate School of Public Health, University of Pittsburgh,, 3Swanson School of Engineering, University of Pittsburgh, 4Massachusetts Institute of Technology, 5Tufts Medical Center Purpose: To evaluate the spatial relationship between structural and functional progression as measured by CSLO, OCT, and VF. Methods: 107 eyes of 64 glaucoma, glaucoma suspect and healthy subjects were followed for a mean of 5.5 years (range: 1.6-8.1). Each subject had baseline and final visits within 6 months from one device to the other. Four generations of OCT were used to perform retinal nerve fiber layer (RNFL) thickness measurements over this time period and then standardized by applying calibration equations. Superior and inferior quadrant RNFL thicknesses, rim areas, and VF mean sensitivities in the corresponding locations were used for analysis. Progression with each parameter was defined as a significantly negative linear regression slope on at least two consecutive visits. Results: Of the 107 eyes studied, 5 eyes showed global RNFL progression by OCT with 4 eyes (3 superior, 1 inferior) showing progression by quadrants. 6 eyes progressed globally by CSLO measured rim area with 10 eyes (5 superior, 5 inferior) showing regional progression. Six eyes showed global progression by VF with 5 eyes (5 superior, 0 inferior) showing regional progression. There was no agreement of global progression between CSLO and OCT while 2 eyes (1 superior, 1 inferior) showed spatial agreement. Only 2 eyes agreed in global progression with VF and OCT but there was no agreement between VF and CSLO and no spatial agreement between VF and OCT or CSLO. Conclusions: Despite a lengthy follow-up period, and large cohort there was very poor global or spatial agreement between OCT, CSLO, and VF. No device has proven to be a superior tool and therefore no individual device can be recommended for detection of glaucoma progression. Commercial Relationships Disclosure (Abstract): Dingle Foote: Commercial Relationship: Code N (No Commercial Relationship) | Gadi Wollstein: Commercial Relationship: Code N (No Commercial Relationship) | Divya Narendra: Commercial Relationship: Code N (No Commercial Relationship) | Yun Ling: Commercial Relationship: Code N (No Commercial Relationship) | Richard Bilonick: Commercial Relationship: Code N (No Commercial Relationship) | Hiroshi Ishikawa: Commercial Relationship: Code N (No Commercial Relationship) | Larry Kagemann: Commercial Relationship: Code N (No Commercial Relationship) | Cynthia Mattox: Commercial Relationship: Code N (No Commercial Relationship) | James Fujimoto: Commercial Relationship(s);Zeiss:Code P (Patent);Optovue:Code P (Patent);Optovue:Code I (Personal Financial Interest) | Joel Schuman: Commercial Relationship(s);Zeiss:Code P (Patent) 44 01:45 PM-02:00 PM Program Number: 16 Identification of Glaucoma using Biomarkers of Retinal Vascular Morphology and Blood Flow Computed from Retinal Fundus Images Author(s): David Meadows, Rick Clark, Daniel Dickrell University of Florida Purpose: To determine if morphological and blood flow characteristics based on Constructal Analysis of the retinal vasculature provide robust biomarkers for screening glaucomatous patients. Methods: Studies have recently reported retinal blood flow is compromised in a large percentage of glaucoma patients. Two suggested mechanisms for vascular dysfunction are increased resistance to flow and/or reduced perfusion pressure. A new method of automatically classifying the blood flow capacity of retinal vascular networks into healthy or glaucoma categories has been developed (OQULUS™). Color fundus photographs are used to characterize the morphology and geometry of arterial and venous networks followed by Constructal Analysis. Based on connectivity and flow capacitance of individual vessel segments, the overall network flow capacities were calculated. Arterial bifurcations were carefully characterized using metrics such as junction exponents, diameter ratios, area ratios and branching angles. These vascular metrics define the ability for blood to pass efficiently through the interconnected series of retinal vessels. 23 high-resolution color fundus images from 13 healthy and 10 glaucomatous patients were analysed. (http://www5.cs.fau.de/research/data/fundus-images/). Biomarkers were identified for the arterial and venous networks from each image Results: Results identified large differences between healthy and glaucomatous eyes for overall network flow rates. Healthy arterial networks had average flow capacity of 1.50 ± 0.74 µL/kPa-s while the glaucomatous arterial networks had average flow that was reduced by 70% to 0.43 ± 0.16 µL/kPa-s (ROC analysis: Area = 0.85, Sensitivity = 0.82, Specificity = 0.85). The diminished flow capacity of retina vasculature clearly showed glaucomatous patients had global narrowing of vessel networks. Ocular blood flow deficiency has been suggested as a cause of optic nerve damage, either directly or indirectly through raised intraocular pressure, supporting the utility of OQULUS™ algorithms. Other strong biomarker signals include: artery and vein diameter, artery tortuosity, artery and vein asymmetry index, artery bifurcation angle. Conclusions: Results for the OQULUS™ software based on Constructal Analysis algorithms clearly identified biomarkers that enable the automated screening of glaucoma patients from color fundus imagery. Commercial Relationships Disclosure (Abstract): David Meadows: Commercial Relationship(s);Sentinel Diagnostic Imaging:Code I (Personal Financial Interest) | Rick Clark: Commercial Relationship(s);Sentinel Diagnostic Imaging:Code I (Personal Financial Interest) | Daniel Dickrell: Commercial Relationship(s);sentinel Diagnostic Imaging:Code I (Personal Financial Interest) 45 02:00 PM-02:15 PM Program Number: 17 Measurement of BMO plan-based anterior lamina cribrosa surface depth (ALCSD) parameter using a deconvolution approach applied to 3D spectral domain optical coherence tomography optic nerve head images Author(s): Akram Belghith, Christopher Bowd, Zhiyong Yang, Felipe Medeiros, Robert N. Weinreb, Linda M. Zangwill Hamilton Glaucoma Center Purpose: To propose a new approach for locating the Bruch's membrane opening (BMO) and the anterior lamina cribrosa surface (ALCS) of 3D Spectralis SD-OCT images (Heidelberg Engineering, 48 enhanced depth imaging EDI radial B-scans centered on the optic nerve head). Methods: We formulated the detection of the BMO and the ALCS as a missing data problem where we jointly estimated the noise hyper-parameters and the segmented image. To deal with the overlapping of the Bruch's membrane and the retinal pigment epithelium layers and the poor image resolution around the lamina cribrosa area, we proposed the use of an image deconvolution approach that consists of assigning to each layer a specific shape (or filter) and then estimating its hyper-parameters. The BMO plan-based anterior lamina cribrosa surface depth (ALCSD) parameter was generated as the average perpendicular distance from ALCS relative to the BMO reference plane along two of the 48 radial scans (one vertical (12:00 to 6:00) and one horizontal (9:00 to 3:00) scan. An expert (ZY) manually marked the best 4 locations visible as the border of the ALCS on the vertical and horizontal scan for a total of 8 points. We compared the ALCSD measurements using automated ALCS detection to those obtained by expert manual segmentation. Glaucoma diagnostic accuracy [area under receiver operating characteristic (AUROC)] was estimated using 20 glaucoma and 20 healthy eyes. Results: The BMO plan-based ALCSD measurements with the new deconvolution approach using Spectralis EDI radial scans were similar to expert measurements (Figure 1). The correlations between the manual and the automated measurements was R2 = 0.95 (p <0.001). The diagnostic accuracy of ALCSD for differentiating between healthy and glaucoma eyes in this limited sample was AUROC = 0.78 (0.62-0.93). Identification of the ALCS was particularly challenging when the radial scan dissects large vessels and when there is a shallow optic cup. Conclusions: This deconvolution segmentation method shows promise for automated identification of the ALCS. The clinical importance of this measurement should be evaluated in a larger longitudinal sample of glaucoma and healthy eyes. 46 Commercial Relationships Disclosure (Abstract): Akram Belghith: Commercial Relationship: Code N (No Commercial Relationship) | Christopher Bowd: Commercial Relationship: Code N (No Commercial Relationship) | Zhiyong Yang: Commercial Relationship: Code N (No Commercial Relationship) | Felipe Medeiros: Commercial Relationship(s);Alcon Laboratories Inc.:Code F (Financial Support);Bausch & Lom:Code F (Financial Support);Carl Zeiss Meditec Inc.:Code F (Financial Support);Heidelberg Engineering, Inc:Code F (Financial Support);Merck Inc:Code F (Financial Support);Allergan Inc:Code F (Financial Support);Sensimed:Code F (Financial Support);Topcon, Inc:Code F(Financial Support);Reichert, Inc:Code F (Financial Support);National Eye Institute:Code F (Financial Support);Alcon Laboratories Inc:Code P (Patent);Allergan Inc:Code P (Patent);Carl Zeiss Meditec Inc:Code P (Patent);Reichert Inc.:Code P (Patent);Allergan, Inc:Code C (Consultant);Carl-Zeiss Meditec, Inc:Code C (Consultant);Novartis:Code C (Consultant) | Robert Weinreb: Commercial Relationship(s);Aerie:Code F (Financial Support); Carl Zeiss Meditec:Code F (Financial Support); Genentech:Code F (Financial Support);Heidelberg Engineering GmbH:Code F(Financial Support);National Eye Institute:Code F (Financial Support);Nidek:Code F (Financial Support); Novartis:Code F (Financial Support);Optovue:Code F (Financial Support);Topcon:Code F (Financial Support);Alcon:Code C (Consultant);Allergan:Code C (Consultant);Amkem:Code C (Consultant);Bausch&Lomb:Code C (Consultant);Carl Zeiss Meditec:Code C (Consultant);EyeTechCare:Code C (Consultant);Quark:Code C (Consultant);Sensimed:Code C (Consultant);Topcon:Code C (Consultant);Solx:Code C (Consultant) | Linda Zangwill:Commercial Relationship(s);Carl Zeiss Meditec Inc:Code F (Financial Support);Heidelberg Engineering GmbH:Code F (Financial Support);Optovue Inc:Code F (Financial Support);Topcon Medical Systems Inc:Code F (Financial Support);Topcon Medical Systems Inc:Code R (Recipient) 47 02:15 PM-02:30 PM Program Number: 18 Magic Angle-Enhanced MRI of Fibrous Structures in the Eye upon Intraocular Pressure Loading Author(s): Leon C. Ho1, 2, Ian A. Sigal1, 3, Ning-Jiun Jan1, 3, Alexander Squires4, Zion Tse4, Ed X. Wu2, Seong-Gi Kim3, 5, Joel S. Schuman1, Kevin C. Chan1, 3 1 University of Pittsburgh, 2The University of Hong Kong, 3University of Pittsburgh, 4The University of Georgia, 5 SKKU Purpose: The sclera and cornea are collagenous fibrous connective tissues that are central to several eye diseases such as glaucoma and myopia. Their roles on disease pathogenesis however remain unclear, partly due to limited non-invasive techniques to assess and monitor these fibrous structures globally, longitudinally and quantitatively. Magic angle-enhanced MRI has been used clinically to evaluate collagenous fibers in normal and diseased tendons, ligaments and cartilages in vivo. We hypothesized that magic angle-enhanced MRI can detect changes in corneoscleral shell tissues due to intraocular pressure (IOP) alternation. Methods: Seven pairs of ovine eyes were extracted and fixed. One eye from each sheep was loaded at IOP=50mmHg to mimic ocular hypertension, and the contralateral eye was unpressurized. The sclera and cornea were aligned at different angular orientations relative to the static magnetic field (B o) inside a 9.4Tesla MRI scanner. T2 and T2* mapping using spin-echo (SE) and gradient-echo (GE) MRI was applied to quantify the magic angle effect on the corneoscleral shells. Results: SE and GE signal intensities were found to be maximal when the tissues were oriented near the magic angle at ~55o to Bo. Such magic angle enhancement was stronger in GE than SE MRI, while higher T2- and T2*weighted signal intensities were found in loaded than unloaded ocular tissues at magic angle (Figure), suggestive of rearrangement of the collagen fibers. Transverse relaxation times in loaded sclera (T2=31.5±4.2ms and T2*=11.3±1.4ms) were significantly higher than unloaded sclera at the magic angle (T2= 24.5±5.2ms and T2*=9.0±2.0ms) (p<0.05). T2 (41.9±17.7ms) and T2* (32.0±8.4ms) of loaded cornea were also significantly higher than unloaded cornea (T2=31.6±10.5ms and T2*=24.0±12.6ms) (p<0.05). Conclusions: Magic angle-enhanced SE and GE MRI can detect and quantify differences in ocular fibrous structures upon IOP loading. This technique may open up new avenues for non-invasive and longitudinal assessments of the biomechanics and biochemistry of ocular tissues in aging and in diseases involving the corneoscleral shell. Representative gradient-echo T2*-weighted MR images of the sclera (left) and cornea (right) with (red arrows) or without (blue arrows) IOP loading at 50mmHg. The green boxes indicate the tissue sections oriented near the magic angle at ~55o to Bo. 48 Commercial Relationships Disclosure (Abstract): Leon Ho: Commercial Relationship: Code N (No Commercial Relationship) | Ian Sigal: Commercial Relationship: Code N (No Commercial Relationship) | Ning-Jiun Jan: Commercial Relationship: Code N (No Commercial Relationship) | Alexander Squires: Commercial Relationship: Code N (No Commercial Relationship) | Zion Tse: Commercial Relationship: Code N (No Commercial Relationship) | Ed Wu: Commercial Relationship: Code N (No Commercial Relationship) | Seong-Gi Kim: Commercial Relationship: Code N (No Commercial Relationship) | Joel Schuman: Commercial Relationship(s);Zeiss, Inc.:Code P (Patent) | Kevin Chan: Commercial Relationship: Code N (No Commercial Relationship) 49 02:30 PM-02:45 PM Program Number: 19 Accuracy of a Method for Measuring Micron-Scale Collagen Fiber Orientation Author(s): Ning-Jiun Jan1, 2, Jonathan L. Grimm2, Bo Wang1, 2, Kira Lathrop2, Huong Tran1, 2, Gadi Wollstein2, Larry Kagemann2, Hiroshi Ishikawa2, Joel Schuman2, Ian A. Sigal2, 1 1 University of Pittsburgh, 2University of Pittsburgh Purpose: Collagen fiber orientation is a critical factor in determining the biomechanical response to loading of ocular tissues. Our goal was to determine the accuracy of a method to measure micron-scale fiber orientation. Methods: Two cases were analyzed: a single fiber of nylon string and a region of a sheep’s lamina cribrosa (LC) with multiple intertwining fibers. The nylon string was mounted to a glass slide, imaged using light microscopy (Olympus BX60, 12-bit grayscale 1600x1200 pixels, 0.73 µm/pixel, 10x objective, NA 0.30), and analyzed to determine local fiber orientation as previously described (Jan NJ, et al., ARVO E-Abstract 65, 2013). A spline trace of the string was drawn and the interpolated orientation of the trace (Fig1A) was compared to the measured fiber orientation (Fig1B). A sheep eye (<2 yo) was fixed in formalin (10%) within 24 hours of death. Following fixation the optic nerve head was cryosectioned coronally (30 µm). A section through the LC was selected and imaged 17 times, as above, with the sample rotated between 0° and 80°. Fiber orientation was computed and the known sample orientation subtracted. Accuracy was computed by comparing the “true orientation change” with the fiber angle change measured at every pixel (Fig2A). Results: For a single fiber, the angle differences between the spline trace and measured orientation were within ±1° (Fig1C). For the LC, the mean angle differences between the true and measured orientation changes were within ±1° (Fig2B). Conclusions: Our method was highly accurate for single and multiple intertwining fibers, enabling accurate fiber tracing and detection of fiber orientation changes. Future work will involve applying this method to measure micron-scale biomechanics of the eye. Measuring Accuracy in a Single Fiber A) The nylon fiber with the trace overlaid in red. B) An image of the measured fiber orientation of the string, with the color representing the angle. C) A Bland-Altman plot of the angle differences between the trace and measured angle. The lines above and below represent the 95 th percentile. 50 Measuring Accuracy in Tissue with Intertwining Fibers A) The region of sheep LC used for analysis. B) Box plots of the distribution of differences between true and measured fiber orientation angle change computed at every pixel in the image of panel A. The lines above and below represent the 95 th percentile. Commercial Relationships Disclosure (Abstract): Ning-Jiun Jan: Commercial Relationship: Code N (No Commercial Relationship) | Jonathan Grimm: Commercial Relationship: Code N (No Commercial Relationship) | Bo Wang: Commercial Relationship: Code N (No Commercial Relationship) | Kira Lathrop: Commercial Relationship: Code N (No Commercial Relationship) | Huong Tran: Commercial Relationship: Code N (No Commercial Relationship) | Gadi Wollstein: Commercial Relationship: Code N (No Commercial Relationship) | Larry Kagemann: Commercial Relationship: Code N (No Commercial Relationship) | Hiroshi Ishikawa: Commercial Relationship: Code N (No Commercial Relationship) | Joel Schuman: Commercial Relationship: Code N (No Commercial Relationship) | Ian Sigal: Commercial Relationship: Code N (No Commercial Relationship) 51 02:45 PM-03:00 PM Program Number: 20 Automated identification of Schlemm’s canal and collector channels from spectral domain optical coherence tomography images. Author(s): Siamak Yousefi1, Amir Marvasti3, Robert N. Weinreb1, Christopher Bowd1, Alex Huang2 1 Hamilton Glaucoma Center, 2USC Eye Institute, 3Boston University Purpose: To develop an algorithm for automated detection of human Schlemm’s canal (SC) and collector channels (CC) from in vivo SDOCT images. Methods: SDOCT images were collected from the right eye of a healthy subject using the Spectralis Anterior Segment lens (Heidelberg Engineering, Heidelberg, Germany). Two separate volumes were obtained along the temporal portion of the eye, each consisting of a sequence of 81 consecutive axial 2D slices at the limbus. Axial resolution of each A-scan was 3.9 µm with a lateral resolution of 11 µm and distance between B-scans of 11 µm. The image processing pipeline for detecting SC, CC and outflow pathways had four main steps: 1) an algorithm was applied to identify the region around the intersection of cornea and iris (region of interest, ROI), 2) an algorithm was applied to the ROI to detect SC/CC, 3) an object detection algorithm was applied to identify SC/CC, and 4) all identified SC/CC and the tissue boundaries were fused for visualization. Each image-processing step included several preprocessing tasks including noise reduction, binarization (using minimization of intra-class variance of the background and object pixels), morphology based object analysis, and shape analysis. Images were then analyzed for detection rate. For each 2D slice, detection was stratified along three criteria: (a) good detection (Fig. 1a; >50% of the visualized SC/CC was identified by the algorithm; arrow), (b) detection (Fig. 1b; ≤50% of the visualized SC/CC was identified by the algorithm; arrow is detected portion and arrowhead is undetected portion), and (c) no detection (Fig. 1c; failure to identify SC/CC; arrowhead). Results: In volume 1, SC/CC were successfully identified in 93% of SDOCT 2D images with a good detection rate of 60%. In volume 2, SC/CC were successfully identified in 91% of SDOCT 2D images with a good detection rate of 62%. Errors in detection included failure to identify SC/CC, identification of extraneous locations (Fig. 1c), and identification within the choroid (where pixel intensity levels paralleled that of SC/CC). Conclusions: SC, CC, and outflow pathways from SDOCT in vivo images can be identified with great fidelity using the proposed image processing pipeline. 52 Commercial Relationships Disclosure (Abstract): Siamak Yousefi: Commercial Relationship: Code N (No Commercial Relationship) | Amir Marvasti: Commercial Relationship: Code N (No Commercial Relationship) | Robert Weinreb: Commercial Relationship(s);Aerie:Code F (Financial Support);;Alcon Laboratories:Code C (Consultant);Allergan Inc:Code C (Consultant);Bausch & Lomb Inc.:Code C (Consultant);Carl Zeiss Meditec Inc.:Code F (Financial Support);Carl Zeiss Meditec Inc.:Code C (Consultant);Genentech:Code F (Financial Support);Heidelberg Engineering GmbH:Code F (Financial Support);National Eye Institute:Code F (Financial Support);Novartis:Code F (Financial Support);Optovue Inc:Code F (Financial Support);Sensimed Inc:Code C (Consultant);Topcon Inc.:Code C (Consultant);Topcon Inc.:Code F (Financial Support) | Christopher Bowd: Commercial Relationship: Code N (No Commercial Relationship) | Alex Huang: Commercial Relationship: Code N (No Commercial Relationship) 53 03:00 PM-03:15 PM Program Number: 21 Functional Microvascular Imaging of the Conjunctiva: a noninvasive tool to measure and quantify subtle variations and abnormalities in the microvasculature Author(s): Delia Cabrera DeBuc1, Hong Jiang1, 2, Nicole Stuebiger3, Che Liu1, Tian Jing1, Gabor Mark Somfai4, Janet Davis1, William E. Smiddy1, Jianhua Wang1 1 University of Miami, 2University of Miami, 3Charité Universitätsmedizin Berlin, 4Semmelweis University Purpose: To demonstrate the advantages of functional microvascular imaging of the conjunctiva for clinical applications where understanding of microvascular pathology may provide useful information for predicting the onset, progression and prognosis of both systemic and central nervous system (CNS) vascular diseases. Methods: The bulbar conjunctival vasculature was imaged using a retinal function imager (RFI, Optical Imaging Ltd, Rehovot, Israel) and a novel functional slit-lamp biomicroscopy (FSLB) imaging device. Hemoglobin in red blood cells was used as an intrinsic motion-contrast agent in the generation of detailed noninvasive capillaryperfusion maps (nCPMs) from RFI images, noninvasive microvascular perfusion maps (nMPMs) from FSLB images and the calculation of the blood flow velocity. Oximetric state of the bulbar conjunctiva was qualitatively investigated from multispectral images obtained with the RFI unit. Results: The RFI and FSLB systems were successfully used to obtain and analyze the angiography of conjunctival blood vessels from a pool of healthy controls and patients with diabetes w/o retinopathy (see Fig. 1), retinal vasculitis of unknown origin, Birdshot chorioretinopathy, suspicion of glaucoma, cerebral small vessel disease (CSVD) and multiple sclerosis. The bulbar conjunctival microvascular network was also investigated in healthy subjects before and after wearing contact lenses The nCPMs obtained with the RFI showed the conjunctival microvasculature in exquisite detail, however nMPMs showed higher-resolution angiography of conjunctival blood vessels obtained with the FSLB device (see Fig. 2). Perfusion deficits and abnormalities were observed as an indication of oximetric changes occurring after several types of challenges to the bulbar conjunctiva. Variations between normal vessels and vessels exhibiting reduced red blood cell velocity were observed in pathological eyes. Particularly, conjunctival vessel changes occurred even before non-proliferative retinopathy develops in diabetic patients. Conclusions: Detection of functional microvasculature abnormalities by direct, noninvasive enhanced visualization of conjunctival vessels may permit diagnosis of diseases and disease progression before anatomic abnormalities become evident, allowing treatment intervention before irreversible microvasculature damage occurs. 54 Commercial Relationships Disclosure (Abstract): Delia Cabrera DeBuc: Commercial Relationship(s);NIH/NEIEY020607:Code F (Financial Support);NIH R01EY020607S:Code F (Financial Support);NIH Center Core Grant P30EY014801:Code F (Financial Support);US 61/139,082:Code P (Patent);University of Miami:Code P (Patent) | Hong Jiang: Commercial Relationship(s);NIH/NEI-EY020607S:Code F (Financial Support);University of Miami:Code P (Patent) | Nicole Stuebiger: Commercial Relationship: Code N (No Commercial Relationship) | Che Liu: Commercial Relationship: Code N (No Commercial Relationship) | Tian Jing: Commercial Relationship(s);NIH/NEI- EY020607:Code F (Financial Support) | Gabor Mark Somfai: Commercial Relationship: Code N (No Commercial Relationship) | Janet Davis: Commercial Relationship: Code N (No Commercial Relationship) | William Smiddy: Commercial Relationship: Code N (No Commercial Relationship) | Jianhua Wang: Commercial Relationship(s);University of Miami:Code P (Patent) 55 03:15 PM-03:30 PM Program Number: 22 Ultra-High Resolution Optical Coherence Tomography for the Differentiation of Ocular Surface Squamous Neoplasia and Melanoma Author(s): Juan Murillo, Anat Galor, Afshan A. Nanji, Madhura G. Joag, James R. Wong, Nabeel M. Shalabi, Marwan Atallah, Ibrahim Sayed-Ahmed, Carol L. Karp Bascom Palmer Eye Institute - University of Miami Purpose: To asses the use of ultra-high-resolution optical coherence tomography (UHR-OCT) as a key diagnostic tool in distinguishing ocular surface squamous neoplasia (OSSN) from melanoma of the conjunctiva. The establishment of the correct diagnosis is crucial. OSSN usually follows a benign course whereas melanoma has a very aggressive behavior with high mortality rates. Methods: In this clinical case series, one hundred and eight eyes of 108 patients with conjunctival lesions: OSSN and biopsy proven melanomas were recorded. Clinical features, slit-lamp photographs and UHR-OCT scans (RTVue premier, Optovue, Fremont, CA, USA) are described. Results: We evaluated 101 OSSN and 7 melanomas with UHR-OCT. In all cases the OSSN revealed a thickened hyperreflective (whitish) epithelial layer often with an abrupt transition from normal to hyperreflective epithelium (Figure 1). The mean epithelial thickness in the OSSN group was 233 ± 165 μm (range 72-1170). The melanoma group, disclosed an overall thinner epithelium, with the presence of a subepithelial mass (Figure 2). The mean epithelial thickness was 69 ± 29 μm (range of 35-117). Differences in the measured epithelial thickness on UHROCT between the two entities were statistically significant (p-value =0.01) to such a degree that a cutoff value of 86.5 microns was able to reliably differentiate melanoma from OSSN with a sensitivity of 94% and a specificity of 86%. Conclusions: Ultra-high resolution OCT is a noninvasive novel diagnostic tool that is helpful in evaluating ocular surface lesions. Morphologic features displayed by the UHR OCT can be an important adjunct in evaluating OSSN and melanoma. Figure 1. Clinical photos and UHR-OCT scans of ocular surface squamous neoplasia (OSSN). Figure 1A and 1B demonstrate elevated, gelatinous limbal lesions and 1C shows a papilomatous limbal lesion. Figures 1D, 1E and 1F display UHR-OCT images with a thickened hyperreflective epithelial layer (white arrows) and an abrupt transition from normal to hyperreflective epithelium (black arrows). 56 Figure 2. Clinical photos and UHR-OCT scans of amelanotic conjunctival melanomas. Figure 2A, 2B and 2C demonstrate raised, mostly nonpigmented, conjunctival lesions. Figure 2D, 2E and 2F show UHR-OCT images with subepithelial lesions (black arrows) beneath a normal to mildly thickened epithelium (white arrows). Commercial Relationships Disclosure (Abstract): Juan Murillo: Commercial Relationship: Code N (No Commercial Relationship) | Anat Galor: Commercial Relationship(s);Bausch & Lomb:Code C (Consultant) | Afshan Nanji: Commercial Relationship: Code N (No Commercial Relationship) | Madhura Joag: Commercial Relationship: Code N (No Commercial Relationship) | James Wong: Commercial Relationship: Code N (No Commercial Relationship) | Nabeel Shalabi: Commercial Relationship: Code N (No Commercial Relationship) | Marwan Atallah: Commercial Relationship: Code N (No Commercial Relationship) | Ibrahim Sayed-Ahmed: Commercial Relationship: Code N (No Commercial Relationship) | Carol Karp: Commercial Relationship(s);NIH Center Core Grant P30EY014801, RPB Unrestricted Award and Career Development Awards, Department of Defense (DODGrant#W81XWH-09-1- 0675)The Ronald and Alicia Lepke Grant, The Lee and Claire Hager Grant, The Jimmy and Gaye Bryan Grant.:Code F (Financial Support) 57 Novel Methods for Small Animal Imaging 04:00 PM-05:30 PM Moderators: Yoshiaki Yasuno, PhD Richard Rosen, PhD 58 04:00 PM-04:15 PM Program Number: 23 Two-photon imaging of inner and outer retina in the living primate eye Author(s): Robin Sharma4, 1, David R. Williams1, 4, Grazyna Palczewska2, Krzysztof Palczewski5, Jennifer Hunter3, 1 1 University of Rochester, 2Polgenix, Inc, 3University of Rochester, 4University of Rochester, 5Case Western Reserve University Purpose: Adaptive optics assisted two-photon imaging of the retina has the potential to simultaneously provide structural as well as functional information from individual cells in the living eye. Previously, it was deployed to capture intrinsic fluorescence from individual cone photoreceptors in the macaque eye. Our goal is to expand the utility of this modality by imaging in vivo a broader range of cell types. Methods: A two-photon adaptive optics scanning light ophthalmoscope was developed for imaging living primates. For this study, two different macaques were imaged under isofluorane anaesthesia. An ultrashort pulsed laser (~ 55 fs pulse-width) with a tunable central wavelength was used to excite two-photon fluorescence. Images were acquired at two different central wavelength settings (730 or 920 nm) using light levels that were below the threshold for retinal damage with each acquisition (< 7 mW average power incident on the cornea). High signal-to-noise ratio reflectance images were simultaneously acquired to correct for eye motion. Results: Consistent with measurements made in excised retina, fluorescence emission was detected throughout the retina in vivo. For 730 nm excitation, the strongest autofluorescence signal originated from near the photoreceptor layer, whereas for 920 nm excitation, the brightest intrinsic fluorescence emanated from the retinal pigment epithelium. Two-photon images of individual cells and other recognizable structures were obtained in multiple retinal layers such as the nerve fiber bundles (at 730 nm), individual rods as well as cones (at 730 nm) and retinal pigment epithelial cells (at 920 nm). During light exposure, autofluorescence signal from the inner retina increased with time in a manner that was qualitatively similar to earlier results obtained in the outer retina. Conclusions: It is possible to resolve single cells in retinal layers other than the photoreceptors using in vivo twophoton autofluorescence imaging. This is an important step towards noninvasively monitoring functional activity in many individual retinal layers. Commercial Relationships Disclosure (Abstract): Robin Sharma: Commercial Relationship(s);Canon, Inc. :Code F (Financial Support) | David Williams: Commercial Relationship(s);Canon, Inc.:Code F (Financial Support);Polgenix, Inc. :Code F (Financial Support);Pfizer:Code C (Consultant);University of Rochester:Code P (Patent);Pfizer:Code R (Recipient) | Grazyna Palczewska: Commercial Relationship(s);Polgenix, Inc. :Code E (Emplyment) | Krzysztof Palczewski: Commercial Relationship(s);Polgenix, Inc.:Code I (Personal Financial Interest);Polgenix, Inc.:Code E (Emplyment);Polgenix, Inc.:Code P (Patent) | Jennifer Hunter: Commercial Relationship(s);Canon, Inc.:Code F (Financial Support) 59 04:15 PM-04:30 PM Program Number: 24 3D-imaging of Rat Retina Using Contrast Enhanced X-ray Microtomography Author(s): Kalle Lehto2, 3, Ilmari Tamminen2, 3, Soile Nymark2, 3, Tanja Ilmarinen3, Hannu Uusitalo4, 5, Heli Skottman3, Antti Aula2, 1, Jari Hyttinen2, 3 1 Imaging Centre, Tampere University Hospital, 2Tampere University of Technology, 3University of Tampere, 4 Tampere University Hospital, 5University of Tampere Purpose: Present methods for preclinical imaging of animal retina are mostly limited to only a part of the retina. High-resolution X-ray microtomography (µCT), enhanced with appropriate contrast agents, has been used for imaging various soft tissues (Metscher 2009, Pauwels et al. 2013). In this study, we further developed contrast enhanced μCT for ex vivo eye imaging and used the method for comparison of the anatomy in healthy and RCS rat eyes. Methods: Control (n=3) and RCS (n=3) rats (24 weeks old) were sacrificed and the eyes harvested, fixed in Davidson's solution and dehydrated in ethanol. Before the imaging, the eyes were immersed in 15 ml of absolute ethanol, augmented with 1% w/v iodine, for at least 10 days. The eyes were then scanned with a Xradia MicroXCT400 with scanning parameters 75kV/133µA. The achieved voxel size was 3.1 µm. Moreover, the area around the optic nerve bundle was imaged with 1.2 µm voxel size. Reconstructed 3D image stacks were post-processed with Avizo Fire 8.0.1 software (FEI Visualization Sciences Group). The images were filtered with edge-preserving nonlocal means filter and segmented by semi-automatic watershed algorithm with manual correction. Thickness of the retina was calculated by using the specific surface thickness-function. Results: Eight anatomical layers of retina were identified. Contrast enhanced µCT allowed high-resolution imaging, visualization and morphological analysis of most of the eye tissues (Figure 1). Dystrophic changes in the retina can be clearly assessed from the images (Figure 2). Overall thickness of the retina was 15% lower in the RCS eyes. Conclusions: Morphology of the ex vivo eye structures can be assessed quantitatively in 3D using μCT. The acquired image sets can be used for 3D histology without physically sectioning the sample. However, the data can be virtually sectioned in silico in any direction. Contrast enhanced µCT is a promising imaging modality for preclinical ex vivo studies of the eye. The whole eye (A) can be examined and analysed (B) with 3.1 µm voxel size. Moreover, specified regions of interest, for example the optical nerve (C), can be zoomed into 60 Comparison of a histological section (top) and µCT images of healthy (middle) and dystrophic (bottom) eyes showed the potential of µCT in preclinical studies of the eye anatomy. The loss of outer segments of the photoreceptor layer is evident in the dystrophic eye (arrows). Commercial Relationships Disclosure (Abstract): Kalle Lehto: Commercial Relationship: Code N (No Commercial Relationship) | Ilmari Tamminen: Commercial Relationship: Code N (No Commercial Relationship) | Soile Nymark: Commercial Relationship: Code N (No Commercial Relationship) | Tanja Ilmarinen: Commercial Relationship: Code N (No Commercial Relationship) | Hannu Uusitalo: Commercial Relationship: Code N (No Commercial Relationship) | Heli Skottman: Commercial Relationship: Code N (No Commercial Relationship) | Antti Aula: Commercial Relationship: Code N (No Commercial Relationship) | Jari Hyttinen: Commercial Relationship: Code N (No Commercial Relationship) 61 04:30 PM-04:45 PM Program Number: 25 The Influence of Metabolism on Retinal OCT Imaging: What We’ve Learned from a Hibernating Animal Model Author(s): Brent A. Bell1, Yichao Li2, Fengyu Qiao3, Haohua Qian2, Joe G. Hollyfield1, Wei Li3 1 Cleveland Clinic, 2National Eye Institute, 3National Eye Institute Purpose: To evaluate retinal changes in active and hibernating ground squirrels using a commercially available ultra-high resolution Spectral Domain Optical Coherence Tomography (OCT) system. Methods: Thirteen-lined ground squirrels (n=13) were imaged prior to, during, and after hibernation using a Bioptigen Envisu R2200 UHR system with theoretical axial resolution <2µm. Post-mortem imaging was performed on euthanized animals for comparison. Horizontal and vertical B-scans (20 frames by 1000 A-scans/B-scan) were acquired ventral to the visual streak. Scans were coregistered and averaged in linear signal units. Absolute (ABS) and ratiometric (RM) changes were analyzed from in-depth signal amplitudes of retinal lamina. Retinal morphology was compared to published (Reme & Young, 1977) and acquired histomorphology data. Results: Non-hibernating animals showed well-defined retinal lamina that correlated well with retinal histology. Morphology appearance was identical in either B-scan orientation. Hibernation resulted in dramatic changes to signal amplitude and image contrast, with no significant changes to thicknesses of any outer retinal layer relative to non-hibernating conditions. Measurements of photoreceptor inner (20.8±1.5µm) and outer segments (6.5±1.1µm), as well as dimensions of the myoid (~12µm) and ellipsoid (~8µm) regions were similar to published data. Choroidal thickness was significantly reduced (44%, p=.0008) during torpor, but returned to normal by 1 hr posthibernation. Signal magnitude for a band at the ellipsoid (a region with high density of mitochondria) location showed the greatest change (ABS-55%/RM-70%; p<.0001). On average, signal magnitudes were partially and fully restored to pre-hibernation levels after 1-3 & 24 hours of recovery, respectively. Results from post-mortem animals were similar to those observed in animals under awake and hibernating states. Conclusions: The ground squirrel is a unique model for understanding the influence of metabolic activity on OCT imaging. Retinal signal amplitude is substantially altered during hibernation yet rapidly returns post-hibernation. The most dramatic changes occurred in the photoreceptor ellipsoid, which suggests that OCT is capable of discerning differences in mitochondrial architecture, number or volume as a result of changing metabolic activity in animals undergoing circannual hibernation. 62 Commercial Relationships Disclosure (Abstract): Brent Bell: Commercial Relationship: Code N (No Commercial Relationship) | Yichao Li: Commercial Relationship: Code N (No Commercial Relationship) | Fengyu Qiao: Commercial Relationship: Code N (No Commercial Relationship) | Haohua Qian: Commercial Relationship: Code N 63 04:45 PM-05:00 PM Program Number: 26 Spatial relationship between retinal loss and neurodegeneration of the visual system using optical coherence tomography (OCT) and diffusion tensor MR imaging (DTI) Author(s): Bo Wang1, 2, Leon C. Ho1, 3, Ian P. Conner1, 2, Richard A. Bilonick1, 4, Hiroshi Ishikawa1, 2, Amanda Woodside1, Chieh-Li Chen1, Gadi Wollstein1, Joel S. Schuman1, 2, Kevin C. Chan1, 2 1 University of Pittsburgh School of Medicine, 2University of Pittsburgh, 3The University of Hong Kong, 4University of Pittsburgh Purpose: Recent studies have indicated the early involvement of degeneration along both anterior and posterior visual pathways in ocular diseases and injuries. However, the spatial relationship between retinal damage and neurodegeneration in the posterior visual pathway is not fully elucidated. In this study, we use OCT and DTI to investigate the effects of retinal loss on neurodegeneration of the visual system in an N-methyl-D-aspartate (NMDA)-induced rat model. Methods: Four Sprague-Dawley rats (6 week old) were intravitreally injected with NMDA in the right eye, with the left eye serving as an internal control. One month later, OCT volume scans centered on the optic nerve head were taken and automatically segmented to determine total retinal thickness (TRT) along a band with inner and outer radii of 0.39 and 0.49mm, respectively. DTI scans were taken in a 9.4 Tesla horizontal MRI scanner to assess the microstructural integrity at the optic nerve and optic tract via 4 DTI parameters: fractional anisotropy (FA), axial diffusivity (λ||), radial diffusivity (λ┴), and mean diffusivity (MD). Paired t-tests were used to determine the difference between parameters in the visual pathways projected from injured and control eyes, and linear mixed effects model was used to determine the relationships between NMDA treatment, TRT and DTI parameters. Results: Mean TRT was 223±16μm for control eyes and 174±13μm for NMDA-injured eyes (p<0.01). TRT was positively correlated with FA in both optic nerve and optic tract (p<0.05) and with λ|| in optic tract (p<0.05). TRT was negatively correlated with λ┴ in optic nerve and optic tract (p<0.05) (Figure E). In general, correlation plots between TRT and DTI parameters showed steeper slopes in optic nerve than in optic tract, with λ ┴ being significantly steeper in optic nerve than optic tract (p<0.05). Conclusions: OCT and DTI findings suggested that with retinal injury, there is 1) compromise of overall microstructural integrity (decreased FA), 2) axonal damage (decreased λ ||) and 3) demyelination (increased λ┴) along the visual pathway. Our results demonstrated the linear relationship between excitotoxic retinal injury and the microstructural changes occurring in the brain in vivo, with more pronounced changes in DTI parameters closer to the site of insult. 64 Commercial Relationships Disclosure (Abstract): Bo Wang: Commercial Relationship: Code N (No Commercial Relationship) | Leon Ho: Commercial Relationship: Code N (No Commercial Relationship) | Ian Conner: Commercial Relationship: Code N (No Commercial Relationship) | Richard Bilonick: Commercial Relationship: Code N (No Commercial Relationship) | Hiroshi Ishikawa: Commercial Relationship: Code N (No Commercial Relationship) | Amanda Woodside: Commercial Relationship: Code N (No Commercial Relationship) | Chieh-Li Chen: Commercial Relationship: Code N (No Commercial Relationship) | Gadi Wollstein: Commercial Relationship: Code N (No Commercial Relationship) | Joel Schuman: Commercial Relationship(s);Zeiss:Code P (Patent) | Kevin Chan: Commercial Relationship: Code N (No Commercial Relationship) 65 05:00 PM-05:15 PM Program Number: 27 Engineering of Gold Nanorods for Contrast-Enhanced Retinal OCT Author(s): Andrew Gordon1, Jason Craft2, Ashwath Jayagopal1, 2 1 Vanderbilt University Medical Center, 2Vanderbilt Eye Institute Purpose: Biocompatible exogenous contrast agents based on gold nanorods (GNR) were synthesized and characterized for applications in retinal optical coherence tomography (OCT). Cell culture and animal models were used to detect GNR uptake in specific retinal cell types. Methods: GNR were synthesized with a surface plasmon resonance (SPR) within the 800-900 nm band, tuned to interact with the light wavelengths emitted by the Bioptigen OCT system to generate image contrast. The monolayer of cetyltrimethylammonium bromide (CTAB) found residually on the surface of GNR after their fabrication was substituted with relatively biologically inert polyethylene glycol (PEG) monolayer to render them fully biocompatible with ocular tissue. The PEG layer was modified to include an amine moiety that is amenable to conjugation with GNR targeting ligands for targeting GNR to retinal cells in vivo. Surface modification of GNR and GNR size were verified by electron microscopy, dynamic light scattering, mass spectrometry, and nuclear magnetic resonance (NMR) spectroscopy. Retinal cells were analyzed in vitro for GNR binding and uptake, and C57BL/6J mice were imaged in vivo following intraocular injection of GNR to image contrast enhancement of retinal layers exhibiting GNR uptake. Results: GNR size and PEG functionalization was verified, and GNR uptake into retinal cells in vitro was confirmed using the aforementioned characterization technologies. Following intraocular injection of the PEGylated GNR in mice, retinal contrast enhancement was observed using OCT. Targeting ligands enabled the detection of retinal ganglion cell and endothelial cell biomarkers in animal models. Conclusions: Previous work on fabricating OCT contrast agents for use in the eye also relied on GNR, but encountered major limitations related to degradation of image quality secondary to the contrast agents’ cytotoxic and inflammatory properties. In this report, a method for removing the cytotoxic CTAB layer from GNR provides a route for clinically translatable OCT contrast agents used for detection of disease biomarkers and specific cell types in the retina. Commercial Relationships Disclosure (Abstract): Andrew Gordon: Commercial Relationship: Code N (No Commercial Relationship) | Jason Craft: Commercial Relationship: Code N (No Commercial Relationship) | Ashwath Jayagopal: Commercial Relationship: Code N (No Commercial Relationship) 66 05:15 PM-05:30 PM Program Number: 28 The Effect of Microtubule-stabilizing Agents on the Retinal Ganglion Cell Axons Studied by SecondHarmonic Generation Microscopy Author(s): Hyungsik Lim1, John Danias2 1 Hunter College, CUNY, 2SUNY Downstate Medical Center Purpose: To demonstrate the utility of second-harmonic generation microscopy (SHGM) for evaluating the efficacy of pharmacological treatments to stabilize and rescue the major cytoskeleton of axonal transport in the retinal ganglion cells (RGCs) Methods: A couple of common fixatives as well as microtubule-stabilizing agent (Taxol) were tested using the retina of 4-week old Sprague-Dawley rats. The retinal flatmounts were prepared and treated with agents, while timelapse SHGM imaging was performed with circularly polarized excitation beam. The recorded microtubular SHG (MT-SHG) emission was analyzed to examine the structural changes. Results: The SHG signal from the retinal nerves gradually decreased due to postmortem dissociation of MTs and the rate depended on the ambient conditions. Most chemical fixatives including 4% paraformaldehyde failed to preserve the MT-SHG signal, whereas the retina treated with Taxol exhibited the arrest of signal reduction or even increase in the MT-SHG emission at room temperature as well as 37 degree C. Conclusions: We have demonstrated that the intensity of MT-SHG signal is sensitive only to the form of MT structure that is physiologically active. Our results also show that the ensemble kinetics of MTs in the RGC axon can be examined in the living tissue by SHGM without exogenous labeling, thus providing a practical means to test the feasibility of MT recovery for restoring axonal transport which is known to be implicated in the progression of glaucoma. (Left) Topographic SHG imaging of the rat retina. (Right) SHG intensity from the fresh retinal nerves (N=4) when Taxol is introduced at T=0. Commercial Relationships Disclosure (Abstract): Hyungsik Lim: Commercial Relationship: Code N (No Commercial Relationship) | John Danias: Commercial Relationship: Code N (No Commercial Relationship) 67 Poster Presentations 10:00 AM-10:30 AM 12:00 – 1:30 PM 3:30 – 4:00 PM S 310E - H 68 201 Anterior Eye / Glaucoma Poster Board Number: P1 Applications of photoacoustic tomography to imaging and estimation of oxygen saturation of hemoglobin in ocular tissue of rabbits Author(s): Stella Hennen1, 5, Wenxin Xing2, Ying-Bo Shui3, Yong Zhou2, Jennifer Kalishman 4, Lisa AndrewsKaminsky4, Michael Kass3, David Beebe3, Konstantin Maslov2, Lihong Wang2 1 Hennepin County Medical Center, 2School of Engineering and Applied Science, Washington University in St. Louis, 3School of Medicine, Washington University in St. Louis, 4School of Medicine, Washington University in St. Louis, 5School of Medicine, University of Minnesota Purpose: To evaluate imaging capabilities and safety of measurements of oxygen saturation of hemoglobin (sO2) of ocular tissue obtained with photoacoustic tomography (PAT) modality in rabbits in vivo. Methods: Photoacoustic tomography (PAT) was used to collect images from the iris and ciliary body vasculature (arteries and veins) of seven New Zealand White rabbits. The sO2 measurements were obtained under conditions of relative hyperoxia, normoxia, or hypoxia. Systemic sO2 was monitored by pulse oximetry. Following imaging, histological analysis of ocular tissue was conducted to evaluate for possible structural damage caused by the PAT imaging. Results: PAT was able to resolve anatomical structures of the anterior segment of the eye. Histological studies revealed no ocular damage. On average, sO2 values obtained with PAT were lower than sO2 values obtained with pulse oximetry (all p<0.001): 86.28±4.16 versus 99.25±0.28, 84.09±1.81 vs. 95.3±2.6, and 64.49±7.27 vs. 71.15±10.21 for hyperoxia, normoxia and hypoxia respectively. Conclusions: PAT imaging modality is capable of providing in vivo sO2 measurements in rabbits. Further studies are needed to modify the PAT modality specifically for use in humans. Having a safe non-invasive method of in vivo imaging of sO2 is important to studies evaluating the role of oxidative damage in pathogenesis of ocular diseases. Commercial Relationships Disclosure (Abstract): Stella Hennen: Commercial Relationship: Code N (No Commercial Relationship) | Wenxin Xing: Commercial Relationship: Code N (No Commercial Relationship) | YingBo Shui: Commercial Relationship: Code N (No Commercial Relationship) | Yong Zhou: Commercial Relationship: Code N (No Commercial Relationship) | Jennifer Kalishman : Commercial Relationship: Code N (No Commercial Relationship) | Lisa Andrews-Kaminsky: Commercial Relationship: Code N (No Commercial Relationship) | Michael Kass: Commercial Relationship: Code N (No Commercial Relationship) | David Beebe: Commercial Relationship: Code N (No Commercial Relationship) | Konstantin Maslov: Commercial Relationship(s);Microphotoacoustics, Inc. and Endra, Inc.:Code P (Patent) | Lihong Wang: Commercial Relationship(s);Microphotoacoustics, Inc. and Endra, Inc.:Code P (Patent) 69 Poster Board Number: P2 Quantitative MRI-derived optic nerve microstructural features in a feline glaucoma model Author(s): Gillian J. McLellan1, 2, Samuel A. Hurley3, Pouria Mossahebi4, Norman M. Ellinwood6, Aaron S. Field5 1 University of Wisconsin-Madison, 2McPherson Eye Research Institute, 3University of Wisconsin-Madison, 4 University of Wisconsin-Madison, 5University of Wisconsin-Madison, 6Iowa State University Purpose: To determine if quantitative MRI-derived microstructural features can detect optic nerve damage in a feline glaucoma model Methods: 6 adult cats (3 normal, 3 with primary congenital glaucoma[PCG]) were anesthetized with ketamine and xylazine. Magnetic resonance imaging (MRI) was performed on a 3T GE Discovery MR750 (GE Healthcare, Waukesha, WI) with an HD transmit/receive knee coil, with approval by the Institutional Animal Care and Use Committee. Optic nerve images were acquired using a T2-weighted CUBE fast spin echo sequence (TR/TEeff = 3000 / 80 ms, voxel dim = 234 x 234 x 800 µm3). Images were then rotated obliquely along each nerve, and crosssectional area measurements were performed using Jim 6.0 (Xinapse Systems, Colchester, UK). Microstructural features were quantified using two spoiled gradient recalled echo (SPGR) images (TR = 30 ms, α = [4 24]°, dim = 375 x 375 x 800 µm3) and one magnetization transfer (MT)-weighted SPGR image (θ = 850°, ∆ = 4 kHz). Correction for non-uniform RF transmit field was obtained using actual flip-angle imaging. These images were analyzed using two different techniques: MTSat was used to quantify T1 [s] (a measure related to bulk water content and microstructural integrity); simplified cross-relaxation imaging (CRI) was used to measure bound pool fraction f [%] (a measure related to macromolecular content). Regions of interest (ROI) were drawn on each optic nerve just anterior to the optic chiasm . The outer edge of pixels within the ROI were eroded to minimize partial volume effects, and the average value of each parameter was computed. Comparisons between normal and PCG groups were made by unpaired t-test, with p<0.05 considered significant. Results: With the exception of T1 the parameters evaluated, including optic nerve cross sectional area, MTSat (%) and f (%) were significantly lower in PCG relative to normal cats (see figure1) Conclusions: Our findings indicate that MRI may be of value in the quantification of glaucomatous optic nerve damage in vivo in this large animal glaucoma model but further studies will be necessary to determine inter-session repeatability. Figure 1: Magnetization transfer percentage saturation (MTSat; p=0.013) and bound pool fraction (f; p=0.015) were significantly lower in glaucomatous (GL) than normal (CTRL) cats. Commercial Relationships Disclosure (Abstract): Gillian McLellan: Commercial Relationship: Code N (No Commercial Relationship) | Samuel Hurley: Commercial Relationship: Code N (No Commercial Relationship) | Pouria Mossahebi: Commercial Relationship: Code N (No Commercial Relationship) | Norman Ellinwood: Commercial Relationship: Code N (No Commercial Relationship) | Aaron Field: Commercial Relationship: Code N (No Commercial Relationship) 70 Poster Board Number: P3 Analysis of the Cellular Dynamics of LysM-Positive Cells in a Corneal Suture Mouse Model using Intravital Imaging Author(s): Mayumi Ueta1, 2, Ayaka Koga1, 2, Masaru Ishii3, Shigeru Kinoshita1 1 Kyoto Prefectural University of Medicine, 2Faculty of Life and Medical Sciences, Doshisha University, 3Graduate School of Medicine and Frontier Bioscience, Osaka University Purpose: Corneal suture is a surgical procedure used to treat corneal trauma or for cases of corneal transplantation. However, suture-related inflammatory cell infiltration (dynamics) in the cornea has yet to be analyzed in detail. In LysM-eGFP mice, which are gene-targeted mice expressing enhanced green fluorescent protein (EGFP) under the control of the endogenous lysozyme M promoter, myeloid granulocyte cells are labeled with GFP in vivo, and the resulting endogenous neutrophils are brightly labeled. On the other hand, intravital imaging is a technique used to analyze cellular and molecular dynamics stereoscopically and time-dependently in an in vivo animal model. In this study, we analyze the dynamics of neutrophils in vivo in a LysM-eGFP corneal suture mouse model using intravital imaging. Methods: A 1-mm 10-1 nylon suture was surgically inserted through all layers in the center of the cornea of a LysM-eGFP mouse. Dynamics of the LysM-positive granulocytes (neutrophils) were then analyzed in vivo using intravital imaging. We also study the effect of steroid eye drops to infiltration of neutrophils due to the corneal suture using fluorescence microscopy; after suture placement, each mouse was administered 5μL of phosphate buffered saline (PBS) or steroid eye drops (0.1% betamethasone sodium phosphate ) 4 times daily. Moreover, we study the alteration of dynamics of neutrophils due to suture removal. Results: In the unsutured normal cornea (0 hours) of the LysM-eGFP mouse model, neutrophils were present in the corneal stroma of only the limbal region. At 2 hours after insertion of the corneal suture, neutrophils migrated from the limbal capillary loop to the cornea and conjunctiva, and reached the corneal suture at 6 hours after insertion. The number of neutrophils then increased and peaked at 48 hours after insertion of the suture. At 72 hours after insertion, infiltration of the neutrophils continued, yet decreased. Steroid eye-drop instillation produced no inhibitory effect on neutrophil infiltration into the cornea. Neutrophils disappeared post suture removal. Conclusions: Corneal suturing is a necessary procedure in some situations. In this study, we found that a corneal suture causes infiltration of neutrophils into the cornea. It is important to understand that due to placement of a corneal suture, inflammatory cells such as neutrophils will infiltrate into the cornea. Commercial Relationships Disclosure (Abstract): Mayumi Ueta: Commercial Relationship: Code N (No Commercial Relationship) | Ayaka Koga: Commercial Relationship: Code N (No Commercial Relationship) | Masaru Ishii: Commercial Relationship: Code N (No Commercial Relationship) | Shigeru Kinoshita: Commercial Relationship: Code N (No Commercial Relationship) 71 Poster Board Number: P4 Optical coherence tomography imaging to assist the iMvalv prototype development Author(s): Rodrigo M. Torres1, 3, Diego Ramirez Arduh1, Fabio A. Guarnieri2 1 Centro de Ojos Dr. Lódolo, 2Facultad de Ingenieria, Universidad Nacional de Entre Ríos, 3Facultad de Ingenieria, Universidad Nacional de Entre Ríos Purpose: The iMvalv is a new concept to modulate and control the ocular fluids dynamics. The main potential function is for glaucoma, as a micro-valve, but with an active mechanism (increase or decrease aqueous humor outflow) based on MEMS technology. The Purpose of this study is to evaluate the potential usefulness of the optical coherence tomography (OCT) as another tool for designing the iMvalv prototype. Methods: An experimental in-vitro surgery was performed to implant the iMvalv in a porcine-eye. Basically, after the conjunctiva and tenon were opened at the limbus to create a pocket, the device was placed in and the tube was introduced in the anterior chamber. The iMvalv was built with silicone multiple layers. A Stratus OCT was utilized to take the images captures, with the anterior segment mode (3.0 scan length). A second experiment was performed with a sole iMvalv prototype (non implanted valve), which was OCT scanned to evaluate his plate. Results: The OCT could show the tube and lumen of the iMvalv (Image 1). It could be observed into the anterior segment porcine-eye, as well as the cornea and the iris, with great detail. To evaluate the iMvalv plate, the OCT images were obtained from the non-implanted micro-valve, where anterior chamber tube, plate and drainage tube could be observed (Image 2); inside this plate reside his MEMS technology to increase or decrease aqueous humor flow. Conclusions: The OCT anterior segment scan was useful to obtain images from the iMvalv different parts. The iMvalv device design is in evolution and the OCT technology is another tool to evaluate it, as this study shows. To evaluate his internal active mechanism, OCT evaluation will be added for a future in-vitro experimental set-up study. Image 1. 72 Image 2. Commercial Relationships Disclosure (Abstract): Rodrigo Torres: Commercial Relationship: Code N (No Commercial Relationship) | Diego Ramirez Arduh: Commercial Relationship: Code N (No Commercial Relationship) | Fabio Guarnieri: Commercial Relationship: Code N (No Commercial Relationship) 73 Poster Board Number: P5 MRI, CT, and UBM imaging after corneal and cataract surgery Author(s): Sotiria Palioura1, James Chodosh1, Lois Hart1, Karen Capaccioli1, Daniel Ginat2, Suzanne Freitag1 1 Massachusetts Eye and Ear Infirmary, 2The University of Chicago Purpose: To report on the imaging characteristics of intraocular changes and complications after corneal and cataract surgery as seen in computed tomography (CT) and magnetic resonance imaging (MRI) scans of the orbits and correlate them with ultrasound biomicroscopy (UBM) images of the anterior segment. Methods: CT and MRI images were collected from the records of the Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital neuroradiology departments. UBM images were obtained at the ultrasonography suite of the Massachusetts Eye and Ear Infirmary. Only images of post-surgical changes or complications were included. Results: CT images include complications after penetrating keratoplasty and after Boston keratoprosthesis type I or II implantation such as expulsive suprachoroidal hemorrhage, endophthalmitis, vitreous hemorrhage, and inclusion cyst formation under surgically closed eyelids. The normal appearance of the Boston keratoprosthesis type I and II devices on CT and UBM imaging is also discussed. Complications after cataract surgery including lens dislocation, retained lens cortex, pseudophakic angle closure, and dystrophic calcification of the lens implant are presented as seen in CT, MRI and UBM images. Finally, MRI images of a normal lens, a posterior chamber intraocular lens implant, and absence of a lens (aphakia) are discussed. Conclusions: We correlate imaging features of changes or complications after corneal or cataract surgery as seen via various imaging modalities (CT, MRI, UBM) and aim to familiarize radiologists and ophthalmologists with such findings. Commercial Relationships Disclosure (Abstract): Sotiria Palioura: Commercial Relationship: Code N (No Commercial Relationship) | James Chodosh: Commercial Relationship: Code N (No Commercial Relationship) | Lois Hart: Commercial Relationship: Code N (No Commercial Relationship) | Karen Capaccioli: Commercial Relationship: Code N (No Commercial Relationship) | Daniel Ginat: Commercial Relationship: Code N (No Commercial Relationship) | Suzanne Freitag: Commercial Relationship: Code N (No Commercial Relationship) 74 Poster Board Number: P6 Rates of Glaucoma Progression as Detected by Optical Coherence Tomography (OCT) and Heidelberg Retinal Tomography (HRT) in a Long-Term Cohort Author(s): Divya Narendra1, Gadi Wollstein1, Dingle Foote1, Yun Ling1, 2, Richard A. Bilonick1, 2, Hiroshi Ishikawa1, 3, Larry Kagemann1, 3, Cynthia Mattox4, James G. Fujimoto5, Joel S. Schuman1, 3 1 UPMC Eye Center, Eye and Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, 2Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, 3Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, 4New England Eye Center, Tufts Medical Center, 5Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology Purpose: Mean retinal nerve fiber layer (RNFL) thickness and neuroretinal rim area are commonly used parameters in OCT and HRT, respectively, for assessing glaucoma progression. Prior studies comparing these devices have typically been limited by short duration of follow-up in a slowly progressing disease. The Purpose of this study is to examine, in a long-term cohort, the correspondence between OCT and HRT in regards to progression events and rates of change as determined by mean circumpapillary RNFL and rim area. Methods: 90 eyes (23 healthy (H), 20 glaucoma suspect (GS), 47 glaucoma (G)) from 52 subjects with at least five reliable tests for each OCT and HRT. Measurements from four generations of OCT were standardized by applying calibration equations. OCT and HRT progression was defined as significant negative slope on two consecutive visits. Mean RNFL and rim area values were standardized as proportions to that eye’s baseline measurements to allow direct comparison. Mean rates of change for these parameters were computed and compared for H, GS, and G subjects, as well as for OCT and HRT progressors. Results: Median follow-up time for the cohort was 6.9 years (range 3.3-13.0). 15 eyes showed OCT progression and 19 eyes showed HRT progression. Of these, 6 eyes showed progression by both Methods . Of these dual progressors, 5 eyes progressed by OCT then by HRT with median lag time of 2.9 years (range 1.1-5.6), and 1 eye progressed by HRT then by OCT with lag time of 1.7 years. Among G subjects, slope for rim area was steeper than that for RNFL (-0.015, -0.004; p<0.05). There was no difference in rim area and RNFL slopes among GS (0.0001, 0.002; p>0.5) and H subjects (-0.002, -0.002; p>0.5). Among HRT progressors, slope for rim area was steeper than that for RNFL (-0.019, -0.002; p<0.05). However, for OCT progressors, there was no difference in rim area and RNFL slopes (-0.023, -0.019; p>0.05). Conclusions: Despite long-term follow-up with OCT and HRT, there were conflicting outcomes in regards to eyes defined as progressing and rates of change among progressors. More eyes progressed by HRT than by OCT, but of eyes that progressed by both, most progressed initially by OCT. Additionally, HRT progressors had a steeper slope for rim area compared with mean RNFL, but for OCT progressors there was no difference in the slopes for the two parameters. Commercial Relationships Disclosure (Abstract): Divya Narendra: Commercial Relationship: Code N (No Commercial Relationship) | Gadi Wollstein: Commercial Relationship: Code N (No Commercial Relationship) | Dingle Foote: Commercial Relationship: Code N (No Commercial Relationship) | Yun Ling: Commercial Relationship: Code N (No Commercial Relationship) | Richard Bilonick: Commercial Relationship: Code N (No Commercial Relationship) | Hiroshi Ishikawa: Commercial Relationship: Code N (No Commercial Relationship) | Larry Kagemann: Commercial Relationship: Code N (No Commercial Relationship) | Cynthia Mattox: Commercial Relationship: Code N (No Commercial Relationship) | James Fujimoto: Commercial Relationship(s);Zeiss:Code P (Patent);Optovue:Code P (Patent);Optovue:Code I (Personal Financial Interest) | Joel Schuman: Commercial Relationship(s);Zeiss:Code P (Patent) 75 Poster Board Number: P7 Estimation of Trabecular Meshwork Thickness by Area and Width Measurements Author(s): Larry Kagemann1, 2, Hiroshi Ishikawa1, 2, Gadi Wollstein1, Bo Wang1, 2, Yun Ling1, 3, Richard A. Bilonick1, 3, Joel S. Schuman1, 3 1 University of Pittsburgh, 2University of Pittsburgh, 3University of Pittsburgh Purpose: Irregularities in the morphology of the inner wall of Schlemm’s canal (SC) create challenges when measuring trabecular meshwork (TM) thickness. A series of linear measurements may be obtained throughout the various thicknesses of TM and averaged, though this is an arduous time-consuming process. A faster estimate of TM thickness may be obtained by measuring TM area and dividing by width. The Purpose: of the present study was to compare a calculation of trabecular meshwork thickness from an area measurement with direct linear measurements. Methods: The temporal limbus of six eyes (3 subjects) was imaged by spectral-domain optical coherence tomography (Cirrus HD-OCT, Zeiss, USA) at baseline and at three intraocular pressure (IOP) levels. Additionally, 3 of the 6 eyes were imaged after dilation. TM thickness in 10 randomly selected B-scans in each of the 28 volumes was measured by two techniques: 1- linear samples between the SC and anterior chamber were obtained and averaged, and 2- TM area between SC and the anterior chamber was measured, as was the width (Figure, left and right, respectively). TM thickness was estimated as the area divided by the width. The time required to measure and record TM thickness for each method was measured and recorded for a subset of 30 B-scans. TM thickness measurements by the two techniques were compared by linear mixed-effects modeling and Pearson’s correlation coefficient. Results: Analysis times of the area and linear techniques 27±3 and 42±6 seconds per B-scan. There was no significant difference between TM thickness measurements obtained by the two Methods. Measurements obtained by the line sample and area Methods were highly correlated (figure). Conclusions: The analysis time for TM thickness measurements can be reduced using the area and diameter technique with no appreciable difference in the estimate of TM thickness. 76 Commercial Relationships Disclosure (Abstract): Larry Kagemann: Commercial Relationship: Code N (No Commercial Relationship) | Hiroshi Ishikawa: Commercial Relationship: Code N (No Commercial Relationship) | Gadi Wollstein: Commercial Relationship: Code N (No Commercial Relationship) | Bo Wang: Commercial Relationship: Code N (No Commercial Relationship) | Yun Ling: Commercial Relationship: Code N (No Commercial Relationship) | Richard Bilonick: Commercial Relationship: Code N (No Commercial Relationship) | Joel Schuman: Commercial Relationship(s);Zeiss, Inc:Code P (Patent) 77 Poster Board Number: P8 Predicting Future Observations of Functional and Structural Measurements in Glaucoma Using a TwoDimensional State-based Progression Model Author(s): Yu-Ying Liu1, Hiroshi Ishikawa2, 3, Gadi Wollstein2, Richard A. Bilonick2, 4, James G. Fujimoto5, Cynthia Mattox6, Jay S. Duker6, Joel S. Schuman2, 3, James M. Rehg1 1 Georgia Institute of Technology, 2UPMC Eye Center, Eye and Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, 3Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, 4Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, 5Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, 6New England Eye Center, Tufts Medical Center Purpose: To evaluate the predictive performance of a novel progression analysis method based on two-dimensional (2D) state-based longitudinal models accounting for both structural and functional components. Methods: 81 glaucomatous eyes from 46 patients were followed for an average of 12.4 +- 4.3 years, and each eye has at least 6 visits (average 8.5 +- 2.9 visits). Visual field index (VFI; Humphrey Field Analyzer; Zeiss) and optical coherence tomography (OCT) global mean circumpapillary retinal nerve fiber layer (RNFL) thickness from multiple generation of OCT (proprietary prototype OCT, OCT 1 and 2, Stratus OCT, Cirrus OCT (Zeiss)) were measured at every visit. Calibration equations were employed to normalize RNFL thickness measurements across OCT machines as a one-parameter continuum. A 2D continuous-time Hidden Markov Model using VFI and mean RNFL thickness for 2D disease state definition was employed to model progression. In evaluating predictive performance, 10-fold cross validation was used for model training and testing. In testing, the first 5 visits data were used to decode the underlying disease states. Then, prediction for the future observations was based on the learned model. The same setting was done for conventional linear regression estimates, where the slopes from the first 5 visits were used for prediction. The mean absolute error (MAE) between the predicted values and the actual measurements along the future follow-up period was used for performance assessment. Results: The 2D state-based method performs significantly better than linear regression in predicting future VFI (MAE: 4.88 +- 8.44 vs. 5.95 +- 9.79, respectively; t-test, P<0.001) and RNFL thickness values (MAE: 8.25 +- 7.89 vs. 16.34 +- 19.65, respectively; t-test, P<0.001). Conclusions: The proposed novel 2D state-based progression analysis integrating structural and functional information and modeling their temporal dynamics resulted in more accurate estimates of future observations (VFI and RNFL thickness) compared to the conventional linear regression method. 78 Examples of prediction results using the 2D CT-HMM method Commercial Relationships Disclosure (Abstract): Yu-Ying Liu: Commercial Relationship: Code N (No Commercial Relationship) | Hiroshi Ishikawa: Commercial Relationship: Code N (No Commercial Relationship) | Gadi Wollstein: Commercial Relationship: Code N (No Commercial Relationship) | Richard Bilonick: Commercial Relationship: Code N (No Commercial Relationship) | James Fujimoto: Commercial Relationship(s);Zeiss:Code P (Patent);Zeiss:Code C(Consultant) | Cynthia Mattox: Commercial Relationship: Code N (No Commercial Relationship) | Jay Duker: Commercial Relationship: Code N (No Commercial Relationship) | Joel Schuman: Commercial Relationship(s);Zeiss:Code P (Patent);Zeiss:Code C (Consultant) | James Rehg: Commercial Relationship: Code N (No Commercial Relationship) 79 Poster Board Number: P9 Assessment of retinal nerve fiber layer with color and red free images using Smartscope Fundus Camera Author(s): Ramesh S Ve, Krithica Srinivasan Department of Optometry, School of Allied Health Sciences, Manipal, Karnataka, India. Purpose: Smartscope (Optomed Oy, Finland) is a handheld non-mydriatic fundus camera using an IR-LED system and 5MPixel image sensor to image central 30°of retina. We compared the retinal nerve fiber layer (RNFL) based on color and red free images taken on single exposure using Smartscope Fundus Camera. Methods: 56 pairs of retinal images of 38 patients were enrolled from the eye clinic at Dr TMA Pai hospital, Udupi, India. All subjects underwent a comprehensive eye examination including retinal imaging using retinal module EY3-Optomed SmartscopeM5. Subjects with visually significant cataract, history of trauma and ocular surgery were excluded. Images with poor centration and artifacts were also excluded. RNFL appearance in both Color and Redfree (RF) images was graded based on reflectance into 1. Inferior, Superior, Nasal and Temporal (ISNT) pattern and 2. Split nerve fiber layer (SpNFL) pattern (in any quadrant). The disc area (DA) and RNFL area (Superior, inferior) was measured based on reflectivity using image analyzing software (Cy-Pacs, Cynaptix Pvt Ltd, India) in both sets of images. Measurements were made by a blinded observer and the color or redfree images were randomly presented. Results: 112 retinal images (56 pairs) with the mean DA of 2.57 mm2 (SD 0.52, min 1.49, max 4.43) were analysed. The mean difference in DA (0.04, SD 0.46) mm2 between color and RF images was not statistically significant (p=0.558, 95% CI of diff -0.08 to 0.16). Appearance of ISNT pattern between the color and RF images matched in 91% of eyes. SpNFL pattern was observed in 20 (35.71%, 95 CI 23.68 to 49.70) images. The mean DA for color and RF images were 2.56 (SD 0.52) and 2.53 (0.49) respectively, this was not statistically significant (p=0.558, 95% CI of diff -0.08 to 0.16). There was no significant difference in the RNFL thickness across superior RNFL (mean diff 0.17, SD 0.95, p=0.185, 95% CI of diff -0.08 to 0.42) and inferior RNFL (mean diff 0.23, SD 1.10, p=0.130, 95% CI of diff -0.07 to 0.52) regions between the images types. Conclusions: Retinal nerve fiber assessment with color images and red-free images showed good agreement taken using retinal module EY3 of Optomed Smartscope camera. Commercial Relationships Disclosure (Abstract): Ramesh S Ve: Commercial Relationship: Code N (No Commercial Relationship) | Krithica Srinivasan: Commercial Relationship: Code N (No Commercial Relationship) 80 Poster Board Number: P10 Confocal microscopy for the analysis of the sub-basal corneal nerves Author(s): Madhura G. Joag1, Anat Galor2, 1, Nabeel M. Shalabi2, 1, James R. Wong1, Juan Murillo1, Afshan A. Nanji1, Marwan Atallah1, Parke Green3, Mauro Campigotto4, Carol L. Karp1 1 Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, 2Miami Veterans Affairs Medical Center, 3Nidek Inc, 4Nidek Technologies Srl Purpose: To evaluate a new software technology that can quantify sub-basal nerve plexus parameters in confocal microscopy. Using the ConfoScan 4 (Nidek Technologies Srl, Padova, Italy) Methods: Eight healthy volunteers with no prior ocular diseases or surgeries were scanned using the 40x lens on the ConfoScan 4. A single good quality image was then run through the Corneal Nerve Analysis tool, a new automated nerve analysis software program. Results: Median patient age was 58.5 years (range 34-77). The median length density (μm/mm2) in our 8 patients was 11389.82 μm/mm2 (range 9278.36- 16232.29). No relationship was found between density and age (r=0.126) A manual inspection of the images demonstrated that the software was able to detect and capture the sub-basal nerves in each scan accurately. The median length density is similar to the three previous studies in which the manually calculated mean nerve density was found to be 11415 μm/mm2 (range 8404- 14,731) (n=139). Conclusions: The Nerve Analysis Tool is a potentially valuable tool for analysis of sub-basal nerves. Future study is needed to assess reliability and repeatability of this software technology and its application to ocular surface pathologies. Figure1: (A) Preprocessing Image of subbasal nerves. (B) Post processing Image of subbasal nerves (C) Output parameters of Image B Commercial Relationships Disclosure (Abstract): Madhura Joag: Commercial Relationship: Code N (No Commercial Relationship) | Anat Galor: Commercial Relationship: Code N (No Commercial Relationship) | Nabeel Shalabi: Commercial Relationship: Code N (No Commercial Relationship) | James Wong: Commercial Relationship: Code N (No Commercial Relationship) | Juan Murillo: Commercial Relationship: Code N (No Commercial Relationship) | Afshan Nanji: Commercial Relationship: Code N (No Commercial Relationship) | Marwan Atallah: Commercial Relationship: Code N (No Commercial Relationship) | Parke Green: Commercial Relationship(s);Nidek Inc:Code E (Emplyment) | Mauro Campigotto: Commercial Relationship(s);Nidek Technologies Srl, Padova, Italy:Code E (Emplyment) | Carol Karp: Commercial Relationship: Code N (No Commercial Relationship) 81 Poster Board Number: P11 Role of Ultra High Resolution Optical Coherence Tomography (UHR-OCT) in the Diagnosis of Ocular Surface Squamous Neoplasia (OSSN) in Complex Ocular Surface Diseases Author(s): Marwan Atallah, Guillermo Amescua, Anat Galor, Juan Murillo, Madhura G. Joag, James R. Wong, Nabeel M. Shalabi, Afshan A. Nanji, Carol L. Karp Bascom Palmer Eye Institute Purpose: Co-existence of OSSN with non-neoplastic ocular surface pathologies can mask the typical features of OSSN on conventional examination. The Purpose of this study is to evaluate whether UHR-OCT could detect and differentiate OSSN from co-existing ocular surface pathologies. Methods: Eleven patients with known ocular surface diseases presenting with lesions suspicious for OSSN were evaluated. UHR-OCT images of the lesions were taken at presentation. Biopsies were performed in all cases of suspected OSSN by UHR-OCT. Follow up using UHR-OCT was done after appropriate treatment. The images were compared to histological findings. Results: Ten patients were found to have OSSN by UHR-OCT and confirmed by subsequent biopsy. Three patients had OSSN within pterygia, 2 rosacea, 2 limbal stem cell deficiency, 1 Salzmann’ nodular degeneration, 1 vernal keratoconjunctivitis, and 1 ocular cicatricial pemphigoid (Fig 1,2). In 1 case, OSSN was ruled out in the setting of anterior scleritis in favor of pingueculum. In the 10 cases UHR-OCT images revealed epithelial layer thickening and an abrupt transition in epithelium suggestive of OSSN. These findings were confirmed by pathology in all cases. Follow up images detected resolution of the disease (8 cases) or recurrence (2 cases). Conclusions: UHR-OCT can be used to non-invasively detect the presence of OSSN in patients with co-existing complex ocular conditions. (a) Severe rosacea with a thickened area at 5 o’clock. (b) UHR-OCT along the white line revealed a hyper reflective thickened epithelium with an abrupt transition from normal to abnormal (arrow). (c) Pterygium with focus of leukoplakia (arrow). (d) UHR-OCT along the white line showed thickened hyper reflective epithelium. (e) Salzmanns nodular degeneration presenting with an area of opaque epithelium near the limbus at 4 o’clock. (f) UHR-OCT along the white line showed Salzmann nodule (arrow) but also epithelial thickening. Biopsy confirmed OSSN in all cases. 82 (a) Limbal stem cell deficiency (LSCD) with corneal scarring. (b) UHR-OCT done at 4 o’clock reveals epithelial thickening with marked hyper reflectivity. (c) Patient with vernal keratoconjunctivitis and LSCD with corneal scarring. (d) UHR-OCT reveals a thickened hyperreflective area.Biopsy confirmed OSSN in both cases. Commercial Relationships Disclosure (Abstract): Marwan Atallah: Commercial Relationship: Code N (No Commercial Relationship) | Guillermo Amescua: Commercial Relationship: Code N (No Commercial Relationship) | Anat Galor: Commercial Relationship: Code N (No Commercial Relationship) | Juan Murillo: Commercial Relationship: Code N (No Commercial Relationship) | Madhura Joag: Commercial Relationship: Code N (No Commercial Relationship) | James Wong: Commercial Relationship: Code N (No Commercial Relationship) | Nabeel Shalabi: Commercial Relationship: Code N (No Commercial Relationship) | Afshan Nanji: Commercial Relationship: Code N (No Commercial Relationship) | Carol Karp: Commercial Relationship: Code N (No Commercial Relationship) 83 Poster Board Number: P12 Noncontact direct observation of the human cornea by in vivo confocal microscopy with a high-power objective lens Author(s): Kaori Ideguchi, Eriko Abe, Taiichiro Chikama, Yuko Kadohiro, Takashi Sone, Ryotaro Toda, Sosuke Inokawa, Yoshiaki Kiuchi Hiroshima University Purpose: In vivo confocal microscopy with a Heidelberg Retina Tomograph III–Rostock Cornea Module (HRTIIIRCM) allows noninvasive observation of corneal structures and cells layer by layer in high resolution by a contact applanating procedure in which the cornea is separated from a TomoCap with gel. We evaluated noncontact direct observation of the human cornea by in vivo confocal microscopy with a high-power objective lens. Methods: A new adapter was developed for a high-power (×200) noncontact objective lens. Two normal volunteers were recruited into the study and noncontact in vivo confocal microscopy was performed. Results: Under the default condition for imaging, keratocytes and nerves in the corneal stroma as well as the corneal endothelium were observed in both subjects. However, the superficial layer of the corneal epithelium including the tear film was not observable because of high reflectivity. Adjustment of the imaging conditions allowed observation of the superficial corneal epithelium and tear film with or without modification. Conclusions: Noncontact in vivo confocal microscopy with a high-power (×200) objective lens allows the observation of corneal cells and structures at higher magnification (×1.6) compared with contact in vivo confocal microscopy. Further improvement of this procedure should allow the collection of high-quality images with easy handling. Commercial Relationships Disclosure (Abstract): Kaori Ideguchi: Commercial Relationship: Code N (No Commercial Relationship) | Eriko Abe: Commercial Relationship: Code N (No Commercial Relationship) | Taiichiro Chikama: Commercial Relationship: Code N (No Commercial Relationship) | Yuko Kadohiro: Commercial Relationship: Code N (No Commercial Relationship) | Takashi Sone: Commercial Relationship: Code N (No Commercial Relationship) | Ryotaro Toda: Commercial Relationship: Code N (No Commercial Relationship) | Sosuke Inokawa: Commercial Relationship: Code N (No Commercial Relationship) | Yoshiaki Kiuchi: Commercial Relationship: Code N (No Commercial Relationship) 84 Poster Board Number: P13 Analysis of the cornea densitometry using Pentacan with different illuminance Author(s): Fernando Abib, Mariele A. Maximo, Andre Heck Federal University of Parana Purpose: To know the room lighting effect on corneal densitometry (CD) performed by Pentacan. Methods: Thirty three normal patients from an Ophthalmological Clinic - Curitiba, Brazil. Age: 32±8 years. CD performed with Pentacam high resolution software 1.20r10 (Oculus Optikgeräte GmbH, Germany). To measure the illuminance (Il) of the examination room (ER), the digital LuxMeter 1.1 for I-phone (Application manufactory, USA) was utilized. The CD was performed with two different room lighting: fluorescent lamp is on (27-30 lux) and is off (0-1 lux) with GE compact fluorescent lamp Triple 15W 120-127V~60Hz 197mA 15W (Uberlandia, Brazil). The CD was measured in the anterior corneal layer (120µm), posterior corneal layer (60 µm) and central layer at 0-2 mm, 2-6mm, 6-10mm, 10-12mm and total area. Step 1: The results of 33 CD are compared in only one eye per patient, with the light on and off. Step 2: The results of 19 CD, with the light on and off in both eyes, are studied in order to compare the range of the results between the eyes of the same patient. The results are reported by descriptive statistics and the analysis will be performed with t Student, calculated by Microsoft Office Excel 2007 and GraphPad software. Results: The figures report: 1.The results; 2.The analysis of the CD of the different annulus and layers performed in room with light on and off ; 3.The range of the CD between the eyes of the same patient of the different annulus and layers and their analysis. Conclusions: The comparison of the CD of the 0-2 mm and 2-6mm annulus, for all corneal layers, were extremely statistically significant with a different Il. The CD increases with the increase of the Il. There is no difference of the CD range between the eyes of the same patient in the same Il of the 0-2 mm, 2-6 mm and 6-10 mm annulus, for all corneal layers. The Il of the ER significantly altered the results of the corneal densitometry, thus increasing their values. Whereas, Pentacan often must be repeated in the same patient, and its reproducibility is compromised if the Il of the ER changes. It is suggested that Pentacan incorporates a luxmeter to establish a new reliability index for the examination, so that their results of the examined cornea become more reproducible and representative. The required minimum Il for the examination should be objectively defined by the manufacturer with this suggested luxmeter and reliability index. 85 Commercial Relationships Disclosure (Abstract): Fernando Abib: Commercial Relationship: Code N (No Commercial Relationship) | Mariele Maximo: Commercial Relationship: Code N (No Commercial Relationship) | Andre Heck: Commercial Relationship: Code N (No Commercial Relationship) 86 Poster Board Number: P14 OptoVue OCT as an imaging modality of scleral thickness following fluocinolone acetonide implant Author(s): Kristin Biggee1, 2, Nicholas Schubach1, Eric Suhler1, Christina J. Flaxel1 1 Casey Eye Institute, 2Devers Eye Institute Purpose: To report the use of OptoVue OCT imaging of scleral thickness following fluocinolone acetonide (FA) implant Methods: Prospective case series. Repeat measurements of scleral thickness were performed using 3mm line scans in multiple quadrants of the pars plana region in 3 patients with noninfectious posterior uveitis requiring FA implant. Results were compared between implanted and fellow, non-implanted eyes or in the same eye before and after implant insertion. Results: Case 1 involved a 33yo woman with two previous FA implants in her right eye placed 8 years and then 3 years prior to imaging. Her overall mean scleral thickness in the right eye compared to her fellow, non implanted eye was 455 (SD 148) vs 644.5μm (SD 11), P <0.005. A striking anatomical variance was noted in the inferonasal (IN) and inferotemporal (IT) quadrant, which were the sites of her previous implants. Although anatomical landmarks were less defined, estimates in the IN/IT quadrants showed a mean thickness of 269 (SD 53)/372μm (SD52) in the implanted eye vs 645 (SD 4)/644μm (SD 16) in the fellow eye, P=0.006/0.07. Case 2 involved a 45yo woman who received implants in the IN quadrant of both eyes placed 4 weeks apart. The mean scleral thickness in the IN quadrant of the left eye increased from a baseline of 662 (SD 12) to 713μm (SD 3) at postoperative week one, P<0.005. At postoperative week five, the right eye showed an insignificant change in overall mean scleral thickness from a baseline of 614 (SD 35) to 606μm (SD 43). The IN quadrant showed the largest decrease from 641 (SD 22) to 608μm (SD 22), P=0.18. Case 3 involved a 33yo female who received an implant in the IN quadrant of the left eye. Scleral thickness was measured preoperatively and at postoperative week five and showed an overall mean decrease from 663 (SD 31) to 629μm (SD 27) P=0.007. Each quadrant showed a similar decrease in thickness, with a mean change of 35μm (SD 5). Conclusions: OptoVue OCT may be a useful imaging modality to follow scleral thickness following FA implant. It can be used to highlight potential dramatic scleral thinning as seen in the first select case in this study. Longer follow up with a larger cohort of patients is needed to determine the utility and reproducibility of this high resolution imaging following FA implant. Case 1 IN quadrant implanted eye 87 Case 1 IN quadrant nonimplanted eye Commercial Relationships Disclosure (Abstract): Kristin Biggee: Commercial Relationship: Code N (No Commercial Relationship) | Nicholas Schubach: Commercial Relationship: Code N (No Commercial Relationship) | Eric Suhler: Commercial Relationship: Code N (No Commercial Relationship) | Christina Flaxel: Commercial Relationship: Code N (No Commercial Relationship) 88 Poster Board Number: P15 Posterior capsular opacification in intraocular hydrophilic lenses compared to hydrophobic intraocular lenses using Scheimpflug images Author(s): Arturo Olguin-Manriquez, Efrain Romo-Garcia, David Magana hospital civil de culiacan Purpose: To determine the visual outcomes and posterior capsule opacification (PCO) in acrylic intraocular lenses (IOL). Methods: Prospective analysis of 38 eyes of 19 patients who had uneventful phacoemulsification with implantation of a IOL Akreos MI60 or a IOL Acrysof IQ from February 2013 to January 2014. Patients from a single single surgeon, the protocol included the determination logMAR best corrected visual acuity (BCVA), spherical equivalent, contrast sensitivity assessed by the Freiburg Visual Acuity test and PCO scoring using the Evaluation of Posterior Capsular Opacification System (EPCO2000) by digital retroillumination photography and high resolution tomograms from Scheimpflug reconstructions analyzed using ImageJ freeware. Results: The mean follow up was 6.2 months ± 1.4(SD). Contrast Sentivity and BCVA were similar between the lenses. Mean pixel intensity value using EPCO2000 software for Akreos MI60 was 1.08U and 1.08U for Acrysof IQ (p=0.785). Using ImageJ mean value in pixels for Akreos MI60 was 1.76U and for Acysof IQ was 2.56U (p=0.027). There were no significant correlationship between EPCO2000 and Pscheimpflug images (r=.141, p=.412). Conclusions: This study found that the results of visual function were comparable between both lenses. The posterior capsular opacification was seen to be lesser extent with the Akreos MI60 IOL when measured by Scheimpflug images, probably due to the very design of the lens which showed no correlation compared to the digital retroillumination photoghaphy. 89 Commercial Relationships Disclosure (Abstract): Arturo Olguin-Manriquez: Commercial Relationship: Code N (No Commercial Relationship) | Efrain Romo-Garcia: Commercial Relationship: Code N (No Commercial Relationship) | David Magana: Commercial Relationship: Code N (No Commercial Relationship) 90 Poster Board Number: P16 Morphologic Changes in Angle Closure Glaucoma After Iridotomies Documented By Ultrabiomicroscopy Author(s): Efrain Romo-Garcia1, 2, Nicolas Corona-Osuna1, Silvia Lizarraga1, David Magaña1, arturo OlguinManriquez1, Miguel Piña1, Felipe Esquivel1, Arturo Ramirez-Mondragon1, Felipe Peraza-Garay1 1 CIDOCS / UAS, 2BuenaVista Foundation Purpose: To describe changes in patients with angle closure glaucoma after performing Nd:YAG Laser iridotomies documented by ultrabiomicroscopy (UBM). Methods: We include 20 eyes (10 patients) were a close angle was detected during gonioscopy. UBM was performed before and 2 weeks after Nd:YAG Laser iridotomies. Follow up include full ophthalmological examination. Results: Anterior chamber central amplitude showed a significant increment (p=.26); peripheral anterior chamber amplitude increment was documented but with no significant changes (p=.07). During follow up gonioscopy a significant difference was detected (p=.000) after iridotomies with Nd:YAG laser. Conclusions: Ultrabiomicroscopy is a useful study to mesure anterior chamber amplitude after treatment with Nd:YAG Laser iridotomy and document changes in the iridocorneal angle. Commercial Relationships Disclosure (Abstract): Efrain Romo-Garcia: Commercial Relationship: Code N (No Commercial Relationship) | Nicolas Corona-Osuna: Commercial Relationship: Code N (No Commercial Relationship) | Silvia Lizarraga: Commercial Relationship: Code N (No Commercial Relationship) | David Magaña: Commercial Relationship: Code N (No Commercial Relationship) | arturo Olguin-Manriquez: Commercial Relationship: Code N (No Commercial Relationship) | Miguel Piña: Commercial Relationship: Code N (No Commercial Relationship) | Felipe Esquivel: Commercial Relationship: Code N (No Commercial Relationship) | Arturo Ramirez-Mondragon: Commercial Relationship: Code N (No Commercial Relationship) | Felipe PerazaGaray: Commercial Relationship: Code N (No Commercial Relationship) 91 Poster Board Number: P17 Ocular Surface Health In Patients With Rheumatoid Arthritis In India Author(s): Ramya Ravindran SRMC AND RI Purpose: The Purpose of this study was to evaluate the ocular surface of the eyes of patients suffering from Rheumatoid Arthritis in India and look for potential problems that can affect these patients. Methods: This is a prospective,non interventional observational study conducted at a multi specialty urban hospital. forty patients suffering from Rheumatoid arthritis were included in this study. Patients with any other local or systemic disease affecting the ocular surface were excluded as were patients with previous history of ophthalmic surgery. These patients were assesed based on ocular surface staining and tear film break up time.Rose bengal was used to stain the ocular surface and the van Bijsterveld staining score was used to estimate the surface viability. Results: Out of the 80 eyes tested for TBUT 63 eyes was found to be lower than normal TBUT score ((78.75%). 48 eyes had a staining score of greater than 3(60%)Out of these 32 eyes had a score between 4-6 and 16 eyes had severe OSD with a score of 7-9. . Out of these one patient had peripheral corneal melt and six patients presented with SPK s. Out of the 40 patients 15 patients only presented with complaints discomfort, tearing, pain and burning sensation. All others were asymptomatic. Conclusions: This study was undertaken to show the importance of ocular surface health in Rheumatoid patients as this disease is rather uncommon in our part of the world and the ocular surface is one of the most under-treated parts of the eye due to a lack of awareness among patients and their primary care physicians. This study proves that ocular surface dysfunction is a serious and morbid problem in patients who are suffering from Rheumatid arthritis. Hence evaluation of the ocular surface, treatment of it's problems and management of the disease should all be undertaken holistically.Missing these problems can lead to serious sight threatening complications like a corneal melt as well as having implications in the quality of life for these patients. Commercial Relationships Disclosure (Abstract): Ramya Ravindran: Commercial Relationship: Code N (No Commercial Relationship) 92 201 Retinal Imaging Poster Board Number: P18 Improving the processing and analysis workflow of adaptive optics retinal imaging Author(s): Benjamin Sajdak1, Robert F. Cooper2, Kathleen Bazan3, Brian Higgins1, Drew Scoles4, Melissa Wilk5, Alfredo Dubra1, 2, Joseph Carroll1, 2 1 Medical College of Wisconsin, 2Marquette University, 3Milwaukee School of Engineering, 4University of Rochester, 5Medical College of Wisconsin Purpose: While adaptive optics (AO) retinal imaging enables high-resolution, in vivo, visualization of retinal pathology, the time required to process and analyze images is prohibitive for widespread adoption of this technology. Here, we sought to expedite two of the more time-intensive aspects of the workflow: image montaging and selecting regions of interest (ROIs) for subsequent density analyses. Methods: Six subjects with normal vision and 3 subjects with albinism were imaged using an AO scanning light ophthalmoscope (AOSLO). Sets of 18-26 partially overlapping images were aligned manually in Adobe Photoshop (San Jose, CA) and also semi-automatically with i2k Retina (DualAlign LLC, Clifton Park, NY) montaging software. We selected 100 x 100µm ROIs both manually and with custom software at 9-12 parafoveal locations. Montaging and ROI selection methods were timed to evaluate efficiency of manual and semi-automated techniques. For each ROI, cone density was measured to evaluate the accuracy of the semi-automated workflow. Results: Using i2k Retina reduced montaging time by 7-53 minutes, or 25-79%. The semi-automated ROI selection software reduced processing time by between 18-63 minutes, or 76-90%. Therefore, the semi-automated workflow resulted in a combined reduction of 29-75 minutes, or 50-80%. Cone density measurements obtained from the semiautomated workflow were on average 2,563 cones/mm2 less than those obtained using the manual workflow (95% CI = -9,465 to 4,339 cones/mm2, or 11 to 23%). Conclusions: While the time-saving benefits of automated image processing methods are appealing, accuracy appears to suffer. A current limitation of i2k Retina is that montages need to be assembled in piecemeal; further time savings could be realized if no user oversight was required. The ROI selection software was used for comparison of montaging techniques, and greatly improved the speed of the workflow process. The semi-automated workflow greatly reduced the time required for analysis, however, the discrepancy in cone density measurements may be too large to enable immediate adoption in its' current form. This study demonstrates the potential for an automated workflow, and identifies important design improvements needed in future iterations of automated montaging approaches. Commercial Relationships Disclosure (Abstract): Benjamin Sajdak: Commercial Relationship: Code N (No Commercial Relationship) | Robert Cooper: Commercial Relationship: Code N (No Commercial Relationship) | Kathleen Bazan: Commercial Relationship: Code N (No Commercial Relationship) | Brian Higgins: Commercial Relationship: Code N (No Commercial Relationship) | Drew Scoles: Commercial Relationship: Code N (No Commercial Relationship) | Melissa Wilk: Commercial Relationship: Code N (No Commercial Relationship) | Alfredo Dubra: Commercial Relationship: Code N (No Commercial Relationship) | Joseph Carroll: Commercial Relationship: Code N (No Commercial Relationship) 93 Poster Board Number: P19 Clinical Assessment and Single Cell imaging in Unexplained Vision Loss Author(s): Philip Severn4, Adam M Dubis4, Robert F. Cooper1, Joseph Carroll3, Alfredo Dubra2, Ganeshan K Ramsamy5, Fred W Fitzke4, Gary Rubin4, Cathy Egan4, Michel Michaelides4 1 Marquette University , 2Medical College of Wisconsin Departments of Ophthalmology, 3Medical College of Wisconsin , 4Moorfields Eye Hospital and University College London Institute of Ophthalmology, 5Barts and The London School of Medicine Purpose: Current clinical practice involves gross visual inspection and functional analysis to assess the causes of visual impairments and deficit. While these tests can define most clinical diagnoses, some remain unresolved. Here we applied cellular resolution imaging to examine retinal structure in a patient with an unexplained visual deficit. Methods: Standard clinical assessment including dense Spectralis optical coherence tomography (OCT), extensive electrophysiology (full field ERGs, multifocal ERGs, diffuse flash stimulation, EOG, high contrast pattern reversal, photopic ON and OFF responses including S-cone ERG and colour contrast sensitivity analysis), psychophysics (Nidek MP1 photopic microperimetry and photopic 30-2 Visual Field on a modified Humphrey) were applied to assess visual symptoms. Blood tests were also used to assess potential autoimmune involvement. Cellular imaging was completed using custom built adaptive optics scanning light ophthalmoscopes (AOSLO) at the Medical College of Wisconsin and Moorfields Eye Hospital. Results: Extensive clinical evaluation revealed no abnormalities to explain the patient’s visual symptoms. Single test microperimetry showed normal or only subtle abnormalities that were inconsistent on retest. ERG results were normal for all tests. AOSLO imaging showed small areas reminiscent of small sub-clinical drusen (1). Examples of these structures are shown in Figure A&B. Conclusions: While a few abnormalities were shown with AOSLO, they did not completely explain the visual complaints. However, these structures were more reproducible and conclusive than standard clinical measures. Figure A & B: Adaptive Optics Scanning Light Ophthalmoscope images taken from 3º (A) and 5º (B) temporal to fixation. The arrows delineate regions of abnormal cone patterning, which may be the result of visual complaints. Scale bar is 50 µm. 94 1.Godara, P., Siebe, C., Rha, J., Michaelides, M., Carroll, J. “Assessing the photoreceptor mosaic over drusen using adaptive optics and spectral-domain optical coherence tomography” Ophthalmic Surgery, Lasers, & Imaging, 41(6): S104-S108 (2010). Commercial Relationships Disclosure (Abstract): Philip Severn: Commercial Relationship: Code N (No Commercial Relationship) | Adam M Dubis: Commercial Relationship(s);Patent 8,226,236, (C) Canon USA Inc:Code P (Patent) Robert Cooper: Commercial Relationship: Code N (No Commercial Relationship) | Joseph Carroll: Commercial Relationship: Code N (No Commercial Relationship) | Alfredo Dubra: Commercial Relationship: Code N (No Commercial Relationship) | Ganeshan K Ramsamy: Commercial Relationship: Code N (No Commercial Relationship)| Fred W Fitzke: Commercial Relationship: Code N (No Commercial Relationship) | Gary Rubin: Commercial Relationship: Code N (No Commercial Relationship) | Cathy Egan: Commercial Relationship: Code N (No Commercial Relationship) | Michel Michaelides: Commercial Relationship: Code N (No Commercial Relationship) 95 Poster Board Number: 20 High-resolution En face images of microcystic macular edema in patients with autosomal dominant optic atrophy Author(s): Shuhei Kameya1, Kiyoko Gocho1, Sachiko Kikuchi1, Kei Shinoda2, Atsushi Mizota2, Kunihiko Yamaki1, Hiroshi Takahashi3 1 Chiba Hokusoh Hosp Nippon Med Sch, 2Teikyo University School of medicine, 3Nippon Medical School Purpose: To investigate the characteristics of microcystic macular edema (MME) determined from the en face images obtained by an adaptive optics (AO) fundus camera in patients with autosomal dominant optic atrophy (ADOA) and to try to determine the mechanisms underlying the degeneration of the inner retinal cells and RNFL by using the advantage of AO. Methods: Six patients from 4 families with ADOA underwent detailed ophthalmic examinations. Ophthalmic examinations including spectral domain optical coherence tomography (SD-OCT) were performed. Mutational screening of all coding and flanking intron sequences of the OPA1 gene was performed by DNA sequencing. Highresolution en face images of the fundus were obtained with a flood-illuminated AO fundus camera. Results: All 6 patients had reduced visual acuity and palor of the temporal disc. SD-OCT showed a severe reduction in the retinal nerve fiber layer thickness. A new splicing-defect and two new frameshift mutations with premature termination of the Opa1 protein were identified in three families. A reported nonsense mutation was identified in one family. SD-OCT of one patient showed MME in the inner nuclear layer of the retina. AO images showed microcysts in the en face images of the inner retinal layer. Another patient also had similar microcystic structures in the AO images despite their absence in the SD-OCT images. Conclusions: Our findings implicate the possibility that MME is the results of retrograde trans-synaptic degeneration of cells in the inner nuclear layer of the retina. Our data indicate that AO is a useful method to identify MME in neurodegenerative diseases and may also help determine the mechanisms underlying the degeneration of the inner retinal cells and retinal nerve fiber layer. Commercial Relationships Disclosure (Abstract): Shuhei Kameya: Commercial Relationship: Code N (No Commercial Relationship) | Kiyoko Gocho: Commercial Relationship: Code N (No Commercial Relationship) | Sachiko Kikuchi: Commercial Relationship: Code N (No Commercial Relationship) | Kei Shinoda: Commercial Relationship: Code N (No Commercial Relationship) | Atsushi Mizota: Commercial Relationship: Code N (No Commercial Relationship) | Kunihiko Yamaki: Commercial Relationship: Code N (No Commercial Relationship) | Hiroshi Takahashi: Commercial Relationship: Code N (No Commercial Relationship) 96 Poster Board Number: P21 Magnetic resonance imaging findings of the subretinal space in bilateral congenital retinal detachments in Norrie’s syndrome Author(s): Rocio I. Diaz2, 4, Eric J. Sigler2, 4, Asim F. Choudhri1, 3, Jorge I. Calzada2, 4 1 LeBonheur Children's Hospital, 2Charles Retina Institute, 3University of Tennessee Health Science Center, 4 University of Tennessee Health Science Center Purpose: To characterize the magnetic resonance imaging findings in the subretinal space in patients with bilateral congenital retinal detachment (RD) Methods: Retrospective case-series of infants with an abnormal red-reflex who were further studied with orbital MRI, using T1, T2-weighted and FLAIR modalities. All patients underwent examination under anesthesia, visual evoked potentials, electroretinograms and pars plana vitrectomy Results: Three male infants were included in the study. The MRI of orbits consistently demonstrated bilateral RD with a gravity-dependent fluid level in the subretinal space. These bilateral subretinal effusions demonstrated T1 shortening and T2 prolongation, likely due to layering of blood products (hemosiderin, methemoglobin, and proteinaceous contents). All infants presented bilateral optic nerve hypoplasia and microphthalmia. Genetic testing of one of the infants’ DNA revealed a deletion of exon 1 in the ND gene. All patients underwent examination under anesthesia and the diagnosis of tractional RD was confirmed in all cases. Visual evoked potentials were recordable in some eyes, while electroretinograms were unrecordable in all cases. Pars plana vitrectomy and lensectomy was performed in the eye with the best visual potential Conclusions: Congenital RD associated to Norrie’s syndrome can present a typical fluid level in the subretinal space on MRI. This can help differentiate this syndrome from other causes of infantile RD, like persistent fetal vasculature, Coats’ disease and retinoblastoma Image 1. MRI findings in a 5-month-old male with bilateral RD. A. Axial T1 FLAIR demonstrating bilateral RD, bilateral microphthalmia, and a hypointense collection on the subretinal space of the left eye (arrow). B. Axial T2weighted orbital MRI of the same infant reveals a distinct hypointense deposit, corresponding to layering of blood products (arrow) 97 Image 2. MRI fluid level characteristics in infants with congenital bilateral RD. A. Axial T1-weighted orbital MRI of a one-week-old male revealing total bilateral RD, and a discrete hypointensity on the posterior pole, compatible with a fluid level in the subretinal space. B. T2-weighted MRI of a 8-month- old male demonstrating an area of hypointensity corresponding to bilateral subretinal effusions. The gravity-dependent level, compatible with layering of blood products, is more visible on the left eye Commercial Relationships Disclosure (Abstract): Rocio Diaz: Commercial Relationship: Code N (No Commercial Relationship) | Eric Sigler: Commercial Relationship: Code N (No Commercial Relationship) | Asim Choudhri: Commercial Relationship: Code N (No Commercial Relationship) | Jorge Calzada: Commercial Relationship: Code N (No Commercial Relationship) 98 Poster Board Number: P22 Fluorescence Lifetime Measurement in Central Artery Occlusion Author(s): Chantal Dysli, Sebastian Wolf, Martin S. Zinkernagel Ophthalmology Purpose: Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) is used more recently for non invasive in vivo measurement of lifetimes of natural retinal fluorophores upon laser excitation. Fluorescence lifetimes are dependent of the metabolic environment such as the oxygenation level and the pH concentration. Therefore we aim to characterize fluorescence lifetimes of the retina after central artery occlusion. Methods: A Spectralis® FLIO system (Fluorescence Lifetime Imaging Ophthalmoscope; Heidelberg Engineering, Germany) was used for fluorescence lifetime measurement of the ocular fundus. Fluorescence was excited using a picosecond laser at 473 nm wavelength. Decay times were measured in a short (498–560 nm) and in a long (560– 720 nm) spectral channel. FLIO was performed in eyes after central retinal artery occlusion (CRAO) and compared to the contra lateral healthy eyes. Mean lifetimes were averaged within ETDRS grid areas (center, inner ring, outer ring). Results: In the short spectral channel, mean fluorescence lifetime values in the central area of the ETDRS grid were 296 ± 65 picoseconds (ps) (mean ± standard error of the mean) in eyes after CRAO and 231 ± 26 ps in the healthy control eyes (p=0.01). In the inner ETDRS ring, mean lifetimes were 455 ± 61 ps after CRAO and 323 ± 23 ps in control eyes (p=0.0006). In the long spectral channel, mean lifetimes in the central area were 357 ± 27 ps after CRAO and 341 ± 21ps in the control eyes (p=0.0006). In the inner ETDRS ring, mean lifetimes were 429 ± 26 ps after CRAO and 379 ± 22 ps in control eyes (p=0.0001). Conclusions: Central retinal artery occlusion led to disease associated changes in fluorescence lifetimes of retinal fluorophores. Significantly longer lifetimes were observed in all ETDRS areas, potentially caused by altered cellular metabolism after retinal ischemia. In future, fluorescence lifetime measurement might be used for diagnostic Purpose , disease and therapy monitoring, and might even have prognostic value. Commercial Relationships Disclosure (Abstract): Chantal Dysli: Commercial Relationship(s);Heidelberg Engineering:Code F (Financial Support) | Sebastian Wolf: Commercial Relationship(s);Heidelberg Engineering:Code F (Financial Support);Heidelberg Engineering:Code C (Consultant) | Martin Zinkernagel: Commercial Relationship(s);Heidelberg Engineering:Code F (Financial Support) 99 Poster Board Number: P23 Brownian Motion Imaging With Optical Coherence Tomography and Optical Coherence Tomography Angiography Author(s): Gangjun Liu, Yan Li, Yali Jia, David Huang Oregon Health & Science University Purpose: Investigate the possibility of imaging and quantifying the Brownian motion of particles and red blood cells with Optical Coherence Tomography and Optical Coherence Tomography Angiography. Here, we use splitspectrum amplitude decorrelation angiography (SSADA) method for the angiography analysis. Methods: A custom-built OCT system with a central wavelength of 1050 nm and a speed of 100 thousand A-lines per second is used in this study. Suspensions of microspheres of different diameters (800nm, 3um, 5um and 10um) and different concentration in Borate Buffered Saline (BBS) solution are studied. The suspensions of fresh porcine red blood cells (RBCs) in porcine plasma stabilized with sodium citrate are also investigated. Continuous time sequence B-scan OCT images are obtained from these sample and then processed SSADA. Results: The OCT system can detect single particle in the suspensions when the microsphere concentration is low. OCT signal slope (signal attenuation with depth) changes with the microsphere concentration. Time sequence Bscan OCT images enable us to see fast movement of the microsphere in the suspensions. The microsphere Brownian motion is able to be detected with the SSADA. Imaging of the Brownian motion of RBC in plasma is demonstrated. Conclusions: Optical Coherence Tomography enables us see single small particle and split-spectrum amplitude decorrelation OCT angiography is able to image Brownian motion of RBC in plasma. The OCT structure (1a-1d) and split-spectrum amplitude decorrelation OCT angiography (1e-1h)images of 3um particle suspension with concentration of 0.17% (1a,1e), 0.042% (1b, 1f), 0.005% (1c, 1g) and 0.001% (1d, 1h). 100 The OCT structure (2a-2d) and split-spectrum amplitude decorrelation OCT angiography (2e-2h) images of RBC in plasma suspension with RBC vs plasma ratio of 1:1 (2a, 2e), 1:10 (2b, 2f), 1:100 (2c, 2g) and 1:1000 (2d, 2h). Commercial Relationships Disclosure (Abstract): Gangjun Liu: Commercial Relationship: Code N (No Commercial Relationship) | Yan Li: Commercial Relationship(s);Optouve, Inc. :Code F (Financial Support);Carl Zeiss Meditec, Inc.:Code P (Patent);Optouve, Inc. :Code P (Patent) | Yali Jia: Commercial Relationship(s);Optouve, Inc. :Code P (Patent)| David Huang: Commercial Relationship(s);Optouve, Inc. :Code F (Financial Support);Optouve, Inc. :Code P(Patent);Optouve, Inc. :Code I (Personal Financial Interest); Carl Zeiss Meditec:Code P (Patent) 101 Poster Board Number: P24 Histogram Matching Extends Acceptable Signal Strength (SS) Range on Optical Coherence Tomography (OCT) Images Author(s): Chieh-Li Chen1, 2, Hiroshi Ishikawa1, 2, Gadi Wollstein1, Richard A. Bilonick1, 3, Ian A. Sigal1, 2, Larry Kagemann1, 2, Joel S. Schuman1, 2 1 UPMC Eye Center, Eye and Ear Institute, Ophthalmology and Visual Science Research Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, 2Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, 3Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh Purpose: SS strongly correlates with OCT thickness measurements. This relationship limits the range of acceptable SS, which also limits the applicability of OCT measurements to older/diseased subjects because they tend to have lower best-achievable SS than young/healthy subjects. The Purpose of this study was to minimize the influence of SS variability on OCT measurements using histogram matching (HM). Methods: Seven eyes from seven healthy subjects were scanned with Cirrus HD-OCT (Zeiss, Dublin, CA; Optic Disc Cube 200x200 scan). A series of OCT images with a wide range of SS (maximal range 1 to 10) was acquired from each eye at the same visit. For each cube scan, one circumpapillary B-scan image was resampled along the 3.45-diameter circle centered to the optic nerve head. For each series, the histogram of a resampled image with the highest SS was set as the reference. HM was applied to the other images with lower SS. The process of HM involves minimizing the difference in intensity at each percentile of the histogram between the reference and the target image. The circumpapillary retinal nerve fiber layer thickness (RNFLT) was automatically measured using segmentation software of our own design (HM measurement), which was then compared to the device output (Device measurement). Non-linear mixed effects models were constructed to analyze the relationship between RNFLT and SS across various SS range. In addition, the coefficient of variation (CoV) of the Device measurements within the manufacturer recommended acceptable SS range (SS 6 to 10) was calculated on each case. The lowest SS that achieved similar Device CoV on HM measurements was detected on each case. Results: Two segments of linear relationships were detected on both Device and HM measurements (Figure). The second segment, which represents the linear relationship in the higher half of the SS range, of the HM measurements had flatter slope (less variable) than the Device measurements (0.6 vs. 1.6 μm), while the breaking point was higher with the HM than the Device measurements (4.1 vs. 3.1). The mean Device CoV was 0.025, while HM measurements showed similar CoV with wider SS range (0.022, SS 4 to 10). Conclusions: HM successfully extends the acceptable SS range on OCT images. This broadens the OCT measurement application to subjects whose images are excluded from the quantitative analysis with the conventional method. 102 Commercial Relationships Disclosure (Abstract): Chieh-Li Chen: Commercial Relationship: Code N (No Commercial Relationship) | Hiroshi Ishikawa: Commercial Relationship: Code N (No Commercial Relationship) | Gadi Wollstein: Commercial Relationship: Code N (No Commercial Relationship) | Richard Bilonick: Commercial Relationship: Code N (No Commercial Relationship) | Ian Sigal: Commercial Relationship: Code N (No Commercial Relationship) | Larry Kagemann: Commercial Relationship: Code N (No Commercial Relationship) | Joel Schuman: CommercialRelationship(s);Zeiss:Code P (Patent) 103 Poster Board Number: P25 Effect of Scanning Incident Angle (IA) on Total Retinal Thickness (TRT) Measurement With A Phantom Eye Using Spectral-Domain Optical Coherence Tomography (SD-OCT) Author(s): Hiroshi Ishikawa1, 2, Chieh-Li Chen1, 2, Jigesh Baxi3, Anant Agrawal3, Daniel X. Hammer3, Gadi Wollstein1, Richard A. Bilonick1, 4, Ian A. Sigal1, 2, Larry Kagemann1, 2, Joel S. Schuman1, 2 1 Department of Ophthalmology, University of Pittsburgh School of Medicine, 2University of Pittsburgh, 3Food and Drug Administration, 4University of Pittsburgh Purpose: To investigate the effect of scanning IA on SD-OCT TRT measurement using a phantom eye. Methods: A water-filled phantom eye, mimicking a healthy human retina and optic nerve head with dilated 7 mm pupil, was scanned using a commercially-available clinical OCT instrument (raster volume scan centered at the optic nerve head). The scanning beam was positioned through the center of the pupil, and the retinal image appeared flat on the screen, which was considered to be 0 degree reference angle. To generate different IAs between the scanning beam and the retinal surface, the phantom eye was rotated temporally (defined as positive direction) and nasally (negative direction) up to 12 degrees with 3-degree increments. Five scans were obtained at each IA. The quality index (QI) and TRT (the thickness between the inner and outer borders of the simulated retina, Figure A) were measured automatically on each scan using a software program of our own design. The mean QI and the mean TRT of five scans at each IA were calculated. In order to compensate the interaction between signal strength and TRT, an additional series of scans at the 0-degree position with various signal strengths were obtained to model the relationship between TRT and QI. Results: TRT showed significant correlation with QI (R2=0.83, p=0.004, Figure B). The QI decreased as IA increased in both directions (showing a Λ-shape against IA, Figure C), while the quality compensated TRT increased along with the IA (showing a V-shape against IA, Figure D). Conclusions: Different IAs may add considerable measurement variability for device calibration. However, the variation in TRT measurements due to different IAs was within expected measurement variability, and thus not clinically significant. Figure. A) Cross-sectional image of the phantom eye, the total retinal thickness (TRT) is defined as the distance between the inner and outer borders of the simulated retina; B) Linear correlation between quality index (QI) and TRT; C) and D) Effects of incident angle (IA) on QI and TRT. 104 Commercial Relationships Disclosure (Abstract): Hiroshi Ishikawa: Commercial Relationship: Code N (No Commercial Relationship) | Chieh-Li Chen: Commercial Relationship: Code N (No Commercial Relationship) | Jigesh Baxi: Commercial Relationship: Code N (No Commercial Relationship) | Anant Agrawal: Commercial Relationship: Code N (No Commercial Relationship) | Daniel X. Hammer: Commercial Relationship: Code N (No Commercial Relationship) | Gadi Wollstein: Commercial Relationship: Code N (No Commercial Relationship) | Richard Bilonick: Commercial Relationship: Code N (No Commercial Relationship) | Ian Sigal: Commercial Relationship: Code N (No Commercial Relationship) | Larry Kagemann: Commercial Relationship: Code N (No Commercial Relationship) | Joel Schuman: Commercial Relationship(s);Zeiss:Code P (Patent);Zeiss:Code C (Consultant) 105 Poster Board Number: P26 Modeling the topography of the healthy human retina Author(s): Rui Bernardes1, 2, Silvia Simão3, Ana S. C.Silva2, Angelina Meireles4, João Figueira3,5 1 AIBILI - Association for Innovation and Biomedical Research on Light and Image, 2IBILI- Institute for Biomedical Imaging and Life Sciences, 3AIBILI - Association for Innovation and Biomedical Research on Light and Image, 4 Porto Hospital Center, 5Coimbra University Hospital Purpose: To model the topography of the healthy human retina and derive fitting parameters aiming to monitor changes due to retinal traction. Methods: Optical coherence tomograms of a population of 23 healthy controls aged from 46 to 79 yrs (avg/sd: 58.2/10.1 yrs) were acquired by the SD-OCT (Cirrus OCT, Carl Zeiss Meditec, Dublin, CA, USA), in a total of 43 eyes (22 left and 21 right eyes). Retinal thickness maps from these scans were co-registered to the RT-Atlas previously developed by our research group (OCT Thickness Mapping of the Human Macula, IOVS, May 2008, Vol. 49, No. 5, pp 2046-2052 ) aiming to correct the location and orientation of all scans to a common reference. In this reference, the center of the map (0,0) corresponds to the location of the fovea and the horizontal axis connects the center of the fovea to the center of the optic disc (positive increasing values towards the nasal side and negative values towards the temporal side). Each retinal thickness map was interpolated to a common grid and the data distribution analyzed at each grid point. Extreme values were removed at each grid point and the average retinal thickness was computed. A set of well-known functions were tested to mimic the topography of the resulting surface. Among others, combination of Gaussian and Cauchy distribution curves and a modified second-order quadratic surface were tested and the root mean-square error computed as the measure of the goodness of the fit. Results: A combination of 4 functions, in a total of 23 parameters, were determined allowing to mimic the average topography of the healthy human retina. The distribution of individual parameters, resulting from the fit of the mathematical model to each retina, presents an approximately normal distribution with an average kurtosis of -1.38 and an average skewness of 0.13. Conclusions: A mathematical model of the healthy human retina topography was determined based on a set of 4 functions in a total of 23 parameters. These parameters can be used to compare individual retina's topography to the healthy distribution for classification Purposes. Commercial Relationships Disclosure (Abstract): Rui Bernardes: Commercial Relationship: Code N (No Commercial Relationship) | Silvia Simão: Commercial Relationship: Code N (No Commercial Relationship) | Ana S. C.Silva: Commercial Relationship: Code N (No Commercial Relationship) | Angelina Meireles: Commercial Relationship: Code N (No Commercial Relationship) | João Figueira: Commercial Relationship: Code N (No Commercial Relationship) 106 Poster Board Number: P27 Preliminary evaluation of a prototype metabolic hyperspectral retinal camera in age related macular degeneration patients Author(s): Jean-Philippe Sylvestre1, Rachel Trussart2, Jean Daniel Arbour2 1 Optina Diagnostics, 2Université de Montréal Purpose: The aim of this preliminary study is to compare a novel hyperspectral retinal imaging modality, using a prototype metabolic hyperspectral retinal camera (MHRC), with conventional color fundus and optical coherence tomography (OCT) imaging in patients with wet-ARMD to establish early correlations between the spectral information and the known anatomical landmarks of the disease. Methods: Fourteen volunteers with diagnosed wet ARMD (10 females, average age 75 ± 7 yrs, no intra-ocular lens) had retinal images captured between 470-850 nm using a prototype MHRC (Optina Diagnostics, Montreal, Canada). The MHRC is based on a tunable laser source that permits the selection of a specific wavelength from a supercontinuum source with a spectral bandwidth of 2 nm (FWHM) and a precision < 1 nm. Typical acquisitions were obtained at a rate of 2-3 wavelengths per second. For comparison Purposes, a color fundus image and an optical coherence tomography (OCT) scan were also obtained using a 3D OCT-1000 (Topcon, Tokyo, Japan). Results: High definition retinal imaging at multiple wavelengths was obtained for all subjects. Spectral information could therefore be extracted from the datasets when sufficient quality images obtained at different wavelengths were available and registered satisfactorily. Pathological changes such as hyperplasia and atrophy of the retinal pigment epithelium (RPE) are enhanced when the retina is illuminated with red of near-infrared (NIR) light compared to color fundus images. Similarly, anatomical changes visible with OCT such as intraretinal and sub-RPE fluid, undetected with color fundus, were successfully highlighted at specific wavelengths with the MHRC. Drusen and lipid exudates are characterized by hypereflectance under visible and NIR illumination. Conclusions: The MHRC based on a tunable laser filter can provide anatomical and spectral information from the retina which could help in the automatic recognition of landmarks related to wet ARMD and ultimately contribute to the early detection and optimal management of the disease. Improvements to the prototype MHRC and analysis software are currently underway to significantly increase the acquisition speed (up to 27 wavelengths per second) and registration precision to permit extraction of spectral-rich information from all collected datasets. Commercial Relationships Disclosure (Abstract): Jean-Philippe Sylvestre: Commercial Relationship(s);Optina Diagnostics:Code E (Emplyment);Optina Diagnostics:Code I (Personal Financial Interest) | Rachel Trussart: Commercial Relationship: Code N (No Commercial Relationship) | Jean Daniel Arbour: Commercial Relationship(s);Optina Diagnostics:Code I (Personal Financial Interest) 107 Poster Board Number: P28 Quantitative autofluorescence (qAF) in pseudophakic normal and dry Age-related macular degeneration (AMD) patients Author(s): Camellia Nabati1, Jonathan Greenberg2, Dan Yoon1, Elana Rosenberg1, David Sackel1, Roland Smith1 1 Department of Ophthalmology New York University School of Medicine, 2Columbia University Purpose: Lipofuscin accumulates normally in the retinal pigment epithelium (RPE) with age, but its role in AMD is debated. We measured lipofuscin accumulation with qAF in vivo in elderly normal and AMD patients to shed light on this question. Methods: qAF was calibrated to the internal fluorescent reference in the Heidelberg Spectralis as previously described [Delori et al, Quantitative measurements of AF with the SLO. IOVS. 2011:9379-90.]. All patients were pseudophakic with clear posterior capsules and were dilated to >6.5mm. The transmission spectrum of the intraocular lens (IOL) was then used to calculate an integrated two-pass excitation and emission transmission relative to that of a 20 year-old phakic eye. qAF correction factors were typically 0.955 for blue light filtering IOLs and 0.825 for clear IOLs. Results: Mean (+/- SD) qAF units in 6 zones superotemporally in 22 eyes of 22 pseudophakic patients, ages 61 to 89, 1 late, 7 early AMD, 14 normal was 341 +/- 137 in normals and 277 +/- 32 (P = 0.10) in 8 AMD subjects of similar ages (Figure: normal, early, late). Interestingly, three zone qAF close to geographic atrophy (GA), (mean, 243) in an early GA patient, (arrow,E), was similar to three zone qAF close to GA (mean, 261) in the patient with established GA (arrow, F). Conclusions: In this small sample, a trend towards lower qAF in dry AMD subjects than in normals was observed, with a wide variability in both groups. A large study, with all pertinent environmental and genetic risk factors, is clearly warranted. Top row, original AF images, acquired with reference in place superiorly; bottom row, calibrated qAF images. A, 67 y/o F, normal; B, 86 y/o F with reticular pseudodrusen (RPD) and early signs of geographic atrophy (GA); C, 76 y/o F with established multilobular GA and RPD. Note that although the original AF image in C is brighter, when it is calibrated to the reference, also brighter, to give the qAF image, F, the qAF levels are now lower than the other two, D, E. The mean qAF in the 6 outer superior and temporal analysis zones are: 411, 357, and 269, respectively. The normal patient, although youngest, has the highest qAF; the oldest patient, with early GA and RPD is less, and the patient with established GA, the lowest qAF. Note that qAF in zones near GA in two subjects are similar (arrows, E, F). Commercial Relationships Disclosure (Abstract): Camellia Nabati: Commercial Relationship: Code N (No Commercial Relationship) | Jonathan Greenberg: Commercial Relationship: Code N (No Commercial Relationship) | Dan Yoon: Commercial Relationship: Code N (No Commercial Relationship) | Elana Rosenberg: Commercial 108 Relationship: Code N (No Commercial Relationship) | David Sackel: Commercial Relationship: Code N (No Commercial Relationship) | Roland Smith: Commercial Relationship: Code N (No Commercial Relationship) 109 Poster Board Number: P29 Comparison of Fundus Autofluorescence Imaging by 488 nm and 532 nm Confocal Scanning Laser Ophthalmoscopy in Central Serous Chorioretinopathy Author(s):Seong-Woo Kim2, Jaeryung Oh3, Cheol Min Yun1, Kuhl Huh1 1 Korea University, Guro Hospital, 2Korea Univeristy, Ansan Hopsital, 3Korea University, Medical center Purpose: To compare lesion characteristics between blue-light (488 nm) and green-light (532 nm) confocal scanning laser ophthalmoscopy (cSLO) autofluorescence (AF) of central serous chorioretinopathy (CSC). Methods: The lesion characteristics were compared between 488 nm and 532 nm cSLO fundus autofluorescence (FAF) images in acute CSC. The mean disease duration and subretinal fluid (SRF) height in the spectral domain optical coherence tomography were compared according to the FAF image characteristics. Results: The study included 63 eyes of 61 patients; 63 pairs of FAF images were compared before CSC resolution and 31 pairs of FAF images were compared after CSC resolution. Before CSC resolution, 48 (76.2%) images of acute CSC were hypo-AF to no change, 3 (4.8%) were hyper-AF, and 12 (19.0%) were mixed-AF in 488 nm FAF images whereas 9 (14.3%) images were hypo-AF to no change, 44 (69.8%) were hyper-AF, and 10 (15.9%) were mixed-AF in 532 nm FAF images (p<0.0001). There was no significant difference in the lesion composite pattern between the two FAF image wavelengths. Patients with lesions that were hyper-AF in 532 nm AF and hypo-AF in 488 nm AF had a shorter disease duration and greater SRF height than those who were hyper-AF in both 532 nm and 488 nm images. Conclusions: The two types of FAF image showed similar lesion characteristics in CSC. However, 532 nm AF imaging showed increased background AF in detached retina, whereas 488 nm AF imaging showed decreased background AF in acute CSC. 110 Commercial Relationships Disclosure (Abstract): Seong-Woo Kim: Commercial Relationship: Code N (No Commercial Relationship) | Jaeryung Oh: Commercial Relationship: Code N (No Commercial Relationship) | Cheol Min Yun: Commercial Relationship: Code N (No Commercial Relationship) | Kuhl Huh: Commercial Relationship: Code N (No Commercial Relationship) 111 Poster Board Number: P30 Cone photopigment distribution measured using green autofluorescence imaging Author(s): Kanako Itagaki, Kimihiro Imaizumi, Akira Ojima, Tetsuju Sekiryu fukusima medical univeicity Purpose: To evaluate the feasibility of using green autofluorescence imaging to measure cone photoreceptor's pigment distribution in normal subjects and patients with central serous chorioretinopathy (CSC). Methods: Twelve normal eyes of 12 subjects and 9 eyes with CSC were studied using autofluorescence imaging obtained using a confocal scanning laser ophthalmoscope (F-10, Nidek, Gamagori, Japan). Green autoflurescence was used (excitation :532 nm , Emi. > 555 nm), the angular field was 40°, and images were acquired at 6/images per second (corneal irradiance: 110 microW). Autofluorescence images for the light adapted state were obtained after 20 minutes of light adaptation in the room light. 60 images were taken continuously during 10 second. The photopigment topographical distribution was calculated from the difference of logarithms the averaged 5 images at the beginning and the end of image acquisition. The square area (300x300 pixels) centered at the fovea on the fundus image was evaluated. The photopigment density was normalized by the value at the adjucent healthy area in the eyes with CSC to compare the changes of the photopigment distribution during the course of the disease. Results: The distribution of the photopigment showed a concentric pattern in all of normal eyes. The mean density at the center of the fovea (0.23 log unit) was highest in the square. The mean photopigment density decreased gradually toward the edge of the area. The photopigment density at the center of the fovea in the eyes with serous retinal detachment was ranged -0.02 to 0.2 log unit. That incresed in 5 of 9 eyes (55%) after reattachment, whereas that decrease in the remaining 4 eyes (45%). Conclusions: The distribution of the photopigment showed a concentric pattern in all of normal eyes. The mean density at the center of the fovea (0.23 log unit) was highest in the square. The mean photopigment density decreased gradually toward the edge of the area. The photopigment density at the center of the fovea in the eyes with serous retinal detachment was ranged -0.02 to 0.2 log unit. That incresed in 5 of 9 eyes (55%) after reattachment, whereas that decrease in the remaining 4 eyes (45%). Commercial Relationships Disclosure (Abstract): Kanako Itagaki: Commercial Relationship: Code N (No Commercial Relationship) | Kimihiro Imaizumi: Commercial Relationship: Code N (No Commercial Relationship) | Akira Ojima: Commercial Relationship: Code N (No Commercial Relationship) | Tetsuju Sekiryu: Commercial Relationship: Code N (No Commercial Relationship) 112 Poster Board Number: P31 Fundus Autofluorescence to Identify Plaques and Diagnose and Follow Retinal Artery Occlusions Author(s): Yannis M. Paulus, Aazim Siddiqui, Adrienne W. Scott Wilmer Eye Institute, Johns Hopkins University Purpose: Retinal artery occlusions can require invasive testing with fluorescein angiography for diagnosis. The associated etiologic plaques are often difficult to identify. We examine the role of fundus autofluorescence (FAF) as a noninvasive imaging modality to identify plaques, diagnose, and follow-up of patients with retinal artery occlusions. Methods: A series of four patients who presented to a single tertiary care referral center were diagnosed with retinal artery occlusions. Fundus autofluorescence was performed along with conventional imaging and FAF characteristics were evaluated over time. Results: In all three patients who presented acutely, fundus autofluorescence demonstrated a sharply-demarcated region of hypoautofluorescence in the distribution of nonperfused retina in branch retinal artery occlusions that occured on initiation of symptoms. This region of hypoautofluorescence normalized and disappeared by 1 to 1.5 months after onset in all patients with long-term follow-up. In two patients without discernable plaques on examination or fundus photography, fundus autofluorescence showed a very bright hyperautofluorescent plaque that persists for at least a couple months and likely indefinitely for the duration of the plaque (Figures 1 and 2). The third patient had a visible plaque on physical exam that was not hyperautofluorescent. The fourth patient with a remote history of central artery occlusion had no identifiable plaque or hyper or hypoautofluorescence on FAF. Conclusions: In all three cases who presented acutely, FAF showed initial sectoral hypoautofluorescence of the nonperfused retina which resolves over 1 month. The etiology of the hypoautofluorescence may be secondary to inner retinal or ganglion cell thickening blocking the RPE autofluorescence, or the emission spectra of oxygenated and deoxygenated NADH and FAD. This is the first description of hyperautofluorescence of the arterial plaques in retinal artery occlusions that persists to at least 1.5 months later. Plaque components, such as calcium or cholesterol, could determine the plaque's autofluorescence characteristics. This technique could be a non-invasive alternative to fluorescein angiography to document retinal non-perfusion in retinal artery occlusions in patients without an easily identifiable plaque and may direct the embolic work-up to identify plaques, diagnose, and clinically follow retinal artery occlusions. Commercial Relationships Disclosure (Abstract): Yannis Paulus: Commercial Relationship: Code N (No Commercial Relationship) | Aazim Siddiqui: Commercial Relationship: Code N (No Commercial Relationship) | Adrienne Scott: Commercial Relationship: Code N (No Commercial Relationship) 113 Poster Board Number: P32 Infrared and Fundus Autofluorescence Imaging in the Evaluation and Monitoring of Peripheral Retinoschisis Author(s): Timothy Kao, Sandra R. Montezuma, Dara Koozekanani, Philip Turner, Torey Miller University of Minnesota Purpose: To describe the previously unreported appearance of peripheral retinoschisis with infrared (IR) and fundus autofluorescence (FAF) imaging. Methods: Patients at the University of Minnesota found to have peripheral retinoschisis underwent IR and FAF imaging in addition to color fundus photography and optical coherence tomography (OCT). IR and FAF images were obtained using a Heidelberg Spectralis HRA + OCT with 102 and 55 degree non-contact lenses, respectively. Retinoschisis was confirmed by clinical exam and OCT. Results: Five eyes of five patients with peripheral retinoschisis underwent peripheral IR imaging, and four also had peripheral FAF imaging. Peripheral OCT confirmed the presence of retinoschisis in all eyes. IR and FAF imaging in all but one eye showed retinoschisis as clearly demarcated areas of elevation with hypoautofluorescence, respectively. Subtler changes were seen in the last eye, which had more shallow retinoschisis. In most cases, IR and FAF imaging enabled better visualization of the retinoschisis borders compared to color photos, especially relative to retinal vascular landmarks and with media opacity, as demonstrated in one case with a cataract. Inner retinal holes were well visualized on IR imaging. In one case, the retinoschisis had a hyperautofluorescent border. Conclusions: Peripheral IR and FAF imaging are useful modalities that can supplement traditional Methods of evaluating and monitoring peripheral retinoschisis. This case series demonstrates how IR and FAF imaging may allow better discrimination of retinoschisis borders relative to retinal landmarks compared to color photos alone, especially in the presence of media opacities. As the collection of IR and FAF images in retinoschisis grows, further work will be done to identify features that correspond to chronicity and stability of retinoschisis. A. FAF image showing superotemporal hypoautofluorescence at site of retinoschisis with hyperautofluorescent border B. IR image showing clear edge of retinoschisis and inner retinal hole C. Color photo showing bullous retinoschisis D. OCT confirms retinoschisis 114 A. FAF image showing hypoautofluorescence inferotemporally at site of retinoschisis B. IR image showing clear edge of retinoschisis C. Retinoschisis is difficult to visualize on color photos D.OCT confirms retinoschisis Commercial Relationships Disclosure (Abstract): Timothy Kao: Commercial Relationship: Code N (No Commercial Relationship) | Sandra Montezuma: Commercial Relationship: Code N (No Commercial Relationship) | Dara Koozekanani: Commercial Relationship: Code N (No Commercial Relationship) | Philip Turner: Commercial Relationship: Code N (No Commercial Relationship) | Torey Miller: Commercial Relationship: Code N (No Commercial Relationship) 115 Poster Board Number: P33 False Negatives in the Delineation of Age-related Geographic Atrophy by Fundus Autofluorescence “ Author(s): David J. Ramsey1, Carol Applegate2, Janet S. Sunness2 1 Massachusetts Eye & Ear Infirmary, 2Greater Baltimore Medical Center Purpose: To demonstrate instances where, paradoxically, geographic atrophy (GA) is present on color photographs, but is not visible on fundus autofluorescence (FAF) images. Methods: Color fundus photographs and FAF images were analyzed for the study eye for each of 71 participants in a clinical trial for GA. Baseline, year 1, and year 2 images were analyzed. GA was outlined in the best macular image for each modality, and the findings were compared. Results: As is common, FAF often helped to distinguish small areas of GA from drusen, and often gave sharper borders of GA. Color fundus images were useful for defining the extent of foveal involvement, since blockage by xanthophyll darkens the foveal region and may mask the presence of spared areas. Color fundus images were also useful for determining that small areas with loss of FAF were indeed GA and not drusen. For 2 patients, there was atrophy in the foveal region that was not identified in the FAF image because of the pre-existing darkness of the central region. Surprisingly, for 3 patients (4%), there were significant areas of what appeared to be definite extrafoveal GA on color images that was not identified on FAF images. At baseline, these measured 3.3 mm2 in one patient and 3.0 mm2 in the second. The third patient had 2 areas, measuring 1.8 mm2 and 2.5 mm2. Over the followup, FAF began to show evidence of GA in these areas, but there was not complete agreement between FAF and the color even at 2 years. For 3 of the 5 patients, infrared reflectance images were available and they showed the GA that was missed on the FAF images. Conclusions: FAF is extremely sensitive for the presence of GA, but rarely there are regions that would clinically be considered GA and yet the FAF does not show loss of autofluorescence. Some complement to FAF is thus needed, and the IR reflectance image is likely to perform nearly as well as color images for delineating GA in difficult cases. Commercial Relationships Disclosure (Abstract): David Ramsey: Commercial Relationship: Code N (No Commercial Relationship) | Carol Applegate: Commercial Relationship: Code N (No Commercial Relationship) | Janet Sunness: Commercial Relationship(s);Acucela:Code C (Consultant);Advanced Vision Therapies:Code C (Consultant);Alcon:Code C (Consultant);Cell Cure:Code C (Consultant);Eyetech:Code C (Consultant);Genentech:Code C (Consultant);GSK:Code C (Consultant);Health Advances, LLC:Code C (Consultant);Jerini:Code C (Consultant);Johnson & Johnson:Code C (Consultant);Merck:Code C (Consultant);Neurotech:Code C (Consultant);Novartis:Code C (Consultant);Ophthotech:Code C (Consultant);Othera:Code C (Consultant);Pfizer:Code C (Consultant);Potentia:Code C (Consultant);Shire:Code C (Consultant);Sucampo:Code C (Consultant);ReVision:Code C (Consultant) 116 Poster Board Number: P34 Inexpensive 3D Telemedicine: Integrating smartphone technologies in an ophthalmological stereoscopic evaluation Author(s): Jorge-Emmanuel Morales-León Instituto de Oftalmologia Fundacion Conde de Valenciana IAP Purpose: To present a novel method of capturing and viewing stereoscopic ophthalmological pictures and videos of anterior and posterior segment using inexpensive smartphone technology applied to a common slit lamp. Methods: Smartphone slit lamp adapters have turned common slit lamps into powerful photographic devices. By using two simple smartphone adapters attached to slit lamp oculars and combining these with a voice-trigger application and a prism stereoscopic viewer, we can obtain high defintion state-of-the-art images of ophthalmic examination for different clinical applications using simple applied technology. Results: We were able to adapt this system to almost every kind of slit lamp available in our hospital and to send and recieve images taken with that method and viewing them in 3D. We will discuss the different clinical applications and implications of this kind of imaging. Conclusions: It is possible to obtain quality stereoscopic imaging of anterior and posterior segment by combining everyday technology props and mobile devices and applications. Commercial Relationships Disclosure (Abstract): Jorge-Emmanuel Morales-León: Commercial Relationship: Code N (No Commercial Relationship) 117 Poster Board Number: P35 Fundus mask and lens dust detection in retinal images with applications to automated diabetic retinopathy screening Author(s): Kaushal Solanki, Malavika Bhaskaranand Eyenuk, Inc. Purpose: Retinal images contain retinal information only in certain regions that can be identified by a fundus mask. Therefore it is essential that fundus masks are computed accurately to constrain further automated DR analysis to only regions with retinal information. Furthermore, lens dust artifacts are common in real-life retinal images and in many cases can be mistaken for lesions by both human readers and image analysis algorithms, possibly leading to incorrect diagnoses. These artifacts are caused either due to improperly cleaned lenses or light flares/reflections. In this work, we propose fully automatic algorithms to compute fundus masks and detect lens dust artifacts. Methods: We recognize that for all images captured during an encounter (given visit of a given patient), the fundus masks are identical and the lens dust manifest as persistent artifacts. We utilize these facts to compute the fundus mask and detect lens dust using computationally simple algorithms. The fundus mask is computed by first taking the differences between each pair of the images within the encounter, and then thresholding the median of differences. Lens dust detection is performed after normalizing the images using novel local background estimation to enhance the image. Differences of pairs of the normalized images are computed and a pixel is declared to be due to lens dust if the differences are small-valued and lie within a small interval. Results: The test image set consists of 836 images belonging to 165 encounters each with 4-8 images. Our fundus mask algorithm achieves high accuracy across this test set and Fig. 1 shows results for 3 encounters. The lens dust detection algorithm identifies artifacts ranging from prominently visible to faint as shown in Fig. 1. The algorithm parameters have been chosen so that true lesions are not mistakenly marked as lens dust. Conclusions: The proposed algorithms for detecting the fundus mask and lens dust artifacts in retinal images are accurate and computationally inexpensive. They can be used to inform automated DR analysis algorithms for improved performance. 118 Fig. 1: Fundus masks and lens dust masks for different encounters. The fundus mask is accurately detected. Various types of lens dust artifacts (indicated by arrows in images) are detected: lens flare (encounter A); large, dark artifact (encounter B); and faint lesion-like artifact (encounter C). Commercial Relationships Disclosure (Abstract): Kaushal Solanki: Commercial Relationship(s);Eyenuk, Inc.:Code E (Emplyment) | Malavika Bhaskaranand: Commercial Relationship(s);Eyenuk, Inc.:Code E (Emplyment) 119 Poster Board Number: P36 Non mydriatic hand held camera -An effective screening tool for diabetic population in hands of paramedical health workers Author(s): Sundaram Natarajan1, 2, Purva Valvekar1, Deepen Sheth1, Sunita Mohan2, Radhika Krishnan2, Pandurang Kulkarni1 1 Aditya Jyot Eye Hospital, 2Aditya Jyot Foundation for Twinkling Little Eyes Purpose: To bridge the gap between health care personnel through hand held camera for screening of diabetic slum population. Methods: Study design -Cross sectional Study period – 1 month Sample size- 100 known type 2 diabetic patients. Source of patients- Known Type 2 diabetic patients from the slum areas of Dharavi Research material- Hand held non mydriatic camera {Optomed Smartscope M5 , Optomed Oy (Ltd.), Oulu, Finland} and trained health care paramedical workers. Awarness among the slum population about diabetic retinopathy and its resulting visual loss was emphasized using fundus photographs. 100 known type 2 diabetic patients from the slum areas of Dharavi were screened by trained paramedical health workers. Data was analyzed by retina specialist for diagnosis & grading of diabetic retinopathy. Patients who required treatment were called to base hospital for further evaluation and management. Results: Prevalence of diabetic retinopathy was 14%. Around 3 % had sight threatening diabetic retinopathy requiring treatment. Conclusions: Diabetic retinopathy screening with a compact handheld non-mydriatic fundus camera improved the quality of care for diabetic patients in slums of Dharavi. This screening method was cost effective, easy tool to identify patients requiring prompt referral to the ophthalmologist for further complete eye examination and treatment. It was found possible to extend this screening to the door step through community health workers. Commercial Relationships Disclosure (Abstract): Sundaram Natarajan: Commercial Relationship: Code N (No Commercial Relationship) | Purva Valvekar: Commercial Relationship: Code N (No Commercial Relationship) | Deepen Sheth: Commercial Relationship: Code N (No Commercial Relationship) | Sunita Mohan: Commercial Relationship: Code N (No Commercial Relationship) | Radhika Krishnan: Commercial Relationship: Code N (No Commercial Relationship) | Pandurang Kulkarni: Commercial Relationship: Code N (No Commercial Relationship) 120 Poster Board Number: P37 Hand-held non-mydriatic digital fundus imaging for the detection of diabetic retinopathy Author(s): Steven R. Cohen, Grace E. Boynton, Cagri G. Besirli, Maria A. Woodward, Paula Anne Newman-Casey University of Michigan Purpose: To describe early experiences using a hand-held non-mydriatic digital fundus camera for diabetic retinopathy (DR) screening. Methods: In this prospective pilot study, diabetic patients underwent non-mydriatic, hand-held fundus imaging (Pictor, Volk®) followed by mydriatric ultrawide-field (UWF) imaging (Optos®) and dilated fundus examination by a retina specialist. Forty-five degree-field fundus images were obtained in 3 fields (posterior pole, nasal, superotemporal) prior to dilation using the hand-held digital imager. The hand-held fundus images were taken by both a certified ophthalmic photographer and a medical student not trained in ophthalmic photography. A single, masked retina specialist graded all images to assess image quality and presence of DR. Results: Twenty-three eyes (12 patients) underwent ophthalmic imaging. Patient ages ranged from 31-73 years and mean Hemoglobin A1c was 8.0 (6.0-14.0). No eyes had significant media opacities. Twenty-one of 23 (91%) UWF images were gradable. Of the 68 fields taken with the hand-held camera, 34 (50%) were gradable. Of the hand-held images taken by the ophthalmic photographer, 20/35 (57%) were gradable, while 14/33 (42%) of the images taken by the medical student were gradable. The nasal images had the poorest quality (9/23 gradable), while the superotemporal images had the highest quality (18/23 gradable). In 5 eyes, all 3 fields were gradable with the handheld camera. Of these 5 eyes, DR was accurately detected in 4 (80%). One patient had mild nonproliferative DR (NPDR) on exam that was not detected on fundus imaging. Of the eyes that had at least 1 gradable 45°-field, DR was accurately assessed in 14/18 (78%). Of the 4 eyes that were not accurately assessed, NPDR was present in 3 eyes on clinical exam. Of the 21 gradable UWF images, DR was accurately assessed in 19 (90%). Conclusions: Non-mydriatic, hand-held digital fundus imaging may have a useful role in DR screening in the future. Non-ophthalmic personnel can effectively perform the imaging, although the greater proportion of higher quality images taken by the ophthalmic photographer reveals the importance of strong training in this new screening modality. Used with appropriate training in a primary care setting or in underserved areas, hand-held imaging may provide a cost-effective screening method to serve the growing diabetic population. Commercial Relationships Disclosure (Abstract): Steven Cohen: Commercial Relationship: Code N (No Commercial Relationship) | Grace Boynton: Commercial Relationship: Code N (No Commercial Relationship) | Cagri Besirli: Commercial Relationship: Code N (No Commercial Relationship) | Maria Woodward: Commercial Relationship: Code N (No Commercial Relationship) | Paula Anne Newman-Casey: Commercial Relationship: Code N (No Commercial Relationship) 121 Poster Board Number: P38 Can Heidelberg MultiColor images be used interchangeably with color fundus photography for grading agerelated macular degeneration features? Author(s): Katie Graham3, Patrick Larkin2, 3, Katherine Alyson Muldrew2, 3, Vittorio Silvestri1, 3, Graham Young1, 2, Philip McIntyre1, Helen McAtamney1, Ruth E. Hogg3 1 Belfast Health and Social Care Trust, 2Queen's University Belfast, 3Queen's University Purpose: To characterize the appearance of age-related macular degeneration features (AMD) on Heidelberg MultiColor images(MCI) and then systematically compare their appearance with color fundus photography (CFP). Methods: Study design: Observational case series. Participants: 30 patients attending Macular clinics in Belfast and 30 participants from the Northern Ireland Cohort for the Longitudinal study of aging (NICOLA). Images were obtained after dilation using both CFP and cSLO MCI (Heidelberg Engineering, Germany) using standardized protocols. Color fundus photographs were assessed and clinical features of AMD noted (hard drusen, soft drusen, reticular pseudodrusen, geographic atrophy, haemorrhage and fibrosis), the constituent images from the cSLO imaging were assessed in turn (infrared(IR), green reflectance(GR), blue reflectance(BR) and composite MultiColor) and the presence or absence of the features noted on CFP was determined. Features present on MultiColor and absent on CFP were also noted. Test characteristics were determined and a matrix describing the appearance of AMD features on the different images was constructed. Examples of artefact’s were also collected. Results: A total of 99 eyes with gradable images were available for comparison (56 eyes from patients and 43 eyes from NICOLA study participants). Using CFP as the gold standard, sensitivity values for MCI ranged from 100% for fibrosis to 68% for soft drusen. Specificity values were high (95%+) for all features except hard drusen (75%). For all AMD features except haemorrhage there were instances where features were noted on MCI but not on CFP. When features were present on MCI their edges usually appeared more distinct than on CFP. Conclusions: Although sensitivity and specificity values were high for most AMD features it is unlikely that these technologies could be used interchangeably. Careful interpretation is also required given the different appearance of features on CFP and MCI. Given the improved definition of features on MCI it may prove most useful in situations where measurement of lesion size is important. Commercial Relationships Disclosure (Abstract): Katie Graham: Commercial Relationship: Code N (No Commercial Relationship) | Patrick Larkin: Commercial Relationship: Code N (No Commercial Relationship) | Katherine Alyson Muldrew: Commercial Relationship: Code N (No Commercial Relationship) | Vittorio Silvestri: Commercial Relationship: Code N (No Commercial Relationship) | Graham Young: Commercial Relationship: Code N (No Commercial Relationship) | Philip McIntyre: Commercial Relationship: Code N (No Commercial Relationship) | Helen McAtamney: Commercial Relationship: Code N (No Commercial Relationship) | Ruth Hogg: Commercial Relationship: Code N (No Commercial Relationship) 122 Poster Board Number: P39 Ultra high resolution imaging of subepithelial ocular pathologies Author(s): James R. Wong1, Madhura G. Joag1, Afshan A. Nanji1, Juan Murillo1, Nabeel M. Shalabi1, 2, Marwan A. Atallah1, Ibrahim Sayed-Ahmed1, Anat Galor1, 2, Carol L. Karp1 1 University of Miami Miller School of Medicine, 2Miami Veterens Affairs Medical Center Purpose: To describe subepithelial ocular pathologies using ultra high resolution optical coherence tomography (UHR OCT) Methods: Twenty five patients with subepithelial pathologies, consisting of 9 lymphomas, 4 lymphangiectases, 4 with Salzmann’s nodular degeneration (SND), 2 conjunctival amyloidoses, 2 corneal keloids, 2 anterior basement membrane dystrophies (ABMD), 1 vernal keratoconjunctivitis (VKC) with Horner-Trantas dots, and 1 benign lymphoid hyperplasia (BLH). Clinical features, slit-lamp photos and UHR OCT scans (RTVue premier, Optovue, Fremont, CA, USA) are described. Results: UHR OCT assisted in the diagnosis of the subepithelial lesions. In SND, small, hyperreflective, discrete, well-circumscribed, nodules occurred between the epithelium and Bowman’s layer, with thinning of the overlying epithelium. Changes in ABMD were very subtle in comparison, but similarly showed hyperreflective, moderately thickened, subtle subepithelial material extending anteriorly into the epithelium (Fig. 1). Corneal keloid appeared as a hyperreflective, inhomogeneous, elevated, well-circumscribed, space-occupying lesion with variable depth of involvement. In VKC, Horner-Trantas dots appeared as intermediately reflective lesions with variable depth and some intraepithelial involvement. Conjunctival amyloidosis appeared as a well-demarcated lesion with hyporeflective areas interspersed with areas of inhomogeneous hyperreflectivity. Lymphangiectasis appeared as hyporeflective spaces with hyperreflective borders suggestive of dilated channels (Fig. 2). Lymphoma appeared as a homogenous, hyporeflective lesion with small stippled, hyperreflective dots suggestive of a homogenous cellular infiltrate. BLH appeared similarly as a well-circumscribed, homogenous, hyporeflective lesion with some shadowing. However, these last two lesions could not be differentiated by UHR OCT. Conclusions: UHR OCT is a useful adjuvant tool in the diagnosis of subepithelial ocular pathologies Fig. 1. A: SND (arrows), B: corresponding UHR OCT shows hyperreflective material deposited above Bowman’s layer (arrow). C: ABMD (arrow), D: corresponding UHR OCT shows subtle hyperreflective material (arrows) 123 Fig. 2. A: Biopsy-proven conjunctival amyloidosis, B: corresponding UHR OCT shows interspersed heterogeneous hyporeflective (up arrow) and hyperreflective material (down arrow). C: Conjunctival lymphangiectasis, D: corresponding UHR OCT shows dilated lymphatic channel (arrow) Commercial Relationships Disclosure (Abstract): James Wong: Commercial Relationship: Code N (No Commercial Relationship) | Madhura Joag: Commercial Relationship: Code N (No Commercial Relationship) | Afshan Nanji: Commercial Relationship: Code N (No Commercial Relationship) | Juan Murillo: Commercial Relationship: Code N (No Commercial Relationship) | Nabeel Shalabi: Commercial Relationship: Code N (No Commercial Relationship) | Marwan Atallah: Commercial Relationship: Code N (No Commercial Relationship) | Ibrahim Sayed-Ahmed: Commercial Relationship: Code N (No Commercial Relationship) | Anat Galor: Commercial Relationship(s);Bausch + Lomb:Code C (Consultant) | Carol Karp: Commercial Relationship: Code N (No Commercial Relationship) 124 Poster Board Number: P40 Topographic analysis of outer retinal atrophy in type 2 idiopathic macular telangiectasia Author(s): Ferenc B. Sallo1, 2, Irene Leung1, Valérie Krivosic5, Vincent Rocco1, Kiyoko Gocho8, Michel Paques6, 7, Tunde Peto4, 1, Alan C. Bird3, Alain Gaudric5 1 Moorfields Eye Hospital, 2UCL Institute of Ophthalmology, 3Moorfields Eye Hospital, 4NIHR Biomedical Research Center for Ophthalmology, at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, 5Université Paris Diderot, Hopital Lariboisière, 6CHNO des Quinze-Vingts, 7Institut de la Vision , 8 Chiba Hokusoh Hospital, Nippon Medical University Purpose: Type 2 macular telangiectasia (MacTel) is associated with outer retinal abnormalities at and near the foveal centre. Optical Coherence Tomographic (OCT) topographic mapping of the IS/OS junction layer (or ellipsoid zone) is a validated method for assessing disease severity in MacTel. On OCT, the photoreceptor outer segment tips as well as the tight junctions between the photoreceptors and Muller cells are associated with clear signals (POST line or interdigitation zone and external limiting membrane, ELM respectively). Adaptive optics (AO) imaging offers a clarity and resolution superior to commercially available SD-OCT systems. Our aim was to examine outer retinal morphology using these two imaging modalities. Methods: Patients were selected from the MacTel Study cohort. OCT volume scans with 11-30µ B-scan intervals were acquired using Heidelberg Spectralis OCT units. Automated segmentation and topographic mapping of the POST (IZ), IS/OS (EZ) and ELM layers was reviewed and corrected manually. AO images of the fundus focusing on the photoreceptors were captured using an Imagine Eyes rtx1 unit. OCT topographic maps and AO images were superimposed and aligned. Lesions characteristic of the disease were analyzed in each imaging modality and results were compared. Results: Nineteen eyes of 10 MacTel patients (ranging in age 34-69 years, mean age 54.4, SD=14.1 years) were examined. In 3 eyes no break was seen in any layer on OCT and the photoreceptor mosaic was imaged clearly and appeared normal in AO images. 16 eyes demonstrated a defect in the IS/OS layer (EZ). Consistently, the POST (IZ) break appeared larger, the ELM break (if present) smaller than the break in the IS/OS (EZ). In AO images, areas corresponding to a break appeared featureless, their boundaries corresponded closest to those of the POST (IZ) break. Conclusions: AO imaging demonstrates abnormalities in the photoreceptor matrix corresponding to the defects in the outer retinal layers seen on OCT. A topographic analysis of the outer retina may adjunct current Methods and provide a tool for early detection as well as clues to the sequence of cellular degeneration in MacTel. Commercial Relationships Disclosure (Abstract): Ferenc Sallo: Commercial Relationship: Code N (No Commercial Relationship) | Irene Leung: Commercial Relationship: Code N (No Commercial Relationship) | Valérie Krivosic: Commercial Relationship: Code N (No Commercial Relationship) | Vincent Rocco: Commercial Relationship: Code N (No Commercial Relationship) | Kiyoko Gocho: Commercial Relationship: Code N (No Commercial Relationship) | Michel Paques: Commercial Relationship: Code N (No Commercial Relationship) | Tunde Peto: Commercial Relationship: Code N (No Commercial Relationship) | Alan Bird: Commercial Relationship: Code N (No Commercial Relationship) | Alain Gaudric: Commercial Relationship: Code N (No Commercial Relationship) 125 Poster Board Number: P41 Predicting Progression of Geographic Atrophy in Age-Related Macular Degeneration with Retinal Thickness Measurements using Spectral Domain Optical Coherence Tomography Author(s): Praveena Gupta2, Kevin Wells1, Vincent Nguyen3, Bernard F. Godley1, Gibran Khurshid1 1 University of Texas Medical Branch, 2UNiversity of Texas medical Branch, 3Teaxs A&M Health Science Center School of medicine Purpose: To test whether retinal thickness measurements, as measured by spectral domain optical coherence tomography (SD-OCT), can be utilized to predict the enlargement rate (ER) of geographic atrophy (GA) secondary to age related macular degeneration. Methods: Patients with the diagnosis of GA and 2 sets of imaging studies (fundus autofluorescence [FAF] and SDOCT) at least 6 months apart were identified. Fifteen eyes from 20 patients were included in this study. The ER of GA for each patient was determined utilizing FAF images. Retinal thickness measurements were determined by analyzing the patient’s initial SD-OCT B-scan that corresponded with the area of greatest GA in the linear X-axis. The retinal layer boundaries were identified and manually separated. Three separate zones for each retinal layer were analyzed: (1) the zone of GA, (2) the transition zone (200um lateral to the zone of GA), and (3) the peripheral zone (200um lateral to the transition zone). The average thickness of each of these zones was determined and was correlated with the ER of GA. All measurements were performed using the software ImageJ (NIH, Bethesda, MD). Results: The mean follow-up time was 2.64 years. The average ER of GA was 1.77mm2/year. When applying the square root transformation of the GA area measurements, the average ER was 0.30mm/yr. The combined thickness of the RPE and photoreceptor layer at the nasal transition zone inversely correlated with the square root transformation ER (Spearman r=-0.638, p=0.010, n=15). However, a photoreceptor layer was only identified in 9 of the 15 eyes at the nasal transition zone. The thickness of the photoreceptor layer in those 9 eyes inversely correlated to the square root transformation ER (Spearman r=-0.669, p=0.049, n=9). All other thickness measurements did not correlate with the ER. Conclusions: SD-OCT microstructure analysis of the transitional zone can provide unprecedented insight into the progression of the geographic atrophy. Such additional information can serve as a promising marker for disease monitoring and therapeutic interventions. Commercial Relationships Disclosure (Abstract): Praveena Gupta: Commercial Relationship: Code N (No Commercial Relationship) | Kevin Wells: Commercial Relationship: Code N (No Commercial Relationship) | Vincent Nguyen: Commercial Relationship: Code N (No Commercial Relationship) | Bernard Godley: Commercial Relationship: Code N (No Commercial Relationship) | Gibran Khurshid: Commercial Relationship: Code N (No Commercial Relationship) 126 Poster Board Number: P42 En-Face Analysis of Spectral Domain Ocular Coherence Tomography (SD-OCT) in Acute Multifocal Placoid Pigment Epitheliopathy (AMPPE) Author(s): Kanchan Bhan1, Adam Dubis1, 2, Carlos Pavesio1 1 Moorfields Eye Hospital, 2University College London Purpose: To establish what role En-face analysis in SD-OCT may have in diagnosis, monitoring and understanding the pathophysiology of AMPPE Methods: We present a case (within a series) of AMPPE on which pre and post treatment macular SD-OCT (Spectralis, Heidelberg) and En-face analysis (generating C Scans using Image J) was performed. SD-OCT images were correlated with En-face analysis and further correlation was undertaken with indocyanine green angiography (ICGA), fluorescein angiography (FA) and clinical examination. Results: Pre-treatment SD-OCT revealed acute phase hyper-reflectivity of the photoreceptor inner segment/outer segment (IS/OS) junction with multiple serous sub neurosensory retinal detachments bilaterally. Serous detachments contained hyper-reflective material. Acute phase En-face analysis revealed discrete hyporeflective areas at the level of the IS/OS junction which correlated positively with hypocyanescent areas on ICGA. These areas, in turn, correlated well with placoid fundus lesions visible clinically and on FA. Serous detachments also appeared as hyporeflective areas on En-face analysis with hyper-reflective material within at the former level of the IS/OS junction. Hyper-reflective spots within the choriocapillaris on ehanced depth imaging (EDI) SD-OCT were revealed. Post steroid treatment SD-OCT revealed decreased reflectivity of the IS/OS junction and resolution of sub retinal fluid. Post-treatment En-face analysis revealed thinning of the IS/OS junction and mottled increased reflectivity at this level which correlated with RPE changes visible clinically. Conclusions: En-face analysis of SD OCT correlates well with hypocyanescent lesions on ICGA diminishing the need for ICGA in diagnosis and disease monitoring. En-face analysis also enables accurate depth localisation of the pathophysiological process, in this case, suggesting that the IS/OS junction is involved in the acute process EDI findings suggest that the pathophysiology includes that of inflammation of the choriocapillaris. 127 Pre-treatment SD-OCT showing left serous sub retinal fluid with hyper-reflective material within correlating well with hypo-reflective area on en-face analysis<br /> <br /> Post treatment SD-OCT showing right IS/OS junction thinning correlating with mottled reflectivity on en-face analysis Commercial Relationships Disclosure (Abstract): Kanchan Bhan: Commercial Relationship: Code N (No Commercial Relationship) | Adam Dubis: Commercial Relationship: Code N (No Commercial Relationship) | Carlos Pavesio: Commercial Relationship: Code N (No Commercial Relationship) 128 Poster Board Number: P43 Optical Coherence Tomography (OCT) detects epiretinal membrane formation after intravitreal injection of anti VEGF in cases of Diabetic macular edema Author(s): Soheir Mahmoud Ali Cairo University Purpose: To assess the frequency of formation of epiretinal membrane after intravitreal injection (IV) of ranibizumab (Lucentis) and bevacizumab (Avastin) in cases of Diabetic macular edema using spectral domain OCT Methods: The study included 60 eyes of NPDR having Diabetic macular edema that required intravitreal injection of anti VEGF. Each eye had full ophthalomological examination ( best corrected visual acuity,anterior segment examination, intraocular pressure measurement, fundus examination) then OCT was performed for each eye to record central foveal thickness, juxtafoveal thickness in the four quadrants, presence of cystoid spaces. Exkusion criteria were: #Previous intraocular surgery, or intravitrel injections or laser treatment. #Presence of epiretinal membranes or vitreoretinal traction.#Elevated IOP. Eyes were divided into two groups each of 30 eyes. Group I had IV injection of Lucentis and Group II had Iv injection of Avastin. Recording epiretinal membrane formation or vitreoretianl surface changes was performed by OCT at 1,2 and 3 months after injections. Results were recorded , correlated to IS/OS integrity and retinal thickness then statistically analyzed. Results: After 1 month ERM was detected in 72% of cases of group 1 and 70% of group 2. After 2 month ERM was detected in 76% of cases of group 1 and 74% of group 2. After 3 months no significant chages were detected compared to features after 1 and 2 months. Fragmented ERM was 20% in gp1 and 26% in Gp 2. Thightly aherent ERM was 30% in Gp1 and 35% in Gp2. Cleavage lines were detected in 30% in GP1 and 28% in Gp2. Free edges were detected in 40% in Gp1 and 35% in Gp2. Vitreoretinal traction was detected in 10% in GP1 and 12% in Gp 2. No significant correlation was detected with IS/Os segment regularity in both GPs. Conclusions: OCt can successfully detect ERM fomation as a complication after IV injection of antiVEGf which was highly significantly detected. ERM formation percentage was more after Avastin than after lucentis injection but the results did not show high significant difference. Commercial Relationships Disclosure (Abstract): Soheir Mahmoud Ali: Commercial Relationship: Code N (No Commercial Relationship) 129 Poster Board Number: P44 Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Chinese Normal Highly Myopic Eyes Author(s): Fenghua Wang2, 1, Yanping Zhou1, Xiaodong Sun1 1 Shanghai Firist People's Hosptial, 2Shanghai First People Purpose: To investigate the choroidal thickness and characteristics by enhanced depth imaging optical coherence tomography (EDI OCT) in the subjects of high myopia with good corrected visual acuity. Methods: 55 subjects were recruited, from whom 91 eyes were diagnosed as high myopia with best corrected visual acuity (BCVA) equivalent to 20/20. Subjects were scheduled for a spectral-domain optical coherence tomography (SD-OCT) scanning with a HD line Raster in two directions (Horizontal & Vertical) with the enhanced depth imaging technique. The choroidal thickness (CT) was manually measured in 12 locations (0.5mm, 1.5mm and 3mm away from the fovea in four directions). Furthermore, the central foveal retinal thickness (CFRT) and the central subfoveal choroidal thickness (CSFCT) were also analyzed for their correlations with age and axial length (AxL). Results: Mean age of the 55 subjects (91 eyes) is 35.7±10.7 years old, mean spherical equivalent refraction is 8.56±1.61D, and mean AxL is 26.97±0.87mm. The mean central foveal retinal thickness was 106.8±5.4μm and was the thinnest both in vertical and in horizontal direction. The mean central subfoveal choroidal thickness is 173.6±57.4μm, negatively correlated with age and axial length. Horizontally, choroidal thickness became thinner from the temporal side to the nasal side. The choroid was thinnest at 3.0 mm nasally away from the fovea, while the CSFCT was thinnest in vertical direction. Conclusions: In the eyes without myopic maculopathy, the foveal retinal thickness of normal highly myopic eyes remains in the normal range. Nevertheless, the central subfoveal choroidal thickness of highly myopic eyes decrease compared with normal eyes. Choroidal thinning is related with high myopia which may be a useful diagnostic parameter for high myopia and even a predictor to monitoring the continuing progress of pathological myopia. Commercial Relationships Disclosure (Abstract): Fenghua Wang: Commercial Relationship(s);Carl Zeiss Meditec:Code C (Consultant);Heidelberg Engineering:Code R (Recipient) | Yanping Zhou: Commercial Relationship: Code N (No Commercial Relationship) | Xiaodong Sun: Commercial Relationship: Code N (No Commercial Relationship) 130 Poster Board Number: P45 Optical Coherence Tomography (OCT) to Detect Disease Progression in Birdshot Chorioretinopathy (BCR) – A Novel Multi-View Approach Author(s): William R. Tucker1, Gregory Short2, Robert Nussenblatt1, Nida Sen1 1 NEI, 2National Institutes of Health Purpose: To highlight a valuable ability of Spectral Domain OCT scanners to non-invasively show retinal vascular leakage during the treatment and monitoring phases of BCR. OCT guided detection and monitoring of uveitic macula edema secondary to BCR is well established, however fluorescein angiography (FA) is the accepted gold standard for identifying the posterior pole vascular leakage common during disease recrudesence. We aim to demonstrate that simple, safe, quick OCT techniques can provide similar information. Methods: Five BCR patients were selected for inclusion and follow-up in this pilot study. As part of their standard of care at each visit they received a fovea centered OCT macula cube 512 x 128. In addition a macula cube was obtained centered on the optic disc, superotemporal arcade and inferotemporal arcade. The standard software was able to compare retinal thickness differences between visits and highlighted areas of thickening or thinning next to the vessels as demonstrated in Figure 1. Perivascular thickening suggestive of increased vascular leakage was confirmed with subsequent FA. Results: Mean length of follow-up during which the OCTs were obtained was 7 months (range 4 to 24 months). During this time 4/5 patients experienced a disease flare with increased symptoms, worsening FA findings and functional testing (e.g. Visual field testing). 5/5 patients also had periods of disease remission after initiation of higher dose treatments. OCT was able to detect perivascular thickening during disease flares and thinning during disease remission. Conclusions: Modern OCT scanners have the ability to precisely measure retinal thickness, with software that can detect subtle changes between visits. We hope to highlight a simple yet novel adaptation of scanning technique which can provide clinically important information. In disease entities like BCR, characterized by posterior pole vascular leakage, it can be used to detect recurrence, guide the need for FA and monitor the response to treatment. 131 Figure 1: A) Multi-view OCT thickness map of right eye in an asymptomatic BCR patient on oral prednisone 20mg once daily B) OCT map 2 months later following taper of prednisone to 7.5mg and return of symptomatic floaters C) Thickness comparison map demonstrating perivascular retinal thickening, confirmed on FA (not shown) as secondary to vascular leakage Commercial Relationships Disclosure (Abstract): William Tucker: Commercial Relationship: Code N (No Commercial Relationship) | Gregory Short: Commercial Relationship: Code N (No Commercial Relationship) | Robert Nussenblatt: Commercial Relationship: Code N (No Commercial Relationship) | Nida Sen: Commercial Relationship: Code N (No Commercial Relationship) 132 Poster Board Number: P46 Inferior chiasmal syndrome diagnosed by Optical Coherence Tomography (OCT) before any visual field defects Author(s): Shawkat S. Michel1, Monica Michel2 1 ophthalmology, Alberta, Canada, 2Akron General Hospital Purpose: Optical Coherence Tomography (OCT) is widely used to study the macula and the retinal nerve fiber layer (RNFL). Axons of the retinal ganglion cells form the RNFL that converge onto the optic nerve. These nerve fibers run a long course in the orbit and intra-cranial to end at synapsis with the nerve cells of the lateral geniculate body (visual fibers) or the nerve cells of the pretectal nucleus (pupillary fibers). Along their long course the nasal RNFs decussate at the optic chiasma and go to the opposite optic tract. OCT provides invaluable information about the structure and function (anatomy and physiology) of these long RNFs through its scanning of the RNFL and accurately computing the thickness of the RNFL all around the optic disc. Methods: This is a case study of a 36 year old male who complained of frequent headaches and whose OCT showed abnormal thinning of the RNFL in exactly corresponding points inferiorly in each eye; the patient did not have glaucoma. The striking point that led to the thought of an inferior chiasmal syndrome was that RNFL thinning was in exactly corresponding points in each eye and there was also a great degree of symmetry as to the shape and size of the area of the thin RNF (please see OCT image). Octopus eighty degrees static visual field test was repeatedly normal in both eyes. Due to the RNFL defects in both eyes in this OCT I requested a pituitary MRI that showed pituitary adenoma of significant size and the patient had partially hypophysectomy through the nasal route. Results: Interpreting results of OCT must take in account the anatomy, physiology and pathology of different layers of the retina and the RNFL. Because the RNFs extend a long course from the retina ganglion cells through the optic nerve, the optic chiasma and the optic tract; invaluable information may be obtained by carefully interpreting scans of the RNFL. Conclusions: There have been some papers looking into OCT importance in the prognosis of cases that had resection of pituitary adenomas. To the best of my knowledge there has been no papers talking about the possibility of diagnosing pituitary enlargement by OCT. 133 This OCT made me think of possible inferior chiasmal syndrome; pituitary MRI showed significant enlargement of the pituitary gland. Commercial Relationships Disclosure (Abstract): Shawkat Michel: Commercial Relationship: Code N (No Commercial Relationship) | Monica Michel: Commercial Relationship: Code N (No Commercial Relationship) 134 Poster Board Number: P47 Assessment of choroidal metastases with the Enhanced Depth Imaging Optical Coherence Tomography Author(s): Efthymia Pavlidou1, Amit Arora1, Victoria Cohen1, Mandeep S. Sagoo1, 2 1 Moorfields Eye Hospital & Bart's and the London Hospital, 2UCL Institute of Ophthalmology Purpose: To assess and describe the imaging features of choroidal metastases with the enhanced depth imaging optical coherence tomography Methods: Case series of patients with choroidal metastases Results: 20 eyes of 14 patients with choroidal metastases underwent full ophthalmological examination and imaging with enhanced depth imaging- optical coherence tomography. 5 patients had primary breast cancer, 6 patients had primary lung cancer, 2 had prostate cancer and 1 patient had carcinoid metastatic lesions. All the cases (100%) presented clumps of hyperreflective deposits in the subretinal space and/or in the vascular choroidal layers in variable degree. Subretinal fluid was present in 18 eyes (90%). The RPE / choriocapillaries complex showed multiple, consecutive elevations causing a lumpy appearance in all the cases. The layer of the choriocapillaries was almost diminished, while the major vascular choroidal layers appeared mainly as dilated hyporeflective lobules in cases with prostate cancer followed by cases of breast and lung cancer. Secondary deposits from prostate and breast cancer appeared more lobulated whilst those from lung cancer were more diffuse. Conclusions: The enhanced depth imaging optical coherence tomography shows characteristic imaging patterns in cases with choroidal metastases. These images can contribute to the diagnostic approach but further studies need to establish its role better Commercial Relationships Disclosure (Abstract): Efthymia Pavlidou: Commercial Relationship: Code N (No Commercial Relationship) | Amit Arora: Commercial Relationship: Code N (No Commercial Relationship) | 135 Victoria Cohen: Commercial Relationship: Code N (No Commercial Relationship) | Mandeep Sagoo: Commercial Relationship: Code N (No Commercial Relationship) 136 Poster Board Number: P48 Development of Imaging Biomarker Algorithms to Assess Drug Efficacy and Predict Responders Author(s): Kristie Lin1, Tom Chang1, Allen Ho2, Rami Mangoubi3, David O'Dowd3, Nathan Lowry3, Lei Hamilton3, John Irvine3, Sicco Popma4 1 Retina Institute of California, 2Wills Eye Hospital, 3C.S. Draper Laboratory, 4Janssen Research and Development Purpose: Investigate the potential of retinal image based algorithms to assess drug efficacy and response prediction. Methods: Quantitative statistical features were extracted from OCT and SLO images and were correlated to changes in Best Corrected Visual Acuity (BCVA) observed in a clinical study. Images and BCVA were drawn from 2 patient visits: the pre-procedure visit, and one post-procedure visit. Six biomarkers were mined from these images and statistically analyzed individually. Algorithms were then applied to statistically fuse/pair features from promising biomarkers to more accurately predict procedure success, and explain efficacy. The resulting algorithms were tested for their ability to correctly classify 25 subjects into three categories: significant improvement (>15 letters of BCVA), moderate improvement (0 to 15 letters of BCVA), and no improvement (<0 letters of BCVA). Results: Six biomarker features were selected, which generated 384 statistical features. Linear regression analysis showed a relationship between changes in features value and BCVA. Three of the regression values positively correlated with BCVA (between 0.22 and 0.38) and three others were inversely correlated (between -0.11 and 0.44). Individually, none of the 384 fused features separated the subjects into the 3 classification groups reliably. However, 1300 paired features were identified as potential biomarkers of value (p=<0.02). Applying these pairing exploratory algorithms to the subject data (n=25) showed approximately 200 pairs correctly classified 20 out of the 25 subjects (80%) and 32 pairs correctly classified 22 out of 25 subjects (88%). Independent, masked, statistical analysis showed that these paired features were twice as significant compared to random data, thus increasing confidence in the algorithms. Conclusions: Results demonstrated that mined individual statistical imaging features are combinable into fused/paired features, enabling classification results among the 3 categories; significant, moderate and no improvement of BCVA. Future studies will focus on a larger sample size and automation of image feature extraction to verify the algorithms in assessing efficacy and response prediction. However, initial imaging algorithms are promising for prediction and efficacy. Commercial Relationships Disclosure (Abstract): Kristie Lin: Commercial Relationship(s);Janssen Pharmaceuticals, Inc:Code C (Consultant);Thrombogenics :Code C (Consultant) | Tom Chang: Commercial Relationship(s);Janssen:Code C (Consultant) | Allen Ho: Commercial Relationship(s);Janssen:Code C (Consultant);Alcon:Code F (Financial Support);Allergan:Code F (Financial Support);NIH/NEI:Code F (Financial Support);Ophthotech:Code F (Financial Support);Regeneron:Code F (Financial Support);Thrombogenics:Code F (Financial Support);Digisight:Code C (Consultant);Endooptiks:Code C (Consultant);Genetech:Code C (Consultant);Regeneron:Code C (Consultant);Thrombogenics:Code C (Consultant);Alcon:Code C (Consultant);Allergan:Code C (Consultant);PRN:Code C (Consultant);Second Sight:Code F (Financial Support) | Rami Mangoubi: Commercial Relationship(s);Janssen:Code F (Financial Support) | David O'Dowd: Commercial Relationship(s);Janssen:Code F (Financial Support) | Nathan Lowry: Commercial Relationship(s);Janssen :Code F (Financial Support) | Lei Hamilton: Commercial Relationship(s);Janssen:Code F (Financial Support) | John Irvine: Commercial Relationship: Code N (No Commercial Relationship) | Sicco Popma: Commercial Relationship(s);Janssen Research and Development:Code E (Emplyment) 137